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Abstract 
Recently, there has been a rise in the incidence of neonatal infections among babies born with 
low birth-weights and under-developed immune systems in neonatal intensive care units 
(NICUs). There are several risk factors to neonatal infection, the most important of which include 
the use of medical devices such as nasogastric enteral feeding tubes (NEFTs) and through 
contamination of infant feeding formula. Therefore, bacterial analysis of feeding tubes used in 
the NICU is important to identify infection risk factors during neonatal enteral feeding.   
The aims of this study were (a) to determine the potential risk to neonates posed by ingestion 
of A. baumannii and Enterobacter spp., in particular E. hormaechei either through feeding tubes, 
infant formula, or by contaminated milk, (b) to determine whether some of the isolated strains 
originate from common sources, such as being transferred between the babies within specific 
neonatal units. Additionally, a longitudinal study for premature twin babies aimed to compare 
potentially pathogenic E. faecium isolates within and between the feeding tubes and faeces of 
twin babies over time.  
PFGE indicated that all of the A. baumannii strains formed two different STs (ST193 and ST113). 
All ST113 strains were multidrug-resistant and demonstrated an ability to form significant 
biofilms at 37 °C in infant formula. Tolerance of acidic conditions, desiccation, resistance to 
human serum and persistence inside macrophages were shown by the majority of strains tested. 
E. hormaechei strains from feeding tubes exhibited similar behaviour to those isolated from 
sepsis cases, since both were able to adhere to and invade Caco-2 and HBMEC cell lines. Also, 
these strains were able to persist and replicate inside macrophages for up to 72 hours. 
In the longitudinal study, all isolates of E. faecium isolated from preterm infant twins during their 
hospitalisation in the NICU were typed as ST80, belonging to clonal complex CC17. Furthermore, 
they were resistant to ampicillin and were found to carry several virulence-associated genes 
such as esp.  All of these strains were found to be essentially the same strain based on their 
sequence type and genomic analysis and were shown to have high pathogenic potential. These 
strains isolated from different neonatal locations were indeed the same clone, showing that the 
bacteria were able to persist and be transferred between the two premature infants in the NICU. 
This study has provided evidence of colonisation and persistence of opportunistic ESKAPE group 
pathogens in neonatal feeding tubes, which are important causes of nosocomial infection and 
dissemination of multidrug-resistant (MDR) strains. 
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Chapter 1 Introduction 
 
1 
 
Chapter 1. Introduction 
The most susceptible period of a new-born’s life is during the first four weeks after birth. 
This period is considered to pose the highest risk and is a very critical period for neonatal 
survival with regard to infection. There were approximately 2.6 million cases of neonatal 
mortality in the first month of life in 2016 worldwide. Neonatal death can result 
from premature birth, problems in pregnancy during labour and delivery, as well as the 
result of infections such as meningitis, pneumonia and sepsis (WHO, 2017). According 
to the World Health Organisation (2018), 75% of all neonatal mortalities in 2017 
occurred during the first week of their life. One million neonates died within the first 
day, while in the next six days approximately another one million died. 
United Nations Sustainable Development (2017) and UNICEF (2017) reported that the 
annual death rate of children before reaching their fifth year had dropped in 2015 by 
almost half (53%) when compared to the same statistics from 1990. The neonatal 
mortality rate over the same period has dropped by 47%.  Despite the reduction in 
mortality rate among new-borns and children in recent decades, there has been no 
significant decline in infant mortality rate during the first week of their life. The World 
Health Organisation (WHO) reported that  46% of all neonatal deaths under the age 5 in 
2016 were caused by preterm birth complications, congenital anomalies, intrapartum-
related complications, acute respiratory infections, anomalies and diarrhoea, as shown 
in Figure 1-1. However, premature birth, or low birthweight, is one of the major risk 
factors recognised for neonatal deaths. According to the National Statistical Institute of 
the UK (2017), the infant mortality rates increased by 2.3% in 2015 compared to 2014 in 
England and Wales (Patel, 2015). Furthermore, a report by the national press 
highlighted events in the UK, which indicated that nosocomial infections and sepsis 
infections are associated with significant morbidity in preterm neonates in neonatal 
intensive care units NICUs. 
 
Figure 1-1 Causes of death among of neonates and children under the age of five in 
2016 according to the WHO. Source: 
http://www.who.int/gho/child_health/mortality/causes/en/ 
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1.1. Infectious diseases in neonates 
Neonates kept in NICUs are highly susceptible individuals within the paediatric group, 
particularly pre-term neonates with low birth-weights and under-developed immune 
systems. The risk of infection to immunocompromised neonates increases with 
prolonged hospitalisation where a wide variety of medical devices are used. There is also 
increased chance of acquiring nosocomial infections including pneumonia, bloodstream 
infections, meningitis and urinary tract infections among hospitalised infants. 
Nosocomial infections remain one of the major risk factor for morbidity among neonatal 
NICUs (Mohammed and El Seifi, 2014; Rameshwarnath and Naidoo, 2018).  
The NICU environment is recognised as a potential major source of infection to the 
neonates. It may play a significant role in harbouring reservoirs of clinically important 
pathogens. A study carried out by Tajeddin et al. (2016) isolated Staphylococcus 
aureus, Acinetobacter baumannii and vancomycin-resistant enterococci from 
healthcare workers and environmental surfaces in the NICUs in Tehran. Their results 
demonstrated that these bacteria are possibly associated with hospital acquired 
infections (HAIs)  
Another study carried out at Nottingham Trent University (Hurrell et al., 2009a; 2009b) 
demonstrated that neonatal enteral feeding tubes are prone to rapid colonisation by a 
wide variety of opportunistic pathogens of the Enterobacteriaceae, irrespective of 
feeding regime. Indeed, the environmental contamination issue may be a greater 
challenge in the NICU. Equipment and environmental surfaces in the NICU are more 
likely to harbour a high diversity of bacteria associated with nosocomial 
infection in neonates (Hewitt et al., 2013). For example, one of the most frequent 
nosocomial infections is neonatal sepsis. The incidence of this infection occurring in 
neonatal intensive care units is increasing due extended periods of hospitalisation of 
infants (Sadowska-Krawczenko et al., 2012). 
Infants dying within the first week of life is largely attributed to cross-infection through 
microbial contamination of inanimate surfaces, medical devices and the indoor 
environment (Sankar et al., 2016). However, babies born in developing countries are at 
a 3 to 20 times higher risk of bacterial infections compared to those born in developed 
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countries. This may be due to a lack of qualified hospital staff, unhygienic delivery care, 
poor availability of basic requirements such as sterilised tools, and lack of education 
(WHO, 2010).  
Bacterial infections cause serious diseases such as meningitis, sepsis (early or late onset), 
pneumonia and other respiratory infections. For example, neonatal sepsis is a blood 
infection that represents a significant cause of neonatal mortality and morbidity globally, 
particularly in preterm infants with a very low-birth weight (< 1500 g) 
(Shah and Padbury, 2014; Cortese et al., 2016). Sepsis is known as a systemic 
inflammatory response to pathogenic infection, however, the presence of bacteria in 
the blood is termed bacteraemia (Christaki and Bourboulis, 2014). Early-onset sepsis 
(EOS) normally occurs during the intrapartum period due to the transmission of bacteria 
from mothers to infants during the intrapartum process. Whereas late onset sepsis type 
(LOS) is defined as infection that occurs beyond 72 hours from birth, as a result of 
environmental contamination and lack of hygiene by the care providers in the NICU. 
(Shah and Padbury, 2014; Cortese et al., 2016; Mohseny et al., 2018). 
1.2. Bacterial exposure to neonates through Infant Formula   
Breast milk is recognised as the best sole source of nutrition for infants (Martin et al., 
2016). It is recommended by the WHO (2007) that infants are exclusively breastfed for 
the first six months of life, however, human milk may be associated with outbreaks of 
infection in NICUs through collecting, storing and handling, or contamination of medical 
equipment (Cossey et al., 2011; Mense  et al., 2014; Keim et al., 2015). Despite the 
benefits of breast milk in that it contains important factors required for infant growth, 
infant milk formula can be used when breastfeeding is not sufficient, possible or 
desirable. However, powdered infant formula (PIF) product is an unsterile product. 
Although strict and regular control measures are in place for pathogens in the 
manufacture process, low levels of contamination by pathogens may still occur in PIF 
and cause outbreaks of disease. An example of such outbreaks was reported by Acker 
and colleagues (2001) in a NICU in Belgium, where preterm infants with low birth-
weights were fed infant formula contaminated with Cronobacter species. Similarly, an 
outbreak that occurred in Spain (2008) was reported to be associated with the 
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consumption of contaminated infant formula (Rodrígue et al. 2010). Recently, another 
outbreak was reported by the European Centre for Disease Prevention (ECDC) and 
Control and European Food Safety (EFSA) in 2018. This French outbreak affected 39 
neonates and was associated with the consumption of infant formula contaminated 
with Salmonella Agona. 
The Gram-negative organisms, Salmonella and C. sakazakii, have received more 
attention due their association with contaminated PIF and tendency to cause neonatal 
infections (Barron and Forsythe, 2007; Holý and Forsythe, 2014). It is notable that C. 
sakazakii has been isolated from milk powdered infant formula from several countries 
such as China, Germany, Chile and Malaysia (Sani al., 2014; Akineden et al., 2017 Fei et 
al., 2017; Parra-Flores et al., 2018). Also, C. sakazakii strains have shown a strong ability 
to persist in PIF for more than 1 year (Osaili et al., 2009).  Most of the Cronobacter 
species are thermo-tolerant, particularly C. sakazakii, which can survive the production 
process and can be found in PIF as a contaminant after the pasteurisation process (Osaili 
et al., 2009; Kalyantanda et al., 2015). However, other members of the 
Enterobacteriaceae have also been linked to infant infections by WHO-FAO 
microbiological risk assessments of PIF (FAO-WHO, 2004). Enterobacteriaceae members 
that have previously been found to be present in PIF include E. hormaechei, E. cloacae, 
E. cowanii, E. coli, C. freundii, K. oxytoca, and K. pneumoniae (Muytjens et al., 1988; 
Townsend et al., 2008b; Araújo et al., 2015). For instance, 32 out of 75 PIF samples 
collected from pharmacies in Italy were contaminated by Enterobacteriaceae, including 
E. hormaechei and C. freundii (Giammanco et al., 2011). 
Acinetobacter species are also considered as a cause for concern and were later included 
under category B (FAO-WHO, 2006). A study by Araújo et al. (2015) indicated the 
presence of Acinetobacter baumannii-calcoaceticus complex in infant milk formula in 
Brazil. In another study by Cho et al. (2018), it was reported that 
47 Acinetobacter isolates from milk powder samples in Germany were obtained directly 
from the end of the production line of a powdered milk producer company. Indeed, 
there are several studies have reported that of numerous bacteria have been isolated 
from PIF. For example, a study conducted by Forsythe et al. (2005) showed that the most 
common organisms isolated from PIF were members of the Enterobacteriaceae, 
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Clostridium perfringens, Bacillus cereus and S. aureus. However, a meeting by the 
FAO/WHO (2004) addressed and reported the potential risk of a variety of 
microorganisms in PIF, and in addition, the meeting had assigned two other categories 
of microorganisms in PIF. These categories were created on the basis of the evidence of 
a causal association between the presence of these microorganisms in PIF and illness in 
neonates. The reorganised categorisation is shown in Table 1-1. The persistence of 
pathogens in PIF is of concern due to the risk of neonatal infection by the ingestion of 
these organisms and the reduced immunocompetence of neonates (FAO-WHO, 2006).  
 
 
Table 1-1 Categorisation of microorganisms in PIF depends on their strength of illness in 
infants. 
 
This table was adapted from FAO/WHO, (2004), * in 2008, the name Enterobacter sakazakii was amended 
to Cronobacter genus 
Rehydration of infant feeding formula with water at 70 °C or above, was recommended 
by WHO and FAO to decrease the proportion of viable bacteria. Nevertheless, this 
instruction has not been feasible for small volume feeds as required for premature 
neonates, and is not adopted by all countries (Holy and Forsythe, 2014). In recent years, 
contamination of PIF is more likely to occur due to the preparation environment or from 
the staff responsible for preparing the feed than from the manufacturing process 
(FAO/WHO 2004). However, feeding equipment can be a source of infection through 
collecting, storing and handling or contamination of equipment through inadequately 
cleansing. It is a potential health risk to neonates, particularly among premature babies 
in NICUs who lack a developed immune system, and are at greater risk. 
1.3. Bacterial exposure through neonatal feeding tube 
Enteral feeding tubes are medical insertion devices used to feed infants, in particular 
premature infants who are unable to swallow milk. These tubes must be sterile and as 
clean as other medical inserting devices. However, a previous study by Hurrell et al. 
(2009b) revealed the presence of pathogenic bacteria in nasogastric enteral feeding 
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tubes from infants on non-formula feeding regimes. This showed that infants expose to 
Cronobacter was not exclusively through the consumption 
of reconstituted infant formula, but exposure to such pathogens might also be 
associated with general feeding practices. The same authors also reported that neonatal 
enteral feeding tubes are prone to rapid colonisation by a wide variety of opportunistic 
pathogens of the Enterobacteriaceae, irrespective of feeding regime. The most common 
isolates included E. hormaechei, E. cancerogenus, K. pneumoniae, S. marcescens, 
Escherichia coli, Cronobacter species and Yersinia enterocolitica (Hurrell et al., 2009a; 
2009b). Importantly, one quarter of all E. hormaechei isolated from neonatal enteral 
feeding tubes by Hurrell (2009a) were resistant to the 3rd generation cephalosporins, 
cefotaxime and ceftazidime. Another related study showed that E. coli K1 ST95 strains 
isolated from neonatal nasogastric feeding tubes possessed genes encoding numerous 
virulence traits associated with neonatal meningitis (Alkeskas et al., 2015). Similarly, a 
study by Ogrodzki et al. (2017), investigated bacterial colonisation in NEFTs and faecal 
samples. Their study showed that E. hormaechei and E. faecalis were recovered from 
both feeding tubes and faecal samples. The colonisation of the enteral feeding tubes by 
nosocomial bacteria and their impact on earlier gut colonisation of premature new-born 
babies was investigated in a recent study (Moles et al., 2015). The study indicated that E. 
coli, K. pneumoniae, S. aureus, S. epidermidis, Serratia marcescens, E. faecium and E. 
faecalis were the predominant isolates in faeces and milk samples amongst 4,000 
bacterial strains recovered (Moles et al., 2015).  
The risk of infection by such bacterial strains is a concern in the NICU.  An observational 
study was conducted by Petersen et al. (2016) revealed that even within the first day of 
use, nasogastric feeding tubes were colonised by high amounts of bacteria. Their study 
showed that out of 94 tubes, 89% yielded more than 103 cfu /ml bacteria and 55% 
yielded potentially pathogenic Enterobacteriaceae and S. aureus. Although several 
studies have identified PIF contaminated by various pathogenic bacteria (Caubilla-
Barron et al., 2007a; Iversen et al., 2008; Giammanco et al., 2011; Araújo et al., 2015), 
microbiological safety studies should not be limited to focussing exclusively on 
reconstituted infant formula but also on the risk practices associated with 
nasogastric tube feeding. This may reduce or prevent the potential risk of exposure to 
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other pathogenic bacteria that can carry antibiotic resistance. Additionally, heavy 
colonisation by pathogenic bacteria can be prevented by avoiding placement of enteral 
feeding tubes for prolonged periods. 
1.4. The intestinal flora of neonates 
The number of bacterial species that colonise the human gastrointestinal tract is 
estimated to be nearly 1012 bacterial cells. In the last decade, clinicians and scientists 
recognised that the microbiota has a number of important roles, particularly bacteria 
that reside in the gastrointestinal tract, which include host metabolism and protective 
functions (Bull and Plummer, 2014; Jandhyala et al., 2015; Thursby and Juge, 2017). 
Neonatal intestines are considered to be sterile prior to birth but after birth the neonate 
is exposed to different types of microbes. The initial colonisation is linked to microbes 
exposed from their mother, the type of delivery and the surrounding environment 
(Perez-Muñoz et al., 2017; Nagpal and Yamashiro, 2017). The gut microbiome during the 
early life of a new-born is significant and a critical window for immunological and 
physiological development. This period can be altered by many factors such as antibiotic 
use and diet, as indicated by a number of studies (Groer et al., 2014; Milowitz et al., 
2015; Tanaka and Nakayama, 2017). The first food introduced to new-borns is milk and 
the feeding type is believed to directly impact on the initial gastrointestinal microbiota. 
For example, Bezirtzoglou et al. (2011) revealed an increase in numbers of 
Bifidobacterium cells among breast-fed infants when compared to formula-fed infants. 
However, very low birth weight (VLBW) infants develop a very different gut microbiome 
when compared to full-term infants. A study by Drell et al.  (2014) indicated that the gut 
microbiota in low birth weight infants was dominated by facultative anaerobic bacteria 
Staphylococcus spp. and Enterobacteriaceae, with relatively low prevalence of 
bifidobacteria, Bacteroides, and lactobacilli.   
Furthermore, it is likely that the environments of hospitals and homes are very different 
in terms of inhabitant microbes and microbial resistance. The VLBW infant often 
requires prolonged hospitalisation in the neonatal intensive care unit. Those infants 
have a higher chance of developing a hospital-associated gut microbial community due 
to prolonged exposure to this environment. A previous study by Brooks (2014) identified 
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that microbes that appear in the gut of premature infants are introduced from the 
neonatal intensive care unit. Bacterial gut colonisation has been associated with health 
and disease such as inflammatory bowel disease, metabolic disorders, and asthma 
(Carding et al., 2015). The colonising microbiota is likely to play an important role for 
metabolic development and development of the immune system of neonates (Tanaka 
and Nakayama, 2017; Nash et al., 2017). 
1.5. Bacterial outbreaks in neonatal intensive care units. 
Outbreaks in NICUs have become a major concern compared with other types of 
intensive care units (Gastmeier et al., 2007; Kumar et al, 2018). It is evident that medical 
microbiological research has become concerned with NICU outbreaks due to increased 
risk among premature babies (Gastmeier et al., 2007; Camacho-Gonzalez et al., 2015; 
Hensel et al., 2017). Various factors contribute to the onset of an epidemic, such as 
susceptibility of the neonates in the NICU as well as virulence of the pathogen. 
Outbreaks are often caused by multidrug-resistant organisms (MDROs). These 
organisms are predominantly bacteria and were defined as “MDR was defined as 
acquired non-susceptibility to at least one agent in three or more antimicrobial 
categories” (Magiorakos et al., 2011). Over the last few years, the incidence of MDROs 
has increased in NICUs, which is the general problem of healthcare associated infections 
(Hensel et al. 2017; Yusef et al., 2018).  
However, several previous studies have identified an outbreak of multidrug-resistant E. 
faecium in NICUs, especially vancomycin resistant strains. For example, a previous study 
by Lee et al. (2012) reported that the VRE outbreak in the NICU had occurred through 2 
different E. faecium clones in a University Hospital in Korea. Another outbreak was 
reported by Carmona et al. (2012), where five cases of VRE infection were identified, 
with 3 deaths in a tertiary-care paediatric intensive care unit of a University Hospital in 
Brazil. In addition, the members of the Enterobacter cloacae complex can be considered 
as nosocomial pathogens, and E. hormaechei is generally the most isolated nosocomial 
pathogen within this group (Paauw et al., 2008), for instance, an outbreak of E. 
hormaechei was responsible for septicaemia in premature infants caused by 
contaminated parenteral nutrition in Brazil (Campos et al., 2007). 
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A. baumannii is also considered as an important nosocomial pathogen, particularly of 
critically-ill patients, including those in the intensive care unit (Castilho et al., 2017). It 
was reported by Fiji Ministry of Health and Medical Services and WHO (2017) that A. 
baumannii was responsible for the death of 12 patients in the NICU of Colonial War 
Memorial Hospital in Suva, Fiji. The pathogen had been isolated from blood and 
cerebrospinal fluid (CSF) samples and multidrug-resistant strains were identified (Lyman, 
2017). Similarly, sepsis outbreaks in NICUs caused by MDR A. baumannii were reported 
during a six-month period, affecting 17 neonates, with 6 deaths in University Clinical 
Centre Tuzla, Bosnia and Herzegovina (Softic et al., 2013).  
Improving our understanding of opportunistic bacterial pathogens with respect to 
neonatal health risk and ability to prevent and manage such infections in the future is of 
importance. There is a need to trace the dissemination of opportunistic bacterial 
pathogens among immunocompromised infants. Pathogenic bacteria are able to 
cause infection and disease, whereas non-pathogenic bacteria are considered 
harmless. It is presumed that pathogenic bacteria harbour additional virulence features 
but this requires further study of disease isolates.  
1.6. The ESKAPE pathogens and diversity of antibiotic resistance 
The most common microorganisms that are mainly involved in multidrug-resistant (MDR) 
infections have been grouped together and called ESKAPE pathogens, (Enterococcus 
faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, 
Pseudomonas aeruginosa, and Enterobacter species). This group represents an 
important cause of nosocomial infections which significantly contributes to morbidity 
and mortality (Santajit and Indrawattana, 2016; El-Mahallawy et al., 2016; Karlowsky et 
al., 2016). The common cause of nosocomial infections is due to bacteria characterised 
by potential drug resistance mechanisms (Santajit and Indrawattana, 2016). 
Antimicrobial resistance in these pathogens is one of the most serious global public 
health problems and it is most likely to increase as resistance profiles change in the near 
future (Santajit and Indrawattana, 2016). For instance, according to the first list of 
priority antibiotic-resistant bacteria “priority pathogens”, which was recently published 
by the WHO, A. baumannii was being selected as priority 1 and is able to cause severe 
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infections (Knols et al. 2016). E. faecium is another important species of the ESKAPE 
group and the fourth most common cause of hospital-acquired infections. (Deshpande 
et al., 2007; Silva et al., 2017). This group is also related to 
significant morbidity and mortality, particularly in critically ill or immunocompromised 
patients (Table 1-2).  
Table 1-2 Pathogenic characteristics of ESKAPE pathogens (WHO 2011). 
 
 
However, the ESKAPE group pathogens have recently gained further global attention 
due to increasing antibiotic resistance, highlighted by the WHO (2017). Indeed, the 
presence of pathogens belonging to this group is a major problem in the ICU setting, 
thus limiting therapeutic options. A previous study conducted by Llaca-Díaz, et al. (2013) 
reported that 64.5% of pathogens recovered from the ICU of a University Hospital in 
Mexico were from the ESKAPE group. The same authors also reported that A. 
baumannii (15.8%) were most frequently isolated among the ESKAPE pathogens and 
strains with high resistance to carbapenems (75.3%) were detected in this study. Also E. 
faecium vancomycin-resistant isolates were detected, which were found to harbour 
the vanA gene. Moreover, multidrug-resistant Enterobacter spp. were commonly 
isolated and this organism has been implicated in several outbreaks of sepsis in NICUs 
(Kartali et al., 2002; Torkaman et al., 2009; Stoesser et al., 2014). Phoon et al. (2018) 
investigated 358 swab and fluid samples collected from a Malaysian tertiary hospital. 
These samples were obtained from medical devices, Health care workers' hands, the 
patients’ immediate surroundings, and toilets. Their results showed that ESKAPE 
organisms were widely dispersed across the hospital wards. The majority of the isolates 
were MDR of S. aureus, Acinetobacter species, Enterobacter species and K. pneumoniae.  
During the last few decades, the spread of multidrug resistance among nosocomial 
pathogens has been one of the growing problems for public health (Wilson et al., 2002). 
According to WHO (2011), these resistant bacteria are able to combat attack by 
antimicrobial drugs, resulting in failure to respond to treatment which leads to 
persistence and spread of infections (World Health Organization, 2011). In the USA, 
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people are infected by antibiotic-resistant bacteria each year is estimated to be nearly 
two million, while annual deaths of approximately 23,000 are attributable to 
antimicrobial resistance. The annual deaths in both the US and Europe to antimicrobial-
resistant infections are estimated to be 48,000 and 700,000, respectively (Hampton, 
2013; Kuehn, 2014). The European Antimicrobial Resistance Surveillance Network 
(EARS-Net, 2017) have pointed out that the resistance percentages to antimicrobials 
vary widely across Europe. For example, it was indicated that Acinetobacter species have 
high variations of antibiotic resistance across Europe, it was reported that the Baltic 
countries generally have high resistance percentages, as well as from Southern and 
South Eastern Europe (European Centre for Disease Prevention and Control, 2017). 
For E. faecium, the percentages of vancomycin resistance were generally high as 
reported in Eastern and South-Eastern European countries. For example, the percentage 
of vancomycin resistance of E. faecium (VRE) has increased significantly between 2012 
and 2015 in European countries. It was noted that more than 20 isolates of VRE per year 
was observed in 12 out of the 26 countries. However, Methicillin-resistant 
Staphylococcus aureus (MRSA) have been reported from several parts of the world. The 
percentages ranging from zero to 57.2% were observed among invasive of S. aureus 
isolates across Europe (European Centre for Disease Prevention and Control, 2017). 
Indeed, MDR has been noted for both Gram-negative and Gram-positive bacteria. 
According to the information from the Centers for Disease Control and Prevention (CDC), 
the rapid increase in infection cases is due to MRSA, VRE and fluoroquinolone-resistant 
P. aeruginosa. Also, MDR A, baumannii, Klebsiella species and E. coli which have 
emerged as significant pathogens worldwide (Boucher et al., 2009). However, the 
infections are highly associated with a rise in morbidity and mortality of critically ill 
patients in intensive care units (Brusselaers et al., 2011). Of particular concern are 
preterm infants exposed to MDR bacteria during their stay in the NICU because most of 
these MDR bacteria are high-risk and often belong to the ESKAPE group (Moles et al., 
2015). Over the past decade, MDR bacteria have been emerged as significant pathogens 
that cause sepsis in the NICU.  
Pathogenic bacteria utilise a number of mechanisms in order to inactivate antibacterial 
agents such as the beta-lactamase enzyme (β-lactamase). Such enzymes can destroy the 
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amide bond of the β-lactam ring, to inhibit or inactivate the antimicrobial compound. β- 
lactamases can be divided into four classes, based on their chemical structure: penicillins, 
cephalosporins, carbapenems and monobactam (Ghafourian et al., 2014; Öztürk et al., 
2016). For example, Hurrell et al. (2009) reported that many E. hormaechei strains were 
found to be resistant to the 3rd generation cephalosporins. In another study, 
antibacterial susceptibility was investigated to determine the prevalence 
of E. faecium and E. faecalis. This revealed that E. faecium presented resistance to 
vancomycin (16.7%), gentamicin (77.8%), erythromycin (88.9%), ofloxacin (44.4%), 
teicoplanin (19.4%), and augmentin (63.9%). In contrast, E. faecalis showed resistance 
to teicoplanin (27.7%) and to vancomycin (13.8%) (Adesida et al., 2017). 
The nosocomial ESKAPE pathogens are known to use a wide range of antimicrobial 
resistance mechanisms, including antimicrobial resistance genes, drug inactivation, and 
increase in expression of efflux pump or changing cell permeability through porin loss 
(Santajit and Indrawattana, 2016). For example, carbapenemase producing A. 
baumannii strains show resistance to both colistin and imipenem. These strains carry 
oxacillinase serine 𝛽-lactamases (bla𝑂𝑋𝐴) and imipenem metallo- 𝛽-lactamases (blaIMP) 
(Higgins et al., 2013; Cayô et al., 2015). In addition, the multidrug efflux system AcrAB 
has been linked with fitness of clinical E. cloacae isolates. Efflux pumps can expel a broad 
range of antibiotics and also drive the acquisition of additional resistance mechanisms 
(Blanco et al., 2016). Antimicrobial-resistant pathogens therefore place a significant 
economic burden on healthcare systems due to their association with nosocomial 
infection and increased treatment costs.  
1.7.  Potential Virulence Associated Traits 
Pathogenic bacteria can use a number of mechanisms to cause disease in human hosts. 
For example, bacterial haemolysins are enzymes that destroy red blood cells and they 
are classified into different types of haemolysins, including α-haemolysin, β-haemolysin 
and γ-haemolysin (Kong et al., 2016). Also, pathogens may express and secrete 
proteases, which have a number of key roles in the ability of several bacteria to infect 
the host and cause disease (Culp and Wright, 2017).  
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Moreover, phospholipase is a lipolytic enzyme that has been identified as a virulence 
factor in many bacteria. For instance, phospholipase D (PLD) is a known virulence factor 
in A. baumannii, and disrupting the PLD gene results in reduced resistance to human 
serum as well as a decreased capacity for invading epithelial cells (Jacobs et al., 2010). 
Furthermore, endotoxin or lipopolysaccharide (LPS) is one of most important bacterial 
virulence factors associated with Gram-negative bacteria (Arenas, 2012; Tejada et 
al., 2015). This toxin is essential in many Gram-negative pathogens such as E. coli and 
Salmonella (Zhang et al., 2013a). According to a study carried out by Townsend et al. 
(2007b), the LPS is a heat stable endotoxin, giving bacteria their ability to persist in 
PIF during the manufacturing process. Furthermore, this virulence factor can enhance 
the translocation of enteric pathogens from the intestinal tract to the blood brain barrier, 
which may lead to an increased risk of infection among infants especially those with 
undeveloped innate immune systems (Townsend et al., 2007b). However, the important 
features of success for the microorganism during pathogenesis depends on its ability to 
detect and respond to different environments through the natural course of infection of 
the host. The rapid adaptation of the pathogen to the new environment allows it to 
colonise and survive in hostile environments (Wilson et al., 2002). Also, pathogenic 
bacteria are able to express a wide range of molecules that assist attachment and 
invasion of the host cells. The characterisation of these strategies is important for the 
prevention and control of bacterial diseases. The current study is focused on 
understanding the mechanisms used by bacterial pathogens to cause infectious disease.  
Formation of biofilms is also one of the important virulence factors, which is a critical 
feature for the development of clinical infection (Chen and Wen, 2011; Wu et al., 2015). 
It plays a significant role in colonisation by microorganisms, providing an opportunity for 
bacteria to become resistant to environmental stresses. Additionally, biofilm formation 
is believed to be involved in protecting the bacteria from antimicrobial treatment and 
host defences (Aparna et al., 2008; Chen and Wen, 2011; Jacqueline and Caillon, 2014). 
The formation of biofilm is of high concern in the food industry, as it may lead to spoilage 
and contamination of the food products (Hartmann et al., 2010). Similarly, biofilm has 
emerged as a significant clinical problem. Indeed, the ability of bacteria to form biofilms 
on medical devices such as nasogastric enteral feeding tubes (NEFTs) and intravascular 
Chapter 1 Introduction 
 
14 
 
catheters is a major concern (Francolini and  Donelli, 2010; Revdiwala et al., 2012; 
Percival et al., 2015). It is believed that bacterial biofilms would be capable of forming 
on medical device surfaces and are an important risk factor for microbial spreading 
within the host and increases the chance of disease (Kostakioti et al., 2013).  
Iron is one of the most important nutrients for the host and pathogenic bacteria. In the 
human body, iron is rarely found as a free and unbound molecule, and is therefore one 
of the major limiting factors for pathogenic microorganisms. (Hasan et al., 2015). 
However, Iron chelation is a vital part of establishing infections and many pathogenic 
bacteria release siderophores to chelate iron from iron binding proteins. Siderophores 
are low molecular weight chelators and considered as a virulence mechanism in 
bacterial pathogenicity (Eijkelkamp et al., 2011; Penwell et al., 2012; Holden and 
Bachman, 2015; Petrik et al., 2017). Acquisition of iron is essential in host environments 
to help bacteria survive and persist in the host. To counter this, pathogenic bacteria use 
several iron acquisition mechanisms to obtain iron from the host (Penwell et al., 2012). 
For example, the most iron-chelating molecule among A. baumannii is acinetobactin. 
There are various siderophores among different microbial species, some of which are 
presented in Table 1-3, (Balagurunathan and Radhakrishnan, 2007). 
Table 1-3 Most important bacterial siderophores 
 
1.8. The interaction of bacteria with mammalian cells 
Strain Siderophore
Escherichia coli Enterobactin
Enterobacter spp. Enterobactin and Aerobactin
Salmonella spp. Aerobactin
Aeromonas hydrophila Amonabsactin
Acinetobacter calcoacaticus Acinetobactin
Aerobacter aerogenes Aerobacin
Klebsiella spp. Aerobactin
Mycobacterium tuberculosis Mycobactin
Pseudomonas aeruginosa pyochelin and Pyoverdin
Vibrio cholerae Vibriobactin
Yersinia pestis Yersniabactin
Staphylococcus aureus Aureochelin
Klebsiella spp. Aerobactin
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Diversity and abundance of microbes living in the gastrointestinal tract leads to the 
microbial interaction with the host cells. The nature of these interactions can have 
either beneficial or detrimental effects. A variety of factors of microbes can have effects 
on the host epithelium, including environmental exposure to microorganisms, nutrition 
and antibiotic therapy, as well as the colonisation of the neonatal gut 
with microbes during the early period of life (Abraham and Medzhitov, 2011).  
The innate immune system constitutes the first line of defence against invasion of 
microorganisms and their spread inside the host (Mogensen, 2009; Hato and Dagher, 
2015). Nevertheless, some opportunistic pathogens can invade and proliferate inside 
epithelial cells and cause infections (Kim et al., 2010; Ribet and Cossart, 2015). In 
addition, some bacteria are able to form biofilms which protect them from 
various environmental stresses (Limoli et al., 2015).  
New-borns and infants are considered highly susceptible to diseases due to the 
vulnerability of their epidermal layer, which is considered to be part of the innate 
immune response. For example, for neonates at 34 weeks of age the skin barrier 
development increases and the epidermal maturation is complete, whereas skin of the 
premature infant is characterised by reduced functionality in the first 2 weeks of life. 
The outer epidermal layer in the premature infant differs from that of the full-term baby, 
only consisting of three layers in premature infants by the first few weeks, whereas the 
epidermal layer is composed of 16 layers in a full-term infant, which may increase the 
chance of invasion by harmful microorganisms in premature infants (Evans and Rutter, 
1986; Oranges et al., 2015).   
Although there is a presence of numerous host defence mechanisms used by the host 
immune system comprises numerous defences, some bacterial pathogens have the 
ability to avoid these defence systems (Webb and Kahler, 2008). In addition, pathogenic 
bacteria have the ability to adhere to, and in some cases, invade host cells and tissues. 
Many bacterial pathogens have developed methods of avoiding the defences of 
immune systems by secreting various components and toxins (Kim et al., 2010). For 
example, pathogens can express surface capsules to prevent antibody and complement 
deposition on its surface (Finlay and McFadden, 2006). Some bacteria have the ability to 
Chapter 1 Introduction 
 
16 
 
produce capsules which provide protection from the host immune response and 
antibiotics (Cress et al., 2014). Capsules may provide resistance to desiccation, serum 
activity and have a significant role in avoiding phagocytic killing (Ogrodzki and Forsythe, 
2015). 
Bacterial attachment to the host cell is an important initial step in the interaction 
between a pathogenic microorganism and its host and is a vital stage towards bacterial 
pathogenesis (Krachler and Orth, 2013; Ribet and Cossart, 2015). Several virulence 
factors exist which contribute to the ability of bacteria to adhere to the host cell surface, 
which helps them colonise and persist in the host and cause disease. Adhesion is 
commonly mediated by fimbriae, which are one of the most distinguished virulence 
factors of the surface adhesions proteins. Bacterial fimbriae or pili are filamentous 
surface proteins that play a crucial role in the attachment to biotic and abiotic surfaces in 
both Gram-positive and Gram-negative bacteria (Berne et al., 2015). For example, curli 
fimbriae have been described to play a vital role in the adhesion of E. coli and Salmonella 
to host cells. Their presence is linked with severe human infections (Cordeiro et al., 
2016). 
Other studies have reported that curli fimbriae play an important role in biofilm 
formation in many species of bacteria, and they help mediate host cell adhesion and 
invasion (Lasaro et al.,   Kim et al., 2012; Sharma et al., 2016). In addition, flagellar 
biosynthesis-related proteins are generally recognised to play a role in colonisation and 
adhesion in pathogenic bacteria and are considered to be an important virulence factor 
(De Maayer and Cowan, 2016).  In addition to fimbriae and pili, a wide range of bacterial 
surface molecules are required for mediating adhesion of microorganisms to the 
intestinal epithelium. Adhesive matrix molecules, termed MSCRAMMs (microbial 
surface components recognizing adhesive matrix molecules), are recognised by several 
studies to play an important role in the cellular adhesion of E. faecium. They also 
mediate the attachment of S. aureus and S. epidermidis. For instance, the Acm collagen-
binding adhesin of E. faecium contributes to the pathogenesis of experimental 
endocarditis. EcbA, the E. faecium collagen binding protein A, and fibrinogen are able to 
recognise adhesive matrix molecules. Moreover, the efaA gene product was 
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hypothesised to be involved in cell wall adherence (Hendrickx et al., 2009; Sava et 
al., 2010; Soheili et al., 2014, Yang et al., 2016). 
The first step for invading bacteria usually depends on the ability of the adhesion to host 
cells. Pathogens can cross host barriers and get access to deeper within the host tissues 
where they proliferate and can result in disease (Doran et al., 2014 Ribet and Cossart, 
2015). Several pathogens have been described to have the ability to enter host cells. For 
instance, Krzymińska et al. (2009) reported the ability of E. hormaechei and E. cloacae 
strains isolated from human specimens to adhere and invade to human epithelial type 
2 (HEp-2) cells. Additionally, some bacterial pathogens have developed the ability to 
interact with macrophages, whereas others can cross the blood brain barrier and invade 
brain cells. Extracellular invasion occurs once the microbes are able to cause damage to                          
host cells and tissues by invading and spreading in the host while remaining outside of 
host cells. Whereas intracellular invasion occurs while a microbe invades and survives 
within the cells of a host tissue (Wilson et al., 2002).  
Macrophages are an important class of phagocytes that are commonly involved in the 
host response to pathogenic bacterial invasion (Tracey, 2014; Sotolongo et al., 2012). 
Macrophages phagocytose and destroy invading microbes in order to protect the host 
body. Many bacterial pathogens have showed an ability  to survive and replicate inside 
macrophages after invasion (Ribet and Cossart 2015). For example, previous studies 
revealed the ability of C. sakazakii isolates to survive and replicate within human 
macrophages represented by the U937 cell line model (Townsend et al., 2008a; Almajed 
and Forsythe, 2016).  
Bacterial cytotoxicity is another significant virulence factor for the pathogenicity of 
many microorganisms. Their effect on the viability of the epithelial Caco-2 cells was also 
assessed through mitochondrial activity, using the MTT assay. This assay is commonly 
used to assess and analyse cell proliferation and viability, which is a well-known 
biological tool to measure cell mitochondrial activity. The assay measures the reduction 
of tetrazolium into formazan product by the mitochondria of viable cells. (Jo et al., 2015; 
Riss et al., 2013). The MTT test was applied by Almajed and Forsythe (2016) to clarify 
the cytotoxic effect of clinical C. sakazakii strains on the Caco-2 and HBMEC cell lines. It 
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was shown that majority of isolates were able to induce cell death of both cell lines. 
Similarly, the MTT assay was performed by Husain and co-authors (2016), who 
investigated the cytotoxic potential of glutaminase-free asparaginase produced by E. 
cloacae against Human Myeloid Leukemia (HL-60) cells. 
However, the presence of such virulence traits, antimicrobial resistance, biofilm 
formation, haemolysin activity, siderophores (iron uptake) and ability to invade and 
adhere to mammalian cells, is likely to increase the potential risk factors to neonatal 
health. Therefore, the present study has focused on determining virulence traits of a 
bacterial clinical collection which may form a potentially higher risk to neonatal health 
in NICUs. 
1.9. Identification and typing methods of pathogenic bacteria 
Full identification of the microbes involved in human infection is one of the important 
tasks of a microbiology laboratory. This provides insight into their clinical evaluation and 
allows differentiation between causative organisms, as well as application of an 
effective treatment regime. One of the main concerns is that some conventional 
identification techniques are not very accurate. Nevertheless, agar plate detection 
remains the gold standard method, due to its potential for discriminating isolates in a 
mixed bacterial flora on an agar surface. Culture method techniques are well 
understood and routinely used for discrimination, but there are also some limitations in 
terms of sensitivity and specificity (Méndez-Vilas and  Pereira, 2013). In recent years, 
several genotyping methods have received more attention and have been shown to be 
suitable for discrimination between pathogenic bacteria. These techniques improve the 
sensitivity and can be used to classify bacteria into groups of closely-
related isolates based on genomic diversity. 
Numerous methods can discriminate a large number of isolates, such as pulsed-field gel 
electrophoresis (PFGE). This technique is a DNA fingerprinting method which is 
considered as the gold standard technique for many years to discriminate between 
several pathogenic organisms. This method is one of the most discriminatory for typing 
of bacterial strains based on their genomic DNA pattern by digestion with a restriction 
enzyme. Different restriction enzymes can generally be used, such as XbaI, ApaI and 
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Ascal to cut sites within the genome into several fragments. Then these fragments can 
be separated using agarose gel electrophoresis (Bong, 2006; Caubilla-Barron et al., 2007). 
Therefor PFGE was the preferred methods and considered as the method of choice 
when it comes to outbreaks, and allows tracking of infection sources. For example, 
Zarrilli et al. (2007) used PFGE to investigate multidrug-resistant A. baumannii strains 
isolated from 74 patients, between June 2003 and June 2004 in a hospital in Naples, 
Italy. The result of this investigation showed that the isolates revealed two different 
pulsotypes. PFGE pattern 1 was found across 44 patients and then the same pulsotype 
was found identical to that of an epidemic clone isolated during 2002 in another hospital 
in Naples. However, this technique has some limitations due to the expense of the 
equipment, requirement of highly trained technicians, it is time consuming, and non-
identical strains can often give the same profile (Klaassen et al., 2002; Unemo and Dillon, 
2011).  
Multilocus sequence typing (MLST) is a molecular typing technique which is considered 
to be one of the most reliable and informative methods. This is often seen as a 
complementary typing method to PFGE (Tomaschek et al., 2016). MLST has been applied 
in identification and clustering of many pathogenic microorganisms. This technique uses 
partial sequence analysis of multiple housekeeping genes that scattered throughout the 
genome of the organism. MLST approaches have been defined and adopted for many 
prokaryotic and eukaryotic microorganisms. Databases of thousands of MLST profiles and 
sequences are now available via online sequence database provides data for over one 
hundred microorganisms sequences and allelic profiles 
 (Chen et al., 2015; Jolley et al., 2017). Traditionally, MLST was achieved by PCR 
amplification of seven housekeeping genes based on the MLST scheme database 
followed by Sanger sequencing. However, the MLST method has been further developed 
in recent years using a high-throughput next-generation sequencing approach (NGS), 
which is rapidly replacing classical Sanger sequencing (Jolley et al., 2017).  
Recently, whole-genome sequencing (WGS) of bacterial pathogens has become a very 
attractive and provide more data than traditional subtyping methods. WGS has 
widespread applications in research and routine analyses in the field of epidemiology 
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and outbreak surveillance (Kwong et al., 2015; Scott et al., 2017). Next-Generation 
Sequencing (NGS) has revolutionised genetics and genomics studies and has had a huge 
impact on research through the rapid development in the analysis programs in the field 
of genomics. The development of the NGS technology has made significant progress 
in recent years and provides a wealth of new information for our understanding of the 
basic biological knowledge of microorganisms. (Seifi et al., 2017). For instance, a number 
of studies revealed many advantages of WGS when compared to 16S rRNA sequencing. 
One of the major advantages of WGS is that it provides a more accurate species 
level identification. The limitation of the 16S amplicon method is that it sequences only 
a single region while WGS can sequence all regions of the entire bacterial genome 
(Kwong et al., 2015; Deurenberg et al., 2017; Singh et al., 2017). Indeed, it is difficult to 
distinguish among closely related species by using 16S rRNA gene due to the limited 
resolution of this method. A recent study by Ogrodzki et al. (2017) indicated that the 8 
strains isolated from 2 different feeding tubes were identified as E. faecalis by using the 
16S rDNA gene. However, genomic profiling following NGS confirmed that these strains 
formed two distinct clusters according to their sequence type and SNP analysis showing 
as closely related strains in tube and faeces. 
Genotyping techniques including PFGE, 16S rRNA and MLST were applied in the present 
study for accurate identification and typing of pathogens. Moreover, whole-genome 
sequencing and single nucleotide polymorphism (SNP) analysis was also used, in order 
to determine the relatedness and track the source of these isolates. Furthermore, these 
techniques were used to determine the presence or absence of virulence-associated 
genes and antibiotic resistance genes to help provide a complete picture. However, 
different studies have been performed which have focused on bacterial potential 
pathogenicity on the NEFTs rather than to study the persistence of these pathogens and 
their multiplication within the feeding tubes and neonatal gut. These strains only 
provided a snapshot of single samples and lack descriptive metadata, such as patient 
information. Furthermore, no follow up samples for these isolates were available, and 
no information regarding the persistence of these isolates (whether in the NEFTs or 
intestinal tract of the babies), was available. The lack of this information made it 
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extremely difficult to determine whether the strains that infected the babies originated 
from NEFTs. 
1.10. Study objectives:  
In this study, the overall aim of the project was to profile a clinical collection of A. 
baumannii isolated from neonatal feeding tubes from NICUs in two separate hospitals 
in Jordan (chapter 3), and a collection of Enterobacter species, in particular E. 
hormaechei isolated from feeding tubes, CSF and blood samples (sepsis cases) of 
premature babies in NICUs (chapter 4). The present study focussed on phenotyping and 
genotyping analysis for these hospital strains to evaluate potential virulence traits and 
to determine important risk factors with respect to neonatal infections in NICUs. 
Additionally, a longitudinal study of twin babies with different feeding regimes in the 
NICU at QMC hospital, Nottingham (chapter 5), was performed to compare potentially 
pathogenic E. faecium isolates within and between twin pairs over time. Single 
nucleotide polymorphism (SNP) analysis was used, in order to determine the relatedness 
of strains isolated from feeding tubes and faeces from both babies over time. 
Furthermore, this part of the study aimed to determine whether some of the strains 
might have been transferred between the two babies or come from common source. 
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Chapter 2. Materials and Methods; 
2.1. Safety consideration  
Health and safety code of practice for microbiology level two containment laboratories 
at Nottingham Trent University was considered before carrying out any experiments and 
protocols in this project. The procedural COSHH forms and activity risk assessment were 
also completed and considered. Category 2 organisms and materials were disposed of 
according to the recommended instructions. For tissue culture laboratories health and 
safety regulations, hepatitis B antibodies and vaccination were assessed before starting 
any tissue culture experiments.  
2.2. Ethics.  
Ethical approval was given by NRES Committee East Midlands. This permitted the 
collection of feeding tubes, faeces and metadata, but did not permit the storage of 
human tissue, which by definition included faeces. 
2.3. Sterilisation and aseptic techniques  
All buffers, solutions, media, and equipment were decontaminated by autoclave 
sterilisation at 121°C under 15 psi pressure for 15 minutes, 121°C for 5 minutes, filtered 
using 0.2 μm pore size filters (Thermo Fisher Scientific, UK) or sprayed with 70% ethanol, 
as appropriate.  
2.4. Bacterial storage  
All the studied isolates and any additional positive and negative control strains were 
stored at -80°C and -20°C in TSB/ glycerol (80%) (Thermo Fisher Scientific, UK) for long 
term storage. When required, bacteria were recovered from frozen stock and 
subcultured on Tryptone Soya Agar (TSA) and incubated aerobically at 37°C for 18 h. For 
short term storage, bacteria were streaked on TSA and stored at 4°C. 
2.5. General stock reagents and buffers  
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2.5.1. Phosphate buffered saline (PBS)  
The PBS solution was prepared by dissolving one tablet of PBS (Sigma Aldrich, UK) into 
100 ml of distilled water and autoclaved at 121°C for 15 minutes.  
2.5.2. Saline Solution (0.85 %)  
For preparing the 0.85% saline solution, one tablet of saline (Thermo Fisher Scientific, 
UK) was dissolved into 500 ml of distilled water and autoclaved at 121°C for 15 minutes.  
2.5.3. Hydrochloric acid (HCl)  
One molar hydrochloric acid (HCl) was prepared by adding 86ml of 37% HCl (Thermo 
Fisher Scientific, UK) to 914 ml of distilled water. The mixture was gently mixed and used 
to adjust the pH of solutions used in this project.  
2.5.4. TRITON X-100 (1%)  
In order to prepare 1% Triton X-100, 1 ml of TRITON X-100 (Thermo Fisher Scientific, UK) 
was added to 99 ml of distilled water, then autoclaved and then stored at room 
temperature until use.  
2.5.5. 1 M Tris-HCl (pH8)  
For preparing 1 M Tris-HCL, 60.55 g of Tris base (Thermo Fisher Scientific, UK) was 
dissolved into 400 ml of distilled water and then the mixture was adjusted to pH 8 by 
adding HCl and measured by pH meter (HANNA, USA). The volume was completed with 
distilled water to be 500 ml and then autoclaved at 121°C for 15 minutes.  
2.5.6. EDTA (Ethylenediamine tetra-acetic acid, sodium hydroxide) (pH8)  
The preparation of 0.5 EDTA was obtained by dissolving 93 g of EDTA (Sigma Aldrich, UK) 
into 400 ml of distilled water and the mixture then was adjusted to pH 8 by adding 
sodium hydroxide pellets (NaOH) (Sigma Aldrich, UK) and the pH was measured by a pH 
meter. The total volume of the mixture was made up to 500 ml and then it was 
autoclaved at 121°C for 15 minutes. 
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2.5.7. 10 X TBE Buffer (Tris base, boric acid and EDTA buffer)  
The preparation of 10X TBE buffer was obtained by dissolving 108 g Tris base (Thermo 
Fisher Scientific, UK), 55 g boric acid (Thermo Fisher Scientific, UK) into 800 ml of distilled 
water. Once the chemicals were completely dissolved, 40 ml of 0.5 EDTA pH 8 was added 
and the mixture volume was adjusted to 1000 ml by adding distilled water. The prepared 
mixture was then autoclaved at 121°C for 15 minutes.  
2.5.8. 1 X TAE buffer (1 X Tris-acetate-EDTA buffer)  
In order to prepare 1X TAE buffer, 20 ml of 50X TAE buffer (National Diagnostics, UK) 
was diluted with 980 ml of distilled water. The 1X TAE diluted buffer was used for 
preparing agarose gel and filling the gel electrophoresis tanks.  
2.5.9. Glycerol (80%)  
The preparation of 80% of glycerol was completed by adding 80 ml of glycerol (Thermo 
Fisher Scientific, UK) to 20 ml of distilled water. The mixture was autoclaved and stored 
at room temperature until use.  
2.5.10.   Iron III Solution  
This solution was prepared by dissolving 0.0027 g of FeCl3-6H2O (Sigma Aldrich, UK) into 
10 ml of 10 mM HCl.  
2.5.11.  Chrome Azurol Sulphate (CAS) SOLUTION  
CAS solution was prepared by mixing 0.06 g CAS (Sigma Aldrich, UK) with 50ml of sterile 
distilled water.  
2.5.12. Hexadecyltrimethylammonium bromide (HDTMA)  
Exactly 0.1458 g of HDTMA (H6268, Sigma Aldrich, UK) was dissolved in 80 ml of distilled 
water. 
2.5.13. Sodium hydroxide solution. 
This solution was prepared by dissolving 10 g of NaOH into 20 ml distilled water. 
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2.5.14. Lysozyme Solution (for Gram-positive bacteria only)  
The instructions for stock solution of lysozyme were followed as explained by the 
manufacturer. To prepare 1 ml of Lysozyme Solution (L4919), were dissolved in 1 mL of 
Gram-Positive Lysis Solution (L7539). For each DNA preparation to be performed, 200 
μL of Lysozyme Solution was required.  
2.6. General culture media  
2.6.1. Tryptone Soya Agar (TSA)  
According to manufacturer’s instructions for TSA (Thermo Fisher Scientific, UK) the 
media was prepared by dissolving 40 g TSA agar in 1 L of distilled water. The mixture was 
boiled to completely melt the agar and then autoclaved at 121°C for 15 minutes. The 
media was cooled to 50°C and then dispensed into petri dishes about 20 ml each. These 
plates were dried and stored at 4°C until use.  
2.6.2. Trypticase soy broth (TSB)  
Exactly 15 g of TSB (Thermo Fisher Scientific, UK) were dissolved into 500 ml of distilled 
water. This mixture was dispensed to 100 ml in separate bottles. These 100 ml bottles 
were autoclaved at 121°C for 15 minutes and then stored at room temperature.  
2.6.3. MacConkey agar  
To prepare 1 litre, 51.5 g of MacConkey agar (Thermo Fisher Scientific, UK) were added 
to 1 litre of distilled water. The mixture was boiled to completely dissolve the powder 
and then autoclaved at 121°C for 15 minutes after which it was cooled to 50°C and 
dispensed into petri dishes and stored at 4°C until needed.  
2.6.4. Violet Red Bile Glucose Agar (VRBGA)  
The medium was prepared by dissolving 38.5 g of VRBGA (Thermo Fisher Scientific, UK) 
into 1 litre of distilled water. The medium was boiled then cooled to 50°C to be 
dispensed into petri dishes. 
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2.6.5. Luria-Bertani agar (LBA).  
The manufacturer’s directions were followed to prepare Luria-Bertani Agar (Merck KgaA, 
Darmstad, Germany; 1102830). Thirty-seven gram were dissolved in 1 litre of water, 
mixed and then sterilized for 15 min at 121°C.  
2.6.6. Xylose lysine deoxycholate agar (XLD)  
Fifty-three grams of XLD (Thermo Fisher Scientific, UK) agar was added to 1 litre of 
distilled water and heated with frequent agitation until the mixture boiled. The medium 
was transferred immediately to a 50°C water bath and then poured into petri dish plates.  
2.6.7. De Man, Rogosa, Sharpe Agar (MRS agar)  
Sixty-two grams of MRS (Oxoid Thermo Fisher Scientific, UK) agar was added to 1 litre of 
distilled water. The mixture was boiled to completely dissolve the powder and then 
autoclaved at 121°C for 15 minutes after which it was cooled to 50°C, and dispensed 
into petri dishes.  
2.6.8. Bifidus Selective Medium Agar (BSM-Agar) 
55.5 g BSM-Agar (Sigma-Aldrich, 88517) was added to 1 litre of distilled water. The final 
pH was adjusted to 6.8 and then autoclaved at 121°C for 15 minutes. After cooling to 
55°C, 116 mg BSM supplement (Cat. No. 83055; suspended in 5 ml sterile water) was 
added. Then the agar was mixed gently and dispensed into sterile Petri dishes. 
2.6.9. Brain Heart Infusion Agar (BHIA) Brain Heart Infusion Agar (CM131B, Oxoid 
Thermo Fisher Scientific) was prepared according to the manufacturer’s instructions. 
Briefly, 47 g/ L of BHIA was suspended in 1 litre of distilled water, and sterilised at 121°C 
for 15 minutes. After cooling to 45-50°C it was mixed gently and dispensed into sterile 
Petri dishes. These were stored in the fridge at 4°C until required. 
2.6.10. Calcofluor media.  
Cellulose production was investigated by streaking the bacterial strains on 
supplemented LBA medium with Calcofluor White Stain (18909 Sigma, UK). Calcofluor 
media was prepared by dissolving 5 g of tryptone, 2.5 grams yeast extract and 7.5 g of 
technical agar (LP0013 Agar No 3; Oxoid Thermo Fisher; UK) in 500 ml of distilled water. 
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It was mixed until completely dissolved and autoclaved at 121°C for 15 minutes. Then it 
was cooled to 50°C. The agar was supplemented with 25 ml of Calcofluor White Stain 
(18909 Sigma, UK), and about 15 - 20 ml of media was poured into each sterile Petri 
dish. The plates were then stored in a dark and cool place for up to 2 weeks at 4°C, 
followed by incubation 18 h at 37°C and 48h at 30°C.  
2.6.11. Tributyrin agar, base (activity).  
The lipase activity assay was performed by using Tributyrin agar (pre-prepared Oxoid, 
UK). The pre-prepared agar was rehydrated and then poured into petri dishes. The petri 
dish plates were left at room temperature to dry for two to three days and after that 
strains were streaked on tributyrin agar and incubated for 72 h at 37°C. Each strain was 
evaluated for lipase activity by visual observation. A positive result was defined as a clear 
zone around the bacterial colonies.  
2.6.12. Iso-Sensitest agar (ISA)  
Exactly 31.4 g were suspended in 1 litre of distilled water and then the mixture was 
boiled to dissolve the agar and then autoclaved at 121°C for 15 minutes. The medium 
was cooled to 50°C and dispensed into petri dishes. 
2.7. Identification methods and molecular typing  
2.7.1. Bacterial strains and their sources.  
A total of 100 strains were isolated from different clinical sources used in this study. 
Forty-three A. baumannii strains were used in this project, which were isolated from 
nasogastric enteral feeding tubes from neonates in NICUs, from Princesses Rahma 
Hospital (PRH) and King Abdulla Hospital (KAH) in Jordan. The strains had been collected 
from two hospitals between 15/7/2011 and 21/12/2011 as described in chapter 3. 
Twenty-six Enterobacter spp. were selected from the Nottingham Trent University 
culture collection, which had not previously been studied. These strains were isolated 
from Blood culture and CSF specimens. The collection were from sporadic cases at either 
Nottingham City Hospital (NCH) or Queen Medical Centre (QMC) collected during 7 years 
between 2009 and 2015. In addition, 7 strains from blood, nasogastric enteral feeding 
tubes and faeces samples from QMC in Nottingham were also included in the collection 
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as described in chapter 4. Further, 24 E. faecium isolates from two premature babies 
(twins) from the neonatal intensive care unit of Queens Medical Centre were studied, 
as described in chapter 5. The samples were collected from feeding tubes and faecal 
samples from both neonates at different times. The first sample was collected at 4 weeks 
of age and the last sample was collected at 18 weeks. The neonates were fed breast milk, 
fortified and pre-med formula during this period of time (chapter 5). Isolates 
information including source, site and date of isolation are presented in Table 2-1, Table 
2-2 and Table 2-3 
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Table 2-1 A. baumannii strains used in this study isolated from enteral feeding tubes of 
babies in NICU at Jordan Hospitals (chapter 3). 
 
NTU: Nottingham Trent University strain identity number. *A: Pulsed Field Gel Electrophoresis was 
performed. *B: Physiological characterization was performed.  *C: whole-genome sequencing was 
performed. *D: tissue culture was performed. PRH = Princes Rahma Hospital. KHA = King Abdulla Hospital. 
NA = Data not available, D.O.I = Date of isolation. FIF = Flushed infant formula. ** = Various feed regime 
were in practices at the hospitals. These were various powdered infant formula from different 
manufacturers 
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Table 2-2 Enterobacter strains used in this study isolated from sepsis, enteral feeding 
tubes and faecal samples on NICU at Nottingham Hospitals UK (chapter 4). 
 
NTU: Nottingham Trent University strain identity number. *A: Pulsed Field Gel Electrophoresis was 
performed. *B: Physiological characterization was performed.  *C: whole-genome sequencing was 
performed. *D: tissue culture was performed. QMC: Queen Medical Centre. NCH: Nottingham City 
Hospital. NA: Data not available. 
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Table 2-3 E. faecium strains used in this study isolated from enteral feeding tubes and 
faecal samples on NICU at Queen Medical Centre Hospitals UK (chapter 5).  
 
NTU: Nottingham Trent University strain identity number. *A: Pulsed Field Gel Electrophoresis was 
performed. *B: Physiological characterization was performed.  *C: whole-genome sequencing was 
performed. *D: tissue culture was performed.  
2.7.2. Biochemical confirmation;  
Suspected colonies were picked for confirmation by biochemical testing. The colonies 
selected based on colony morphology on each media, were first subjected to Gram 
staining, catalase test and oxidase test. After that, the presumptive isolates were 
subjected to various phenotypic and genotypic analysis.  
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2.7.2.1. Gram stain 
Gram staining is a very crucial first step for identifying, differentiation and classifying 
bacteria either Gram positive or Gram negative. There are four components required for 
Gram staining. In the Gram stain procedure single pure colonies were heat fixed onto a 
clean and labelled microscope slide by passing it over a flame. Then the smear was 
flooded with primary crystal violet dye for about 45 seconds. Before applying Gram’s 
iodine, the slide was washed off with sterile water or tap water to remove primary stain; 
the Gram’s iodine was then added for about 25 seconds. The Gram’s iodine was washed 
off with sterile water. Then ethanol 95% was used to wash the dye off. Finally safranin 
(red dye) was used for 45 seconds, the slide was gently washed off and then dried before 
it was viewed under a light microscope on the oil immersion 100 X objective lens. The 
Gram-staining components that were used in this study were from Remel™ Gram Stain 
Kit (Thermo Scientific, UK). 
2.7.2.2. Oxidase test  
Oxidase reaction was determined with filter paper saturated with N,N,N,N'-tetramethyl-
p-phenylene diamine dihydrochloride (Alfa Products, Damers, MA). Isolates were 
streaked onto the filters with wooden applicator sticks. Purple to black discoloration 
within 10 seconds constituted a positive reaction  
2.7.2.3. Catalase test 
A well-grown 18-24 hours old culture on TSA was picked up and spread on clean glass 
slide, a drop of 3 per cent hydrogen peroxide (H2O2) (Thermo Scientific, UK) added on 
the smear and observed for the immediate development of bubbles which was 
considered as positive for catalase.  
2.7.3. Phenotyping  
Four different media were used to assess the diversity of the colony morphology of 
examined strains according to recovery on TSA, MRS, VRBGA and BSM-Agar. 
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2.7.4. Genotyping assays  
2.7.4.1. Pulsed field gel electrophoresis (PFGE) 
PFGE was used in order to determine whether there indistinguishable strains were 
collected from four different hospitals and the sites or departments. The experiment 
used has been standardised according to the CDC and PulseNet (2004) protocol. PFGE 
analysis for these collections was performed by using the three restriction enzymes Xbal, 
ApaI and Ascal (Promega, UK). CHEF-DR II system (BIO-RAD, Belgium) was used to 
separate the bands at 6V, 14°C for 20 h with initial and final switch of 5 and 50 sec 
respectively. BioNumerics software version 7.1 (Applied Maths, Belgium) was used to 
analysed DNA bands profiles. Less than 95 % of band similarity value was used to 
consider the isolates to be non-clonal (Tenover et al., 1995). 
2.7.4.2. Tris EDTA Buffer (TEB)  
TEB was prepared aseptically by diluting 10 ml of 1M Tris pH 8 and 2 ml of 0.5 M EDTA 
pH 8 with 988 ml distilled water. This buffer was used for making and washing the PFGE 
plugs.  
2.7.4.3. Cell Suspension Buffer (CSB)  
The preparation of CSB was obtained aseptically by diluting 10 ml of 1 M Tris pH 8 and 
20 ml of 0.5 M EDTA pH 8 with 70 ml of distilled water.  
2.7.4.4. Cell Lysis Buffer (CLB)  
CLB was prepared aseptically by diluting 2.5 ml of 1 M Tris pH 8 and 5 ml of 0.5 M EDTA 
pH 8 with 42.5 ml distilled water. 1% Sarkosyl NL (N-Dodecanoyl-N-methylglycine 
sodium salt) (Sigma Aldrich, UK) was dissolved into the mixture before adding 20 mg/mL 
of proteinase K (Sigma Aldrich, UK).  
2.7.4.5. DNA preparation in agarose plugs  
The strains of interest and a marker strain Salmonella enterica serovar Typhimurium 
reference standard H9812 (NTU 732) were screened in this project. About two full loops 
of overnight culture on TSA of the isolates and reference strain were individually 
suspended into cell suspension buffer and centrifuged at 7000 rpm for 4 minutes. The 
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previous step was repeated two times and then, using the same buffer, the optical 
density (OD) of each bacterial suspension was adjusted to be between 1.35-1.5 at 610 
nm. Exactly 400 μl of bacterial suspension was pipetted into a 1.5 ml Eppendorf tube 
and while they were incubated in water bath at 37°C for 10 minutes, 1% agarose gel in 
TEB was microwaved for melting and 0.5% sodium dodecyl sulfate (SDS) was added and 
the gel was left in 55°C water bath. Each Eppendorf tube was mixed with 25 μl 
proteinase K and then mixed with 400 μl of TEB agarose and immediately about 100 μl 
of this mixture was dispensed into five well plug molds. The plugs were transferred into 
15 ml falcon tubes contains 5 ml of CLB and incubated in a shaking water bath at 50°C 
for 2 hours. After the period of incubation, the plugs were washed twice with 15 ml of 
warmed sterile distilled water and incubated in shaking water bath at 50°C for 15 
minutes. Finally, the DNA plugs were washed three times into 15 ml warmed TEB in a 
shaking water bath at 55°C for 15 minutes and stored in 5 ml of TEB at 4°C until needed. 
2.7.4.6. Digestion and Electrophoresis 
Three restriction enzymes Xbal, ApaI and Ascal (Promega, UK) were used for digestion. 
About 2 millimetres of each plug was transferred into 2 ml Eppendorf tube contain 2 μl 
BSA, 20 μl 10X buffer D and 178 μl sterile distilled water and incubated in a water bath 
37°C for 15 minutes. After the incubation, the content of tubes was removed and 
digestion was performed on each plug by adding 2 μl BSA, 20 μl 10X buffer D, 5 μl Xbal 
and 173 μl sterile distilled water and incubated in water bath at 37°C for 4 hours. While, 
two restriction enzymes ApaI and Ascal transferred into 2 ml Eppendorf tube contain 2 
μl BSA, 20 μl 10X buffer B, 3 μl ApaI or Ascal enzyme and 176 μl sterile distilled and 
incubated in a water bath at 37°C for 16 hours (overnight). 1% agarose gel was prepared 
in 100 ml of 0.5XTBE buffer and kept in 55°C water bath. The restricted plugs were then 
loaded on a 15-tooth comb (BIO-RAD Laboratory; Belgium). The comb was inserted in 
the gel tray and the 1% agarose gel was carefully poured into the gel tray. After the gel 
solidified, the comb was removed, it was placed in an electrophoresis cell and covered 
with 2400 ml of 0.5X TBE buffer. The system used for PFGE was CHEF-DR II system (BIO-
RAD, Belgium), it was performed for Xbal at 14°C, 6V for 20 hours, and initial and final 
switch was 5 and 50 seconds respectively. While for ApaI and Ascal, at 14°C, 6V for 20 
hours, and initial and final switch was 5 and 50 seconds respectively. 
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2.7.4.7. Staining and Analysis 
The gel was stained with ethidium bromide (Sigma Aldrich, UK) 0.1 μg/ml for 45 minutes, 
visualised under UV light and photographed using In Genius® gel documentation system 
(Syngene, UK). The DNA band profiles were analysed using BioNumerics software 
version 7.1 (Applied Maths, Belgium).  
2.7.4.8. DNA extraction 
GeneEluteTM kit (NA2110-1KT, Sigma, UK) was used for DNA extraction from target 
strains. The instructions were followed as explained by the manufacturer. The DNA 
concentration was confirmed by using a NanoDrop® ND-2000 UV-Vis spectrometer 
(Thermo Scientific, UK), and the DNA was stored at -20°C for up to 6 months.  
2.7.4.9. PCR 16S rRNA Sequence Analysis 
The partial sequencing of the 16S rRNA loci (528 bp) Table 2-4 was performed using 
primers described by (Ogrodzki and Forsythe, 2017). Cycling conditions were an initial 
denaturation at 95°C for 10 minutes; 30 cycles of denaturation at 95°C for 30 sec, primer 
annealing at 62.6°C for 30 sec, extension at 72°C for 45 sec; followed by a final extension 
step of 72°C for 10 minutes. Regarding to E. faecium, the partial sequencing of the 16S 
rRNA loci (520 bp) Table 2-4 was performed using primers described by (Jiménez et al., 
2008). Cycling conditions were an initial denaturation of 94°C for 5 minutes; 25 cycles of 
94°C for 30 seconds, primer annealing at 48°C for 30 seconds, extension at 72°C for 45 
seconds and followed by a final extension step of 72°C for 4 minutes. 
2.7.4.10. Multilocus sequence typing (MLST)  
The MLST scheme is based on sequences of the conserved regions of the seven 
housekeeping genes, for A. baumannii using the MLST scheme database of the Institute 
of Pasteur (http:/pubmlst.org/abaumannii). Seven housekeeping genes of A. baumannii 
were amplified using the primers; fusA (elongation factor EF-G), gltA (citrate synthase), 
pyrG (CTP synthase), recA (homologous recombination factor), rplB (50S ribosomal 
protein L2), rpoB (RNA polymerase subunit B) and cpn60 (60-kDa chaperonin), as 
showed in Table 2-4. Polymerase chain reaction (PCR) amplification product was 
performed using PCR machine (Techne, UK). A total volume of PCR reaction was of 20 μl 
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composed of GoTaq® Green Master Mix (Promega, UK) which diluted with 50% SDW, 2% 
of primers and 1 μl of bacterial DNA. Reaction condition for all the MLST primers was as 
follows: initial denaturation at 94°C for 2 min; 35 cycles of denaturation at 94°C for 30 s; 
primer annealing at 50°C for 30 s; extension at 72°C for 30 s; followed by a final extension 
step of 72°C for 5 min. With regards to the MLST analysis E. hormaechei and E. faecium 
isolates, the MLST interface on Centre for Genomic Epidemiology (CGEMLST) database 
was used to analyse MLST sequence types using whole-genome data 
(https://cge.cbs.dtu.dk/services/MLST-2.0/). Sequence files were uploaded onto the 
server in order to determine allele identity and sequence types. 
2.7.4.11. Screening for rpoB gene for Acinetobacter isolates 
For screening of RNA polymerase β-subunit (rpoB) gene was performed as described by 
Gundi et al. (2009). DNA. GoTaq® Green Master Mix (Promega, UK) was diluted to 50% 
with sterile distilled water and 2% of primers showed in Table 2-4, was added. One 
microliter of DNA of each isolate was added into 19 μl of master mix with 2% primer and 
the PCR condition was as following: initial denaturation at 94°C for 2 min; 35 cycles of 
denaturation at 94°C for 30 second; primer annealing at 52°C for 30 second; extension 
at 72°C for 1 min; followed by a final extension step of 72°C for 7 min.   
2.7.4.12. Screening for fusA gene for Enterobacter isolates 
Sequence typing of the fusA allele was performed according to the information in MLST 
database http://www.pubmlst.org. DNA. GoTaq® Green Master Mix (Promega, UK) was 
diluted to 50% with sterile distilled water and 2% of primers showed in Table 2-4, was 
added. One microliter of DNA of each isolate was added into 19 μl of master mix with 
2% primer and the PCR condition was as following: initial denaturation at 94°C for 90 
second; 40 cycles of denaturation at 94°C for 10 second; primer annealing at 55°C for 20 
second; extension at 72°C for 50 second; followed by a final extension step of 72°C for 5 
min. 
2.7.4.13. Screening of OXA-51-like β-lactamases  
The screening of blaOXA-51-like gene was performed as described by Feizabadi et al. 
(2008). One microliter of DNA of each isolate was added into 19 μl of master mix with 
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2% primer and the PCR condition was as following: initial denaturation at 94°C for 4 min; 
34 cycles of denaturation at 94°C for 45 second; primer annealing at 52°C for 45 second; 
extension at 72°C for 30 second; followed by a final extension step of 72°C for 10 min. 
2.7.4.14. Screening of Phospholipase Genes 
The PCR method was used to screen for phospholipase A, C and D. Primers were 
synthesized and designed by Eurofins Genomics. The polymerase chain reactions (PCR) 
were applied: Initial denaturation 95°C for 5 min followed by 95°C for 1 min, annealing 
ranged from 52.5 to 64.5°C for 1 min (according to the probes as shown in Table 2-4.), 
and extension at 72°C for 1 min, final extension at 72°C for 5 min. The numbers of cycles 
of these PCRs were 35. 
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Table 2-4 Primers used to amplify 16S rRNA, seven housekeeping genes and virulence 
factor genes for A. baumannii 
 
2.7.4.15. Confirmation of PCR products by agarose gel electrophoresis 
Agarose gel was used to visualize the amplified and size of PCR products. The gel was 
prepared as follows: 1% (w/v) agarose (Fisher Scientific, UK) was made up in 1X Tris-
acetate-EDTA (TAE) buffer (Geneflow, UK). The solution was heated in a microwave oven 
to dissolve the agarose. 0.1 μ/ml (v/v) of SYBR® Safe DNA gel stain (Life Technologies – 
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Invitrogen, UK) was added and dissolved well in the agarose solution. The gel was then 
dispensed into the tray of gel and left for 20 to 30 minute to cool. After making wells, 10 
μl of 1kb ladder (Promega, UK) was loaded as marker into two wells and 10 μl PCR 
products were loaded into each of the well. Gel electrophoresis was performed for 40 
minutes at 100 V in 1X TAE buffer. The gel was then visualized under ultraviolet (UV) 
light. DNA bands were observed using the InGenius® gel documentation system 
(Syngene, UK).  
2.7.4.16. Purification of PCR product  
The amplified products were purified using the MinElute PCR Purification Kits (Qiagen, 
UK) according to the manufacturer’s protocol. The concentration and purity of the 
samples was checked by using the Nano drop 2000 (Thermo Scientific, UK). The purity 
of DNA samples with minimum 260/280 nm values of 1.8 and concentration with 
minimum 260/230 nm values of 15 ng were used. The products were finally eluted in 50 
μl of molecular biology grade water (Fisher Scientific, UK).  
2.7.4.17. PCR product sequencing 
PCR products were Sanger sequenced by Eurofins MWG Operon (London, UK) and 
source Bioscience (Nottingham, UK). The nucleotide sequences were determined on 
each DNA strand using nested sequencing primers. 
2.7.4.18. Whole Genome Sequencing 
Bacterial DNA was extracted from 1-day old cultures using GenElute bacterial genome 
kit (Sigma Aldrich, UK) using the manufacturer’s protocol. Genomes were sequenced on 
an Illumina MiSeq by Pauline Ogrodzki. Genome comparisons were applied to find the 
key physiological and virulence genes of the organisms such as environmental stress, 
attachment, invasion, capsule, cellulose, curli fimbriae and antimicrobial resistance 
genes. This comparative analysis was performed using WebACT comparative tool, 
Artimes comparative tool (ACT) for genome alignment, which has been developed by 
Carver et al. (2005). In addition, BLAST searches were performed using NCBI BLAST 
research facility at; https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_                                                                                                                                                    
TYPE=BlastSearch&LINK _LOC=blasthome. A collaborative approach was taken in this 
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study, and credit must be given to my colleague Pauline Ogrodzki (NTU), who carried 
out the whole-genome sequencing, as part of a parallel PhD study.  
2.7.5. Physiological assays 
Based on PFGE analysis and associated neonatal metadata, representative isolates were 
selected for further characterisation of various virulence traits.  
2.7.5.1. Haemolysis reaction  
Isolates were plated on 5% horse-blood (Oxoid Fischer Scientific, UK) agar and incubated 
at 37 °C  for 24 h. The resultant colony morphology was recorded after 24 h to determine 
the formation of either α-haemolysis, γ-haemolysis or β-haemolysis. Staphylococcus 
aureus NCTC 10788 was used as a positive control for β haemolysis, Streptococcus 
pneumoniae was used as a positive control for α haemolysis and Staphylococcus 
epidermidis was used as a negative control for λ haemolysis.  
2.7.5.2. Iron siderophore detection 
Siderophore detection assay was performed as described by (Shin et al., 2001). Two 
solutions were used to prepare the Chrome azurolsulphate (CAS) agar. The first solution 
which is a dark blue liquid was prepared by using 10 ml of iron III solution (Section 
2.5.10), 50 ml of CAS solution (Section 2.5.11), and 40 ml of HDTMA (Section 2.5.12) and 
then autoclaved at 121°C for 15 minutes, (the total volume of dark solution is 100 ml). 
The second solution was prepared by mixing 900 ml of DW, 15 g agar, 30.24 g PIPES 
(Sigma Aldrich, UK) and 12 g NaOH and then autoclaved at 121°C for 15 minutes. After 
autoclaving, the first solution was mixed with the second solution and then the media 
was dispensed into the petri dishes. Immediately before use, 5mm diameter holes were 
punched into the agar using 5mm diameter gel plug cutter. The bacterial suspension was 
prepared by inoculating five colonies from TSA culture into 10 ml TSB broth containing 
200 μM of 2,2´-dipyridyl (Sigma Aldrich, UK) and incubated at 37°C in shaking incubator 
at 200 rpm for 20 h. Then the samples were centrifuged at 5000 rpm for 10 minutes and 
70 μl of the supernatant was placed into a specific hole. The agar was incubated at 37⁰C 
for up to 8 hours and observed for the presence of an orange zone around the hole 
which indicated that the strain is positive for siderophore production. Yersinia 
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enterocolitica strain 1880 and C. sakazaki 520 were used as positive and negative 
controls respectively.  
2.7.5.3. Protease activity  
Ten percent skimmed milk powder (Thermo Fisher Scientific, UK) was used to prepare 
the skimmed milk solution (SMS) and autoclaved for 5 minutes at 121°C. PCA plate count 
agar was prepared by adding 22.5 g to 1 litre of distilled water and autoclaved at 121°C 
under 15 psi pressures for 15 minutes. 20 ml of 10 % SMS was aseptically mixed with 
980 ml of PCA and then dispensed into Petri dishes to be stored at room temperature 
for 2 days. The tested strains were streaked on the dried plates and incubated at 37°C 
for 72 h and monitored every 24 h. Bacillus cereus was used as a positive control while 
E. coli DH5α NTUCC407 was used as a negative control.  
2.7.5.4. Cellulose production  
LB agar without salt was prepared and supplemented with calcofluor white stain (Fluka, 
UK) as mentioned in 2.6.10. The medium was poured in petri dishes and left to dry for 2 
days. Representative strains were streaked and incubated either at 37°C for 24 h and 
then the cellulose production was visualised by using ultraviolet light at 366 nm.  
2.7.5.5. Congo red morphotype  
To prepare LB agar without salt, 5 g of tryptone (Thermo Fisher Scientific, UK), 2.5 g of 
yeast extract (Melford laboratories, UK) and 7.5 g agar (Thermo Fisher Scientific, UK) 
were mixed in 500 ml distilled water and then autoclaved. Congo red solution dye was 
prepared by dissolving 32 mg of Congo red powder (Sigma Aldrich, Uk) in 8 ml sterile 
distilled water (SDW) and the solution was filtered with 0.20 μm pore filter. After this, 
LB agar without salt was cooled to 55°C, 5 ml of filtered Congo red solution was added, 
gently mixed and dispensed into petri dishes. 
2.7.5.6. Biofilm Formation 
The biofilm formation was performed according to the crystal violet (CV) method as 
described by Zhang et al., (2004) with some modification. Eighteen hour TSB cultures 
were used to inoculate 5 ml of TSB and adjusted to O.D = 0.3 reading at 600 nm. In three 
96 plates, 600 μl of each inoculated TSB was dispensed into 3 wells (200 μl into each 
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well) of each 96 well plate. Also liquid infant formula (Cow and Gate Premium 1) was 
used instead of TSB to detect and compare the ability of examined isolates forming 
biofilm in both media. After measuring the O.D of TSB culture the milk was adjusted to 
a cell density of an O.D = 0.3. Loading plates were incubated for 24 h at 25°C and 37°C. 
After 24 hours of incubation the plates were emptied from the TSB or the milk and 
washed twice with sterile distilled water (SDW) the plates then left for 10 minutes at 
room temperature to dry. Two hundred microliter of 1% crystal violet (CV) was added 
to each well and left for 30 minutes after which all the wells were washed three times 
with SDW. Finally, 200 μl of absolute ethanol was added to each well and after 15 
minutes the content of the plates was transferred into new plates and read using ELx800 
absorbance microplate reader (BioTek, UK) at absorbance 600 nm.  
2.7.5.7. Capsule production assay 
For detecting the ability of the strains to produce capsule, two types of media were used; 
formula whey (Cow and Gate Premium 1) and soy-based (Cow and Gate infasoy). For 
preparing milk agar 800 ml of Plate Count Agar (PCA) was made according to the 
manufacture of instructions. Gently 200 ml of milk (20% final concentrated) was added 
to PCA and mixed and the media then dispensed into petri dishes. All plates were left at 
room temperature for drying. The test strains were plated on the PCA with milk agar and 
incubated at 37°C for 24h.  
2.7.5.8. Serum resistance 
A single isolated colony was inoculated into TSB and incubated at 37 °C for 24 h with 
shaking. The bacterial suspension was then diluted 1:10 in new TSB and incubated under 
the same conditions for 2 h. Forty microliters of the bacterial culture were added to 360 
μl of 50% human serum (Sigma, UK). Strains were compared with negative and positive 
controls which were Escherichia coli K-12 and Salmonella Eenteritidis respectively. The 
remaining viable bacterial cells after 24 h were counted using the Miles and Misra 
technique. All strains were tested in triplicate and in three independent experiments. 
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2.7.5.9. Acid tolerance 
Acid tolerance was studied following the method of Edelson-Mammel et al. (2006) with 
some modification. One colony from a fresh TSA plate was used to inoculate 5 ml of TSB 
and incubated in shaking incubator for overnight at 37°C. To mimic the stomach acid, 
the pH of a liquid infant formula (Cow and Gate Premium 1) was adjusted to pH value of 
3.5 units with 1 M of hydrochloric acid. One millilitre of the bacterial cell suspension was 
inoculated into acidified infant formula at pH 3.5 in a water bath at 37 °C. Viable cells were 
enumerated after 0, 15, 30, 60, 90 and 120 min using the Miles and Misra technique. All 
experiments were performed in triplicate from separate overnight cultures. 
2.7.5.10. Heat tolerance 
Thermal resistance of representative strains were investigated at 55°C. The heat 
tolerance of tested strains were determined as described by (Breeuwer et al., 2003) with 
some modification. Briefly, 1 ml overnight culture was suspended in 9 ml of temperature 
equilibrated sterile liquid infant formula (Cow & Gate Premium 1) in a water bath at 55°C. 
At zero time 20 μl of suspension were transferred to one well of the 96 well plates. This 
was repeated every 10 minutes for 30 minutes. Serial dilutions of the bacterial 
suspension (20 μl) were diluted in saline to 10-7. The Miles and Misra enumeration 
technique on TSA plates was used to determine the number of cells surviving exposure 
to 55°C. The number of survivors at this temperature was plotted against time. The best 
fit-line was extrapolated and the D values were determined (-1/slope of the regression 
line). Each single number presented in this thesis is an average of three replicate 
experiments. The standard deviations of the D value were calculated. 
2.7.5.11. Desiccation stress  
All strains were grown on TSA plates overnight at 37°C. A single colony from a purity TSA 
plate was used to inoculate 5 ml of TSB and incubated in shaking incubator overnight at 
37°C. The overnight bacterial growth was diluted to 1:10 using liquid infant formula (Cow 
and Gate Premium 1) and the bacterial cell density was approximately 109 CFU/ml. 
Aliquots 0.2 ml of the suspension were transferred into six-well plates and air-dried 
overnight in a class II cabinet at room temperature (20 to 25°C) as described by Caubilla-
Barron and Forsythe (2007). After desiccation, the reconstitution time points were 24 h 
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and 14 days. The test strains were re-suspended in 0.2 ml of sterile water and viable 
counts were determined in triplicate using the Miles and Misra method on TSA. 
2.7.5.12. Antimicrobial susceptibility assay 
Susceptibility to antimicrobial agents were tested by the Kirby-Bauer method, as 
described by British Society for Antimicrobial Chemotherapy guidelines (BSAC, 2015). 
The antibiotics tested were augmentin, imipenem, meropenem, ceftazidime, ampicillin, 
chloramphenicol, gentamicin, tobramycin, cefotaxime, vancomycin, doxycycline and 
ciprofloxacin. ESBL production was determined by the combination of cefotaxime + 
clavulanate, cefpodoxime + clavulanate discs according to the manufacturer's 
instructions (Mast Diagnostics, Bootle, United Kingdom). Four colonies of fresh TSA 
culture were suspended in 3 ml of sterile normal saline and the OD adjusted to be 
equivalent to a 0.5 McFarland standard. Suspensions were swabbed onto ISA (OXOID, 
UK) and then the antibiotic disks were applied onto the surface of the ISA plates. The 
plates were incubated at 37 °C for 20 h. The diameters of zones of inhibition were 
measured and interpreted according to the BSAC Protocol (2015). Escherichia coli strain 
10418 and Escherichia coli 13353 were used as negative and positive controls 
respectively. 
2.7.6. Determination of bacterial pathogenicity using tissue culture 
2.7.6.1. Bacterial strains  
Salmonella Eenteritidis strain number NCTC 3046 358 and Citrobacter koseri strain 
number SMT319 48, were used as positive controls for HBMEC and Caco-2 cell lines.  E. 
coli K12 MG1655 was the negative control for all cell lines. A single colony of each test 
and control strain was inoculated into 5 ml of TSB and incubated in a shaking incubator 
at 200 rpm at 37°C for 18 h. 120 μl of overnight culture was added to 5 ml of appropriate 
infection culture media as described below in Section 2.7.6.2 and incubated for a further 
2 h to reach the OD of 0.3-0.5 at 600 nm using the spectrophotometer (JENWAH, UK), 
to obtain 4x106 cfu/ml, which equated to a multiplicity of infection (MOI) 1:100 on the 
cells.  
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2.7.6.2. Culture Media for Caco-2 and HBMEC cell lines  
All media and reagents for cell culture were obtained from Sigma Aldrich, UK unless 
otherwise stated. Growth medium for Caco-2 cells was Minimum Essential Medium 
(MEM) with 10% fetal bovine serum (FBS), 1% non-essential amino acids solution and 1% 
Penicillin-Streptomycin. HBMEC cells were grown in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% FBS, 1% non-essential amino acid solution 
and 1% Penicillin-Streptomycin. The infection medium for the two cell lines was same as 
the growth medium but lacking the 1% Penicillin-Streptomycin. 
2.7.6.3. Human cell lines  
 Human eukaryotic cell lines were used to determine the bacterial adhesion and invasion 
ability as shown in Table 2-5. All cell lines were stored in liquid nitrogen. When a cell line 
was required, a vial was taken from the liquid nitrogen and thawed quickly. The content 
of the cell line tube was mixed into 6 ml of suitable pre-warmed growth medium, as 
explained above in Section 2.7.6.2, in a 15 ml falcon tube. The tube was then centrifuged 
at 1200 rpm for 5 minutes to harvest the cells. After discarding the supernatant, the cell 
pellet was re-suspended into 6 ml pre-warmed growth medium and transferred into a 
25 cm3 tissue culture flask. Finally, the flask was incubated for 48 hours at 37°C in the 
presence of 5% CO2. After the cell line achieved a confluent monolayer, the medium was 
decanted out and the cells were detached using 5 ml of TrypLe™ express (Life 
Technologies, UK). The cell suspension was mixed with 5 ml pre-warmed growth 
medium and centrifuged at 1200 rpm for 5 minutes. The supernatant was discarded and 
the cell pellet was re-suspended in pre-warmed growth medium and then transferred 
into a new 75 cm3 tissue culture flask containing 20 ml of pre-warmed growth medium. 
The cell lines were maintained and split routinely twice a week to keep the continuity of 
growth. 
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Table 2-5 Cell lines used in this study. 
 
2.7.6.4. Determination of the bactericidal concentration of gentamicin  
Before tissue culture assays could be carried out, preliminary experiments were needed 
in order to determine the susceptibility of test strains to gentamicin as this is used to 
discriminate between attached and internalized bacterial cells. Strains were tested at 
the different gentamicin concentrations. Due to the resistance of these strains, this 
concentration was increased to 125 μg/ml and strains were re-tested. The antibiotic 
susceptibility testing was conducted in accordance with the (BSAC guidelines, 2015). The 
inhibitory effects of the gentamicin were determined by the micro-dilution method 
(BSAC, 2015). Bacterial cultures were grown in TSA for 18-20h at 37°C. Their turbidity 
was adjusted to McFarland Standard 0.5 (~1.5x108 cfu /ml) before being diluted to 1:10 
and 1:100. Equal volumes of these dilutions and the gentamicin solution were added at 
a final concentration of 31.2, 62.5, 125 and 250 μg/ml to 96-well plates. Blank bacterial 
suspensions (without gentamicin) were also included as controls for each strain. Plates 
were incubated for 20h at 37 °C. Aliquots (~10 μl) of these overnight suspensions were 
inoculated into TSA plates. The presence or absence of growth recovery was checked 24 
h later. Duplicate results were recorded for each strain. 
2.7.6.5. Attachment to human cells  
For Caco-2 and HBMEC the cells were grown as described above in Section 2.7.6.3. The 
adhesion assay was conducted as described by Townsend et al., (2008b). The cells were 
seeded into 24-well plates (Sarstedt, Germany) at a concentration of 4x104 cells/well in 
growth medium and incubated at 37°C under 5% CO2 for 48 h to achieve a confluent 
monolayer. After achieving the confluent monolayer, the bacterial strains of interest and 
control strains were grown as described in Section 2.7.6.1. Bacterial suspension was 
added to the wells at a concentration of 4x106 cfu /well, which equated to an MOI of 
Chapter 2 . Materials and Methods 
 
47 
 
1:100 on the cells, and 24-well plates were incubated at 37°C with 5% CO2 for 2 h. After 
the incubation period, the plates were washed 3 times with PBS (Sigma Aldrich, UK) to 
remove unbound bacteria, and attached bacterial cells were released by lysing the 
human cells with 1% Triton X-100 (Thermo Fisher Scientific, UK). Serial dilution and Miles 
Misra method on TSA were performed to determine the overall number of viable 
attached bacterial cells. All bacterial strains were added to cells in similar numbers and 
the cfu/well of the original bacterial suspensions were determined. 
2.7.6.6. Invasion of human cells 
The preparation of cell lines and bacterial infection dose were used the same method as 
that of the adhesion assay  as described in Section 2.7.6.1 and 2.7.6.3.  However, after 
3 times washing with PBS the wells were filled with 500 μl infection media supplemented 
with gentamicin at a concentration of 125 μg/ml and the plates were incubated in same 
condition for 1 h to kill any extracellular bacteria. The plates were washed a further 3 
times with PBS (Sigma Aldrich, UK) and invasive bacterial cells were released by lysing 
the human cells with 1% Triton X-100 (Thermo Fisher Scientific, UK). Serial dilution and 
Miles Misra method on TSA were performed to determine the overall number of viable 
invaded bacterial cells. 
2.7.6.7. Uptake and persistence into macrophage cell line U937 
2.7.6.7.1. Culture media  
The macrophage cell line U937 was grown in RPMI medium containing 2 mM L-
glutamine, 10 mM HEPES, and 1 mM sodium pyruvate. The growth medium was 
supplemented with 10% FBS, 1% non-essential amino acids solution and 1% Penicillin-
Streptomycin while infection medium was supplemented just with 10% FBS and 1% non-
essential amino acid solution. The condition of incubation was 37°C under 5% CO2 for 24 
h. 
2.7.6.7.2. Macrophage Assays  
The experiment was performed as described by (Townsend et al., 2008b). The 
macrophage cells were seeded into four 24-well plates (Sarstedt, Germany) at a 
concentration of 4x104 cells/well in growth medium and incubated at 37°C under 5% 
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CO2 for 72 h to achieve a confluent monolayer. However, before seeding the cells into 
24-well plates, the macrophage cell suspension was supplemented with phorbol 12-
myristate 13-acetate (PMA; Sigma Aldrich, UK) at a concentration of 0.1 μg/ml to 
promote cell adhesion. The seeded plates were washed 3 times with PBS before cells 
were infected with the determined infection dose. All tested and control strains were 
prepared as described previously in Section 2.7.6.1; however, the infection dose was at 
a concentration of 4x105 cfu/ml which is equivalent to an MOI of 1:10. The plates were 
incubated at 37°C under 5% CO2 for 1 h and the bacterial infection medium was replaced 
with infection medium supplemented with gentamicin at a concentration of 125 μg/ml 
and incubated in the same condition for further one hour. Three plates were washed 3 
times with PBS and infection medium with gentamicin at a concentration of 50 μg/ml 
was added into the wells and incubated for intervals period 24 h, 48 h and 72 h. The 
infection medium with gentamicin was changed every day. At different time points 1 h, 
24 h, 48 h and 72 h, each plate was washed 3 times with PBS and treated with 1% Triton 
X-100 to lyse the macrophage cells. Serial dilution and Miles Misra method on TSA were 
performed to determine the overall number of viable intracellular bacteria. 
2.7.6.8. Bacterial cytotoxic activity (MTT) 
This assay is based on the reduction of MTT (Sigma Aldrich, UK) by viable cells to its 
insoluble form formazan, which has a purple colour. This experiment was applied as 
described previously (Krzymińska et al. 2009) with some modifications. Human cells, 
Caco-2, were grown in 24-well plates at 4x104 cell/well. The plates were then incubated 
for 48 hours at 37°C in 5% CO2. Bacterial suspensions were prepared by growing bacteria 
for 18 hours prior to infection. These were then added to the wells at 4x106 cfu/well to 
achieve MOI of 100. The plates were then incubated in 5% CO2 at 37°C for 1 hour. The 
wells were then washed three times using PBS before adding 0.5 ml fresh tissue culture 
infection medium. A volume of 50 μl of MTT at a concentration of 5 mg/ml (w/v) was 
added to each well. The plates were then incubated in 5% CO2 for 1 hours at 37°C. Next, 
the medium containing MTT was removed and formazan was solubilised in dimethyl 
sulfoxide (DMSO; Fisher Scientific, UK). The plates were then shaken for 10 minutes 
before measuring the absorbance at 600nm using a plate reader (BioTek, UK). The 
negative control for the assay consisted of uninfected cells. 
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2.8. Statistical analysis 
All the conducted experiments in this study were repeated at least twice. The statistical 
analysis was carried out using unpaired t-test and One-way and Two-way ANOVA (Graph 
Pad Prism Software Version 7.0) to determine statistical significance. A p value of < 0.05, 
< 0.01 and < 0.001 was considered statistically significant, highly significant and very 
highly significant respectively. 
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Chapter 3. Profiling a clinical collection of Acinetobacter baumannii 
strains isolated from nasogastric enteral feeding tubes 
3.1. Introduction 
Premature babies are highly susceptible to infection and one of the major routes of 
infection is through contamination of infant feeding formula. There are several risk 
factors to neonatal infection; the most important of which would include the use of 
medical devices such as nasogastric enteral feeding tubes (NEFTs) and intravascular 
catheters. Easily penetrable epithelial and mucosal barriers and underdeveloped 
immune systems are also factors which predispose neonatal infection (Hurrell et al., 
2009b; Ramasethu, 2017). The gastrointestinal tract of neonates may be sterile at birth; 
however, it is rapidly colonised by bacteria afterwards, making up part of the normal 
microflora (Rodríguez et al., 2015; Chong et al., 2018). 
Premature infants are often fed through a NEFT, with nutrition provided through 
different food types ranging from fortified breast milk, to reconstituted powdered infant 
formula (PIF) (Hunter et al., 2008). None of these nutritional sources can be considered 
as a sterile food type (Drudy et al., 2006). The lumen of feeding tubes acts   as a locus 
where bacterial cells can adhere, colonise, and produce multispecies biofilm, before 
sloughing off as clumps of bacteria and entering the neonatal gastrointestinal tract each 
time fresh feed passes through the tube (Hurrell et al., 2009a; Hurrell et al., 2009b; 
Ogrodzki et al., 2017 ). These clumps of bacteria are likely to be resistant to stress 
conditions such as neonatal low gastric pH, and are therefore able to survive in higher 
numbers (Ogrodzki et al., 2017). 
A potential major source of neonatal infection would be the hospital environment itself. 
It has been reported in previous studies that healthcare practice in neonatal intensive 
care units (NICUs), such as antibiotic exposure play vital role in the nosocomial infections 
(Khan, 2015). Previous investigations carried out at Nottingham Trent University (Hurrell 
et al., 2009a and 2009b) have demonstrated that neonatal enteral feeding tubes are 
prone to rapid colonisation by a wide variety of opportunistic pathogens of the 
Enterobacteriaceae, irrespective of feeding regime.  It is estimated that microbial 
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infections are responsible for up to 50% of infant mortality cases, of which, bacteria are 
considered to be the major cause accounting for 26% of neonatal deaths worldwide. 
In recent years, there has been a rise in the incidence of neonatal infections among 
babies born with low birth weight and undeveloped immune systems, especially among 
those fed via nasogastric tubes, which presents an important risk factor in respect to 
neonatal infections in NICUs. Several different organisms are responsible for causing 
infections in the NICU. Among them, the Gram-negative bacterium Acinetobacter 
baumannii, has received more attention and it is reported widely as an important and 
problematic opportunistic pathogen in the clinical setting (Gonzalez and Garduno, 2016). 
For example, A study by Softic et al., (2013) reported that the outbreaks of sepsis in 
neonatal intensive care units caused by multidrug-resistant Acinetobacter baumannii in 
the University Clinical Centre in Bosnia and Herzegovina (2012). 
The Acinetobacter genus is a member of the Moraxellaceae family of 
Gammaproteobacteria. It is described as a Gram-negative, non-lactose fermenting, 
strictly aerobic, oxidase-negative, indole negative, non-motile, catalase-positive, and 
rod-shaped coccobacillus. Having been discovered since 1911, it was not until the late 
1970’s that it gained recognition as a significant hospital-acquired pathogen (Howard et 
al., 2011). In 1986, 12 phylogenetic groups of Acinetobacter were defined using DNA-
DNA hybridization and 4 new species of this genus were proposed, which included A. 
baumannii (Chan et al., 2012). 
3.1.1. Clinical importance of A. baumannii 
Acinetobacter species which are commonly isolated from hospitals typically belong to 
the Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) complex. However, 
among these species, A. baumannii has attracted significant attention over the 
preceding decades as one of the most globally important pathogens in healthcare 
institutions (Joly-Guillou, 2005). The incidence rate of A. baumannii infection is very high 
in most hospitals and its emergence is becoming a major concern because of its ability 
to make use of a wide range of multidrug resistance mechanisms. For instance, 
Uwingabiye et al., (2017) reported that among 964 patients hospitalized in the ICUs in a 
Moroccan teaching hospital, 81 (8.4%) developed A. baumannii infections. In other 
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study by Cai et al. (2017) reported that the Prevalence of Carbapenem-Resistant 
infections in different hospitals between 2009 and 2013 in the United States 
Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa. 
Additionally, of concern is its ability to persist in the hospital environment for prolonged 
periods of time (Lăzureanu et al., 2016). Study by Juma et al. (2016) to investigate the 
persistence of desiccated Acinetobacter in infant formula; their study showed that the 
ability of A. baumanni, A. calcoaceticus can survive in desiccated infant formula and 
maintain its viability during long-term desiccation for 6 and 9 months. Antimicrobial 
resistance by A. baumannii has recently been identified by the World Health 
Organization (WHO) 2017 as a critical priority pathogen. Additionally, it is reported as a 
one of the most serious ESKAPE pathogens leading cause of nosocomial infections 
throughout the worldwide (Santajit and Indrawattana 2016) . The ESKAPE pathogens 
(Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa, and Enterobacter species) are important of 
nosocomial infection and multidrug resistant strains (Santajit and Indrawattana 2016; 
El-Mahallawy et al., 2016; Karlowsky et al., 2017; Silva et al., 2017). 
3.1.2. Infections caused by Acinetobacter baumannii  
A. baumannii is of particular concern because it has emerged as a clinically significant 
antimicrobial-resistant pathogen that is ubiquitous in the clinical environment (Peleg et 
al., 2008). It is an important nosocomial pathogen, particularly of critically-ill patients, 
including those in the intensive care unit ICU (Alsan and Klompas, 2010; Almasaudi, 
2018). A. baumannii is considered as a typical opportunistic pathogen. It causes a variety 
of different infections, including bacteraemia, pneumonia, wound infection, urinary 
tract infection (UTI), meningitis, and nosocomial post-neurosurgical infections. 
Acinetobacter meningitis is becoming increasingly more common, with many other 
Gram-negative species also proving to be problematic in post-operative care (Howard 
et al., 2012; Santajit and Indrawattana 2016). 
In recent times, Acinetobacter infections, including those of human skin and soft tissue, 
have become highly problematic among inpatients. It was reported that Acinetobacter 
was responsible for around 3% of ICU-acquired skin and soft tissue infection (Howard et 
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al., 2012). A. baumannii was also reported to cause ICU-acquired bloodstream infections, 
which are responsible for the third highest mortality rate among patients in the ICU. For 
example, it was found that A. baumannii was responsible for around 1.5% of all 
nosocomial bloodstream infections among 24 hospital in the United States (Wisplinghoff 
et al.,  2000). While in the Brazil Acinetobacter spp caused 9.2% prospective surveillance 
nosocomial bloodstream infections at 16 hospitals among paediatric patients (Pereira et 
al.,  2013). A previous study has reported that the mortality rates for A. baumannii at 
Hamad General Hospital, Qatar, was 31% among patients had underlying medical 
conditions (Al Samawi et al.,  2016). However, infections are more common in patients 
who have undergone major surgical procedures or suffering from an underlying disease. 
With regards to acquiring the pathogen within the hospital environment, A. baumannii 
can enter the body easily through open wounds, ingestion, mechanical ventilators and 
intravascular catheters. 
3.1.3. Potential virulence-associated traits  
A. baumannii strains demonstrate several potential virulence-associated genes due to 
their involvement in both epithelial cell attachment and invasion and human serum 
resistance. Genes encoding phospholipases plACD have been found to play an important 
role in the virulence of A. baumannii and are also responsible for its survival in human 
serum (Camarena et al., 2010; Jacobs et al., 2010; Stahl et al., 2015). Also, outer 
membrane proteins including (OmpA) have been confirmed to be involved in epithelial 
cell invasion and apoptosis (Kim et al.,  2010; Kim et al.,  2016).  Additionally, 
lipopolysaccharides (LPS) may have a role in causing septic shock as result of A. 
baumannii passing into the bloodstream (Ketter et al., 2014). Other potential virulence-
associated traits include carbapenem-resistance genes which are believed to be a major 
problem in nosocomial infections, especially oxacillinases (OXA). Multidrug resistance 
of A. baumannii infections is the major concern in critical care patients in the ICU (Sileem 
et al., 2017; Blanco et al., 2018). Over the last few years, the rapid increase in the 
number of antibiotic resistance of A. baumannii has become a global issue, due to use 
of extensive of broad- spectrum antibiotics (Gonzalez and Garduno, 2016; Gao et al., 
2017). In 2016, European Centre for Disease Prevention and Control (ECDC) has reported 
the increase of carbapenem-resistant A. baumannii in Europe. Furthermore, it is a one 
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of the most serious ESKAPE pathogens, which they are known for important health 
concerns due to their antibiotic resistant nature (Xie et al., 2018). For instance, in 17 
European countries about 96 carbapenem-resistant Acinetobacter baumannii strains 
were isolated from 25 hospitals (Towner et al., 2011). Another study by Novovic (2015) 
showed that Twenty-eight clinical isolates of carbapenem-resistant A. baumannii strains 
were isolated from pediatric hospital in Serbian, their study showed that the all isolates 
harboured intrinsic OXA-51, AmpC cephalosporinase and OXA-23 was detected in 16 
isolates. 
3.1.4. Biofilm formation 
In addition to the virulence factors mentioned above, biofilm formation is also reported 
as a virulence-associated trait by helping to maintain cell survival on biotic and abiotic 
surfaces (Tomaras et al., 2003; Gaddy and Actis; 2009). In the last three decades, 
bacterial biofilms have been studied extensively, and biofilm formation is recognised as 
a well-known pathogenic mechanism which is involved in a multitude of serious chronic 
infections (Joo and Otto, 2013). Among Gram-negative pathogenic bacteria responsible 
for biofilm-associated infection, A. baumannii has received the most attention 
concerning this due to its ability to form strong biofilms (He et al., 2015; Longo et al., 
2014). This organism has been found to be frequently associated with the surface of 
medical devices such as catheters, intubation tubes, cleaning instruments and water 
lines (Tomaras et al., 2003; Abdi-Ali et al., 2014; Pakharukova et al., 2018). Biofilms are 
complex biological matrices that contain nucleic acids, ions, proteins and polysaccharide 
polymers. One of the major components of biofilms, which has been well described in 
Staphylococcus aureus and Staphylococcus epidermidis, is poly-β-(1-6)-N-
acetylglucosamine (PNAG) (Itoh et al., 2005; Ferreirinha et al., 2016). Choi (2009) 
reported that synthesis of PNAG in A. baumannii is controlled by an operon (pgaABCD) 
which is also present in the genomes of several other Gram-negative bacteria, such as 
Pseudomonas fluorescens, Escherichia coli, Y. enterocolitica and Yersinia pestis. It has 
also been reported that deletion of the pgaABC genes in A. baumannii resulted in 
mutants that are defective for PNAG production and led to strong decrease biofilm 
phenotype (Choi et al., 2009). Another study (Tomaras et al., 2003), reported that the 
presence of pili-like structures on the surface of A. baumannii leads to biofilm formation. 
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The disruption of the csuE and csuC resulted in non-piliated cells and eliminated biofilm 
formation and cell attachment (Tomaras et al.,  2003). Bacteria in biofilms are also 
associated with the expression of several virulence factors, including the quorum 
sensing system and outer membrane protein OmpA (Kim et al., 2016; Subhadra et al., 
2016). Moreover, it has been hypothesised that biofilm formation in Acinetobacter 
mediates prolonged survival of the organism in healthcare settings (Espina et al., 2012). 
The biofilm-forming ability of this microorganism can be considered one of the main 
virulence factors shared among the vast number of clinical A. baumannii isolates 
(Rumbo et al., 2013; Longo et al., 2014; Reena et al., 2017). 
3.1.5. Aim and objectives 
Acinetobacter baumannii is recognised as a pathogen of considerable clinical 
significance. The organism has been associated with several epidemics and has become 
one of the major concerns in healthcare settings worldwide (Almasaudi, 2018). The 
spread of A. baumannii in the clinical environment has been reported to be responsible 
for nosocomial infections associated with blood stream infection, pneumonia and 
mortality rates may reach 35% (Antunes et al., 2014). It has been proposed that the 
organism could cause bacteraemia and spread throughout the body of the neonate. For 
example, those born with low birth weight and undeveloped immune systems. This 
could be of particular concern for neonates fed via a nasogastric tube, which is an 
important risk factor with respect to infections in the NICU. Additionally, nasogastric 
feeding tubes may act as a location for bacterial colonisation due to the formation of 
biofilm in the lumen of the tube (Hurrell et al., 2009b). 
Therefore, the overall aim of the project was to profile a clinical collection of A. 
baumannii isolated from neonatal feeding tubes from NICUs in two separate hospitals, 
Princesses Rahma Hospital (PRH) and King Abdulla Hospital (KAH) in Jordan. This was 
achieved according to the following objectives:  
- Identify their species, source and relatedness of these strains, using PFGE 
method, and MLST techniques to determine whether some of the strains might 
originate from common sources, such as being transferred to multiple patients 
within specific neonatal units. 
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- A range of physiological traits, such as capsule and biofilm formation, acid, serum 
resistance and desiccation tolerance will be characterised to evaluate the 
possible risk to neonates acquiring these organisms through feeding tubes. 
-  Determine the correlation between biofilm formation and ability to adhere. 
Indeed, the quantitative differences in biofilm formation and ability to adhere 
among clinical isolates have been poorly investigated thus far. 
- Genomic analysis of representative isolates to identify virulence and antibiotic 
resistance genes. 
- In vitro virulence characterization of representative isolates by using epithelial 
cell line Caco-2, to determine bacterial attachment, invasion, cytotoxicity and 
their persistence within the human macrophage cell line U937. 
3.2. Materials and Methods 
The methodology of this chapter is described in detail in Chapter 2 above (Section 2). 
Forty-three A. baumannii strains were used in this project, which were isolated from 
nasogastric enteral feeding tubes from neonates in NICUs, from Princesses Rahma 
Hospital (PRH) and King Abdulla Hospital (KAH) in Jordan. The strains had been collected 
from two hospitals between 15/7/2011 and 21/12/2011. However, neonatal 
information regarding sample source, birth of neonate, and date of isolation are 
presented in Table 3-1. Eighteen representative strains of A. baumannii were selected 
for further investigation based on pulsed field gel electrophoresis (PFGE), hospital, 
neonatal sample source information, and birth of neonate. Of the 18 strains tested, 10 
representative strains 1591, 1595, 1601, 1604, 1613, 1615, 1618, 1623, 1624 and 1630 
were selected based on PFGE groups, sample source and virulence factors for whole 
genome sequencing (WGS) and tissue culture. Tissue culture-based virulence studies, 
using the human colonic epithelial cell line Caco-2, were performed in order to 
determine bacterial attachment, invasion, and cytotoxicity. The attachment and the 
gentamicin protection assay was used to assess the invasion ability of A. baumannii 
to invade and to survive within the cell line. In addition, the macrophage cell line U937 
was used with representative strains in order to investigate their ability to internalise 
and persist within human macrophages. 
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Table 3-1 A. baumannii strains used in this study.  
 
PRH = Rahma Hospital. KHA = Abdulla Hospital (Jordan).  
NA = Data not available, D.O.I = Date of isolation. FIF = Flushed infant formula. 
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3.3. Results 
3.3.1. Genotyping Profiles 
3.3.1.1. Pulsed Field Gel Electrophoresis (PFGE) 
Molecular typing by PFGE was performed using the BioNumerics software to study the 
potential relatedness of 43 A. baumannii isolates. These isolates were digested using 
two restriction enzymes ApaI and Ascal. They would be considered to be non-clonal 
when they have less than 95% of band similarity value (Tenover et al., 1995).  
The Apal restriction enzyme digest results shown in Figure 3-1, indicated that the 43 
strains clustered into five pulsotypes. The majority of strains clustered in pulsotype Ac1, 
with a similarity coefficient of 100%, while only one strain, 1623, was shown to be highly 
related with a similarity coefficient of 97%. This was caused by a difference of one band 
extra after restriction with ApaI enzyme. Of particular interest was that all strains of 
pulsotype Ac1 were isolated from NICUs in 2 hospitals, over a 5-month period, from 
neonates ranging from 5 to 47 days old, and described as receiving different types of 
feeding milk. However, after the initial isolation on 15/07/2011, no further isolates were 
recovered until a period between 01/12/2011 and 21/12/2011. Pulsotype Ac5 
comprised two strains, 1594 and 1595, which were isolated on the same day from the 
same patient, aged 8 days old. One strain, 1624, belonged to Ac3 which was a unique 
pulsotype. Also, two strains, (1603 and 1604) which belonged to pulsotypes Ac1 and Ac4 
respectively, were isolated from the same patient in the same hospital. The same strain 
belonging to pulsotype Ac1 was isolated twice from the same neonate on the same day. 
For example, the two strains 1597 and 1598 belonging to pulsotype Ac1 were isolated 
from the same neonate at the same time and date. Pulsotype Ac1, containing the largest 
number of strains (n = 38), was also the most frequently detected pulsotype among 
strains isolated from two hospitals. 
According to hospital, neonatal sample source information, birth of neonate, and 
pulsotype, 18 representative strains of A. baumannii were selected for further study. 
The representative strains similarly grouped into 5 pulsotypes with the second 
restriction enzyme AscI, confirming the ApaI results, as shown in Figure 3-2. 
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Figure 3-1: Apal PFGE profiles of 43 Acinetobacter baumannii strains isolated from 
neonatal enteral feeding tubes. 
It was revealed that the strains clustered into five pulsotypes. Representative strains are highlighted in 
bink color were selected according to pulsotype, hospital, neonatal sample source and birth of neonate. 
Dendrogram construction and band assignment was achieved using BioNumerics software version 7.1. 
For cluster analysis, dice coefficient, un-weighted pair group method with arithmetic mean (UPGMA) was 
used. Band similarity <95% of value was used to consider the isolates to be non-clonal. The tolerance and 
optimization of the bands was 1.5%. AC: indicates PFGE cluster groups, DOI: Date of isolation, PRH: 
Princesses Rahma Hospital, KAH: King Abdulla Hospital. 
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Figure 3-2: Apal and Ascl PFGE profiles of 18 representative Acinetobacter baumannii 
strains isolated from neonatal enteral feeding tube. These strains were selected 
according to pulsotype, hospital, neonatal sample source and birth of neonate. 
Dendrogram construction and band assignment was achieved using BioNumerics software version 7.1. 
For cluster analysis, dice coefficient, un-weighted pair group method with arithmetic mean (UPGMA) was 
used. Band similarity <95% of value was used to consider the isolates to be non-clonal. The tolerance and 
optimization of the bands was 1.5%.AC: indicates PFGE cluster groups, DOI: Date of isolation, PRH: 
Princesses Rahma Hospital, KAH: King Abdulla Hospital.  
Table 3-1 summarises the results of Figure 3-2. The 43 A. baumannii strains were 
isolated from neonatal feeding tubes as a biofilm, from two Jordanian hospitals in 2011. 
The strains were clustered into five pulsotypes; Ac1, Ac2, Ac3, Ac4 and Ac5 and are 
described briefly below.  
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Table 3-1: Summary of PFGE analysis of forty-three A. baumannii strains. 
 
PRH: Princesses Rahma Hospital, KAH: King Abdulla Hospital, P.T: pulsotype, Ac: PFGE cluster groups,  
3.3.1.2. Partial rpoB sequence analysis for Acinetobacter genus identification 
The rpoB gene (350 bp) was amplified and sequenced for 18 representative isolates. 
Based on multiple alignments, sequence similarities of rpoB gene were compared with 
strains of Acinetobacter from GenBank database. All strains were identified as A. 
baumannii and found to be the closest to the A. baumannii strain type in GenBank, yet 
well differentiated from other Acinetobacte spp. reference strains. Most of the isolates 
were identified to the species level with high similarity to A. baumannii. A phylogenetic 
tree was constructed from partial rpoB sequence analysis using the neighbour-joining 
method. It was clear from this analysis that all the species had separated into distinct 
clusters. The phylogenetic tree, which is based on a sequence analysis in zone 1 of the 
rpoB gene, showed homogeneous grouping of A. baumannii (Figure 3-3). Two isolates 
were misidentified by API phenotyping as Acinetobacter lwoffi in the hospital. However, 
rpoB sequencing confirmed the identity of isolates of Acinetobacter to the species level. 
Species Hospital Strain Number P.T Number of 
Strains
Period of 
isolation
Patients
A. baumannii
KAH & PRH 1591, 1596, 1597, 1698, 1599, 1600, 1602, 1603, 
1605. 1606, 1607, 1608, 1609, 1610, 1611, 1612, 
1613, 1614, 1615, 1616, 1617. 1618, 1619, 1620, 
1621, 1622, 1623, 1625, 1626, 1627, 1628, 1630, 
1631, 1632, 1633, 1634, 1635, 1636
Ac1 38 Over five 
month
17
PRH
1601 Ac2 1 Same day 1
1624 Ac3 1 Same day 1
1604 Ac4 1 Same day 1
KAH 1594, 1595 Ac5 2 Same day 1
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Figure 3-3: Phylogenetic relationships within different Acinetobacter spp. 
Representative isolates, rpoB gene sequences of 18 reference strains included in this study), as obtained 
by rooted dendrogram construction on the basis of rpoB gene sequences. The cluster analysis was 
performed using the MEGA 7 software and was based on the Maximum-likelihood tree using species of 
the closest related genus. 
3.3.1.3. Multi locus sequence typing (MLST) 
The A. baumannii MLST scheme is based on sequences of the conserved regions of the 
seven housekeeping genes: fusA, gltA, pyrG, recA, rplB, rpoB and cpn60, using the MLST 
scheme database of the Institute of Pasteur, where publicly accessible databases are 
available from the pubMLST website (http:/pubmlst.org/abaumannii). In this study, 
seven MLST loci have been effectively amplified and sequenced for representative 
strains, as shown in Table 3-3. Two STs were identified by MLST analysis among the 18 
representative of A. baumannii isolates, ST113 (94%), and ST193 (6%). ST113, 
representing the 17 strains belonging to pulsotypes Ac1, Ac2, Ac3 and Ac4, was 
identified as the predominant sequence type. This ST is largely prevalent among 
neonates from the two hospitals, KAH and PRH. On the contrary, the single isolate of 
1636-rpoB
1630-rpoB
1628-rpoB
1624-rpoB
1623-rpoB
1620-rpoB
1618-rpoB
1617-rpoB
1615-rpoB
1613-rpoB
1610-rpoB
1608-rpoB
1607-rpoB
1604-rpoB
1601-rpoB
1597-rpoB
1595-rpoB
1591-rpoB
A. haemolyticus
A. calcoaceticus
A. baumannii
A. lowffii
A. genomosp.9
A. genomosp.3
A. genomosp.11
A. gemeri
A. bouvetii
A. genc
A. johnsonii
A. junii
A. grimotii
A. baylyi
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pulsotype Ac5 that was identified as ST193, appeared in only one hospital (KAH). It was 
interesting to note that strains isolated initially on 15/7/2011 when compared to strains 
isolated 5 months later on 21/12/2011, have identical pulsotypes and belong to the 
same sequence type, ST113.  
Table 3-2: representative A. baumannii isolates, used in this study and their MLST 
profiles. 
 
MLST scheme is based on sequences of the conserved regions of the seven housekeeping genes: 
elongation factor (fusA), citrate synthase (gltA), homologous recombination factor (recA), CTP synthase 
(pyrG), ribosomal protein (rpIB), RNA polymerase subunit B (rpoB) and chaperonin (cpn60). Two STs were 
identified by MLST analysis among the 10 representative strains. PRH: Princesses Rahma Hospital, KAH: 
King Abdulla Hospital, FM: Flushed milk from neonatal nasogastric feeding tubes, BM: Biofilm materials 
from neonatal nasogastric feeding tubes, P.T: pulsotype, Ac: PFGE cluster groups, ST: sequence typing. 
3.3.1.4. OXA-51-like β-lactamases  
The blaOXA-51-like gene is reported to be present in the majority of isolates of A. 
baumannii and generally has been found to be chromosomally encoded (Turton et al., 
2006). Therefore, all 18 representative isolates were subjected to conventional PCR 
assay to detect blaOXA-51-like genes. The results showed that the blaOXA-51-like gene was 
present in all tested isolates (Table 3-6). 
Strain P.T Hospital Isolate 
source
fusA gltA pyrG recA rplB rpoB cpn60 ST
1595 Ac5 KAH BM 1 7 1 7 2 4 3 193
1601 Ac2 PRH BM 3 3 4 7 4 4 3 113
1604 AC4 PRH FM 3 3 4 7 4 4 3 113
1624 Ac3 PRH FM 3 3 4 7 4 4 3 113
1591
Ac1
PRH FM 3 3 4 7 4 4 3 113
1597 KAH FM 3 3 4 7 4 4 3 113
1607 PRH FM 3 3 4 7 4 4 3 113
1608 PRH FM 3 3 4 7 4 4 3 113
1610 PRH BM 3 3 4 7 4 4 3 113
1613 PRH FM 3 3 4 7 4 4 3 113
1615 PRH BM 3 3 4 7 4 4 3 113
1617 PRH BM 3 3 4 7 4 4 3 113
1618 PRH BM 3 3 4 7 4 4 3 113
1620 PRH BM 3 3 4 7 4 4 3 113
1623 PRH FM 3 3 4 7 4 4 3 113
1628 KAH FM 3 3 4 7 4 4 3 113
1630 KAH BM 3 3 4 7 4 4 3 113
1636 PRH FM 3 3 4 7 4 4 3 113
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3.3.1.5. Detection of Phospholipase Genes 
The PCR method was used in this study to investigate the phospholipase A, C, and D 
genes. Primers were designed and synthesised by Eurofins Genomics. The details for the 
selected genes are presented in Table 2-4. The results showed that the detection of 
phospholipase encoding three genes for phospholipases A, C, and D were positive across 
all the 18 A. baumannii strains. 
3.3.2. Phenotyping and virulence traits 
3.3.2.1. Biofilm formation 
Biofilm formation was studied in the 18 representative strains of A. baumannii. These 
enteral feeding tube strains were selected according to their PFGE pulsotypes, hospital, 
date and birth of neonate. The ability of A. baumannii strains to form biofilms on plastic 
surfaces at different temperatures is shown in Figure 3-4. All A. baumannii strains 
demonstrated the ability to form high amounts of biofilms at 37 °C in infant formula 
when compared with un-inoculated infant formula used as negative control, however, 
some levels of variation were observed between the strains.  
The lowest amount of biofilm formation was observed in strain 1595 (ST193) when 
compared to the other strains, in particular 1604, 1618, 1620 and 1628 (ST113), at 37 °C 
(p < 0.05). On the other hand, there was a greater amount of variation between strains 
in biofilm formation at 25°C, even amongst strains belonging to the same pulsotype, 
such as Ac1. The highest amount of biofilm formation was observed in strain 1618, which 
belongs to pulsotype Ac1 (ST113). On the other hand, the lowest amount of biofilm 
produced was noted in strain 1595, belonging to pulsotype Ac5 (ST193). In addition, 
significant differences (p < 0.05) were noted in most of the isolates across the same 
pulsotype (Ac1) when compared to strain 1618; most notably strains 1597, 1613, 1615, 
1617, 1628 and 1630 produced less biofilm than strain 1618 at 25 °C. However, there 
was no statistically significant difference between strains, 1604, 1591, 1607, and 1636 
compared to strain 1618, when analysed by means of one-way ANOVA followed by 
multiple comparisons with a Dennett’s test.  Overall, all strains showed statistically 
significant difference between  37 °C and 25 °C on infant formula by paired t-test, as 
summarised in Table 3-3. 
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Figure 3-4 : Biofilm formation at 25 °C and 37 °C in infant formula using the crystal violet adsorption assay. 
All strains showed an ability to form more biofilm at 37 °C than 25 °C in infant formula(p < 0.05). The lowest amount of biofilm formation was observed in strain 1595 (ST193)  
Un-inoculated infant formula was used as negative control. 
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Table 3-3: Summarises the biofilm formation level on infant formula by enteral feeding 
tube strains from two Jordanian hospitals in 2011. The lowest amount of biofilm 
produced was noted in strain 1595 at 25 °C in infant formula. 
 
PRH: Princesses Rahma Hospital, KAH: King Abdulla Hospital, FM: Flushed milk from neonatal nasogastric 
feeding tubes, BM: Biofilm materials from neonatal nasogastric feeding tubes, P.T: pulsotype, Ac: PFGE 
cluster groups, IF: infant formula, OD < 1 = Low biofilm formation, OD between 1&2 = moderate biofilm 
formation and OD >2 = High biofilm formation. OD, based on the OD values from the crystal violet assay. 
3.3.2.2. Serum resistance  
To determine serum sensitivity, bacterial viability counts were determined at four 
different time points (0 h, 1 h, 2 h and 3 h) in the presence of forty microliters of the 
bacterial culture were added to 360 μl of 50% human serum (Sigma, UK), as described 
in section 2.7.5.8. Figure 3-5 shows that there was robust survival of all A. baumannii 
strains in the presence of serum after incubation for 3 h with slight variations between 
the strains. For instance, strain 1615 demonstrated a medium level of resistance to the 
human serum when compared to all other strains. While strain 1618 and 1623 
maintained the serum resistance. After the first hour of incubation with human serum, 
about 50% of A. baumannii strains showed an increase in their numbers. However, 61% 
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of these strains showed an increase in their viable count after the second hour of 
incubation. Strains 1595, 1601, 1624, 1597, 1607, 1613, 1620, 1628 and 1630 from 
different pulsotypes were able to persist in human serum and revealed increases in their 
initial numbers after the third hour of incubation, while strains 1610 and 1636 showed 
a slight decrease. S. Enteritidis was used as the serum resistant positive control strain 
and E. coli was used as the serum sensitive control strain. 
 
 
Figure 3-5: Sensitivity of A. baumannii (n=18) to human serum over 3 hours of incubation 
at 37 °C. 
All A. baumannii strains (n=18) showed a high level of resistance to the human serum after 3 hours of 
incubation. All examined strains were significantly better at surviving serum compared to the E. coli K12 
(1230) negative control. The assays were performed in duplicate in two independent experiments. Error 
bars represented using standard error. Presented data was showing viable count (log10cfu/ml) among 
the isolates. 
3.3.2.3. Capsule production  
Two different types of media were used in this study to detect the capsule production, 
which included soya and whey-based infant formula. As shown in Table 3-4 all A. 
baumannii strains were unable to produce capsular materials on both media. 
3.3.2.4. Congo red morphotype (curli fimbriae). 
Eighteen A. baumannii strains were cultured in LB agar media supplemented with Congo 
red to indicate the production of curli fimbriae. The morphology of the pigment 
produced on Congo red agar for each strain was defined according to the following 
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pigmentation: red indicates the ability of the bacterium presumed production of curli 
fimbria, while pink as a negative (Figure 3-6). The colony morphology were recorded 
after incubation at 37°C for 24 and 48 hours as an indication of the binding of the Congo 
red dye. All A. baumannii strains showed binding to the Congo red dye and considered 
as produce curli fimbriae according to their appearance on Congo red media as shown 
in Table 3-4. 
 
Figure 3-6: Cell morphology of the pigment produced on Congo red agar, red indicates 
the ability of the bacterium to binding Congo red day, while pink is a negative control. 
3.3.2.5. Cellulose formation 
Cellulose production by eighteen A. baumannii strains was investigated by streaking on 
LBA medium supplemented by 25ml of Calcofluor. Cellulose production an indicated by 
the binding of the fluorescent dye calcofluor-white, were visualised using ultra-violet 
(366nm) fluorescence (Figure 3-7). All strains demonstrated high cellulose production, 
with the exception of 1591, 1608, and 1636 strains, which showed low levels of cellulose 
production, while strains 1595 and 1624 showed no fluorescence as shown in Table 3-4. 
 
Figure 3-7: Cell morphology on Calcofluor media. Fluorescent signal indicated to 
cellulose production, whereas no fluorescent signal indicated to cellulose was not 
produced. 
3.3.2.6. Siderophore production  
Siderophores are considered as major virulence factors in the pathogenicity of 
organisms. Bacteria synthesise and secrete siderophores to chelate iron, which is an 
Red colony morphology indication                        
(+ve) binding of the Congo red dye  
Pink colony morphology indication                        
(-ve) binding of the Congo red dye  
High fluorescent 
Moderate fluorescent 
Low fluorescent 
low fluorescent                                         No fluorescent 
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essential element required by almost all bacteria. In this study, the ability of 18 A. 
baumannii isolates to produce siderophores was analysed. Positive results were verified 
as a formation of halo around the colony growth (Figure 3-8). Table 3-4 shows that all 
strains examined were able to produce iron siderophores on chrome azurol sulphate 
(CAS) agar. Strains of Y. enterocolitica (1880) and and 520 C. sakazaki strain were used 
as positive and negative controls, which measures the ability of the compound to bind 
iron. 
 
 
Figure 3-8: Siderophore activity using CASAD assay, all of A. baumannii strains have 
been able to produce iron sidrophores, CAS agar showing orange halo around the 
wells, however NTU 8081 Y. enterocolitica was positive control and 520 C. sakazaki 
strain was negative.  
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3.3.2.7. Haemolytic assay 
Haemolysin, an extracellular protein produced by pathogenic bacteria, is one of the 
toxins that may play an essential role in causing disease. In the current study, diverse 
haemolytic activity was demonstrated by the 18 representative strains of A. baumannii 
on horse blood. On horse blood agar, β-haemolysis was demonstrated by 10 strains 
(55.5%) when compared to that exhibited by the S. eureus positive control, while 7 
strains (38.8%) showed γ-haemolysis, and only strain (1623) was α-haemolytic (Table 3-
5).  
Table 3-4: A summary of the curli fimbria, cellulose, siderophore and capsule production, 
as well as haemolytic activity among the 18 representative strains of A. baumannii.  
 
PRH: Princesses Rahma Hospital, KAH: King Abdulla Hospital, FM: Flushed milk from neonatal nasogastric 
feeding tubes, BM: Biofilm materials from neonatal nasogastric feeding tubes, P.T: pulsotype, Ac: PFGE 
cluster groups. α: α -haemolysis, β: β-haemolysis γ: γ-haemolysis, F1: infant formula whey based, IF2: 
infant formula soya based, +: positive, -: negative. 
3.3.2.8. Desiccation 
Acinetobacter has been experimentally shown to survive desiccation and have 
demonstrated an ability to maintain their viability on inanimate surfaces in hospitals 
(Chapartegui-González et al., 2018). In this study, a total number of 18 A. baumannii 
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strains were evaluated for their desiccation survival in infant formula over a period of 
two weeks. The first 24 hours of desiccation caused the viability of the majority 
Acinetobacter strains to slightly decrease by 0.1 - 1.5 log cfu/ml. The viable cell counts 
for the majority of strains did not appear to be reduced by a significant amount, whereas 
strains 1623 and 1628 showed the lowest ability to persist under desiccation stress 
conditions for 24 hours. However, the reduction in viability observed over the next 14 
days ranged between 0.6 and 4.1 log cfu/ml. There was some variation between strain 
in terms of their ability to persist under conditions of desiccation stress. Strains 1624, 
1607, 1623 and 1628 showed low persistence compared with the other strains, in 
particular 1623. Strains 1608, 1610, 1613, 1615, 1618, and 1620 were able to persist for 
the longest time under desiccation stress conditions, but all strains remained 
recoverable until the last sampling point on day 14 (Figure 3-9).  
 
Figure 3-9: Survival of A. baumannii strains subjected to desiccation over a period of 2 
weeks. 
The figure shows a slight decrease in viability by 0.1-1.5 log cfu/ml, as a result of the first 24 h of 
desiccation, while the reduction observed after 2 weeks ranged between 0.6 and 4.1 log cfu/ml. Overall, 
it is clear that all strains were successfully able to persist during 2 weeks of desiccation stress conditions. 
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3.3.2.9. Acidity 
Stomach acidity acts as the most important line of defence in protecting against 
infections through the route of ingestion. In this study, 18 strains of A. baumannii were 
challenged by acidic conditions and were assessed for their tolerance to withstand pH 
3.5. The strains were exposed to pre-adjusted infant formula at pH 3.5 for two hours 
and the results are presented in Figure 3-10.  In general, all A. baumannii strains were 
resistant to an acidic exposure of pH 3.5 for 2 hours. During the first 30 min of acid 
exposure, the viability of all 18 strains decreased by 0.4-1.4 log cycles. Sampling points 
at 60 min did not show a significant further reduction in cell counts for the 18 strains 
tested (P > 0.05). Two of the 18 strains (1595 and 1617) exhibited less than 1 log cycle 
decline over the 2 h incubation period. The most acid-sensitive strain was 1613, showing 
an approximate 2.5 log cycle decline. Although all 18 representative strains displayed a 
0.8 to 2.5 log cycle decline during the 2 hours, these strains remained viable at pH 3.5 
during this period, and were therefore regarded as acid-tolerant strains.  
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Figure 3-10 Survival curve of 18 A. baumannii strains in infant formula at PH 3.5. 
Acinetobacter strains were assessed for their tolerance to pH 3.5 for two hours. The viable counts were 
determined by the Miles & Misra method. The figure shows the viability of all 18 strains decreased 
between 0.4-1.4 log cycles during the first 30 min of acid exposure, although, no significant further 
reduction was observed after the 60-min time-point. Overall, all A. baumannii strains showed an ability 
to resist pH 3.5 for the total 2 hours. 
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3.3.2.10. Antibiogram  
Antibiotic susceptibility profiles were determined for the 18 A. baumannii strains, 
isolated from enteral feeding tubes from two Jordanian hospitals. This involved 
screening the sensitivity to six antibiotic groups: penicillins, aminoglycosides, 
carbapenems, cephalosporins, chloramphenicol, and trimethoprim. The antibiogram 
procedure was tested by the Kirby-Bauer disk diffusion method. As shown in Table 3-6, 
all A. baumannii strains belonging to pulsotypes Ac1 were generally highly resistant to 
all antibiotics with the exception of ciprofloxacin, and three strains (1607, 1613, and 
1623) which also displayed susceptibility to trimethoprim/sulfamethoxazole. However, 
strain 1604, belonging to Ac4, showed resistance to all antibiotics but was susceptible 
to ciprofloxacin. Whereas strains 1601 and 1595 (pulsotypes Ac2 and Ac5, respectively) 
were resistant to at least two antibiotics, whilst being susceptible to the majority of 
antibiotics used in this study. Strain 1624, which belongs to Ac3, demonstrated 
resistance to the majority of antibiotics used in this study, whilst it was susceptible to 
the antibiotics meropenem, imipenem, chloramphenicol, and ciprofloxacin. 
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Table 3-5 Sensitivity for A. baumannii strains to Antibiotic agents 
 
S: susceptibility. R: resistance. I: intermediate resistance. PRH: Princesses Rahma Hospital. KAH: King Abdulla Hospital. FM: Flushed milk from neonatal nasogastric feeding 
tubes. BM: Biofilm materials from neonatal nasogastric feeding tubes. P.T: pulsotype. Ac: PFGE cluster groups. AUG: Augmentin. CIP: Ciprofloxacin. CXM: cefuroxime. CTX: 
Cefotaxime. MEM: Meropenem. C: Chloramphenicol. GM: Gentamicin. CRO: Ceftriaxone. AP: Ampicillin. TS: Trimethoprim Sulfametoxa. IMI: Imipenem.
Chapter 3 Profiling a clinical collection of Acinetobacter baumannii isolates 
 
75 
 
3.3.3. Assessment of the pathogenicity of A. baumannii using tissue culture assays 
Of the 18 strains examined in this study, 10 were selected as representative strains to 
evaluate their potential virulence using in vitro attachment, invasion and cytotoxicity 
assays with intestinal epithelial cells Caco-2. Macrophage survival were also examined 
by U937 cell line.  
3.3.3.1. Bacterial attachment on Caco-2 human epithelial cells 
The investigation sought to determine the ability of the A. baumannii strains to attach 
to human cell line Caco-2. To define the level attachment achieved by each isolate, the 
attachment efficiency (%) results were classified into three categories according to the 
observed level of attachment on the controls used in this study: high, medium, and low 
levels of attachment. Low attachment was considered to be less than 2% cfu/ml, while 
attachment efficiency of isolates between 2% and 4% cfu/ml referred to a medium level 
of attachment. Attachment efficiency greater than 4% of recovered cfu/ml was 
considered as a high level of attachment to the Caco-2 human epithelial cells. Statistical 
analysis using one-way ANOVA confirmed that attachment efficiency levels in the 
majority of isolates were significantly higher than that of the negative control strain E. 
coli 1230 (p < 0.001). Execept strain 1595, belonging to pulsotype Ac5 (ST193), had the 
lowest attachment levels among the representative strains analysed in this study. 
Strains 1601, 1613, and 1618 (all ST113) showed moderate levels of attachment, while 
the other strains, 1604, 1624, 1691, 1615, 1623 and 1630 (also ST113), demonstrated a 
high attachment level to the Caco-2 cell line. The highest attachment levels to Caco-2 
was observed in strain 1604, which belongs to pulsotype Ac4 (ST113), as shown in Figure 
3-11. 
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Figure 3-11 Attachment of A. baumannii strains to the human Caco-2 cell line. 
The figure shows the differences in attachment levels among A. baumannii strains to human epithelial cell 
line Caco-2. All strains were able to attach to the epithelial cell line when compared to E. coli 1230                   
(p < 0.001), which was used as negative control, and. S. Enteritidis 358, which was used as a positive 
control. Error bars indicate the standard deviation of six data points taken from two independent 
experiments in triplicate.  
3.3.3.2. Bacterial invasion of Caco-2 human epithelial cells 
The gentamicin protection assay was used to determine the ability of A. buamannii 
strains to invade the Caco-2 human epithelial cells by killing all extracellular bacteria, 
allowing a quantification of intracellular bacteria. Results were classified into three 
categories according to the percentage of recovered cells after invasion. Less than 0.1% 
recovery was used to describe strains that were very poorly invasive (very low invasion), 
while 0.1 to 0.2% recovery was defined as a low level of invasion, 0.2 to 0.4% defined as 
a medium and greater than 0.4% recovery was defined as a high level of invasion. There 
was an observable amount of variation regarding the invasion rates of A. baumannii 
strains. Figure 3-12 shows that most of these strains were able to invade Caco-2 human 
epithelial cells at very low levels comparing with positive control 358, for example, 
strains 1591, 1595, 1601, 1613, 1615, 1623, 1624, and 1630 which all belonged to 
different pulsotypes while strain 1618 showed low invasion potential. When compared 
to the negative control strain, most strains showed no significant difference in invasion 
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levels when analysed by means of one-way ANOVA, followed by multiple comparisons 
with a Dennett’s test. However, strains 1604, 1618, and 1624 showed significantly 
greater invasion levels than the negative control strain when using the same method of 
statistical analysis (P < 0.001). The highest percentage of invasion efficiency in the 
gentamicin protection assay was observed in strain 1604, which interestingly also 
displayed the highest level of attachment rate to the Caco-2 cell line. 
 
Figure 3-12: Invasion efficiency of A. baumannii strains to the mammalian Caco-2 cell 
line. 
The figure shows the differences among A. baumannii strains with regards to their ability to invade the 
human epithelial cell line Caco-2, by performing the gentamicin protection assay. The majority of strains 
invaded Caco-2 human epithelial cells at very low levels. S. Enteritidis 358 and E. coli 1230 were used as 
positive and negative control strains, respectively.  
3.3.3.3. 3.3.3.4   Macrophage survival assay 
Macrophages are an important class of phagocytes that are commonly involved in the 
host response to pathogenic bacterial invasion. This response is known as the innate 
immune process, which involves the macrophages phagocytosing the invading microbes 
in order to protect the host body. Ten representative strains of A. baumannii were 
investigated for their ability to persist and replicate within human macrophages 
represented by the U937 cell line. The NTU collection strain C. koseri 48 was used as a 
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positive control, whilst E. coli K12 strain 1230 (also from the NTU strain collection) was 
used as a negative control.  
Macrophage uptake of all A. baumannii strains was observed at different levels 60 mins 
after the initial inoculation period, except for strain 1618, which was not detected after 
60 min, however the survival of this strain was evident after 24 h (Figure 3-13). After 24 
hours of incubation, all of the strains showed an increase within the macrophages, 
particularly strains 1604 and 1624, which were able to multiply significantly when 
compared to the other strains (P < 0.05). Most of the strains displayed a relative increase 
in their numbers after 48 hours of incubation, whereas 1624 was the only strain to 
demonstrate a slight decline in numbers. All strains displayed a decrease in their 
intracellular numbers after 72 hours of incubation. Strain 1604 exhibited the greatest 
ability to persist and replicate inside the macrophages (Figure 3-13).  
 
Figure 3-13: shows the differences in the ability of A. baumannii strains to persist in U937 
macrophage cell lines for 72 hours. 
The majority of the A. baumannii strains (n=10) demonstrated an ability to persist and replicate within 
the macrophage cell line U937 for up to 72 hours of incubation. The C. koseri 48 strain was used as positive 
control, while E. coli K12 strain 1230 was used as negative control (both from the NTU strain collection).  
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3.3.3.4. 3.3.3.5   Cytotoxicity of Acinetobacter baumannii 
The MTT reduction assay was carried out to measure the effect of A. baumannii strains 
on the viability of the epithelial Caco-2 cells. Viable epithelial Caco-2 cells are able to 
reduce MTT to its insoluble purple form, known as formazan. An S. Enteritidis strain, 
which was used as positive control in this investigation, lowered the amount of MTT 
reduction, thus indicating their high cytotoxic ability. Conversely, Caco-2 cells in 
cell culture medium where is no bacteria been added to the cells was used as a negative 
control, which showed high levels of MTT reduction thus indicating low, or non-existent, 
cytotoxicity. The results were categorised as low cytotoxicity (OD = > 1), moderate 
cytotoxicity (OD 0.5 – 1), and high cytotoxicity (OD < 0.5). Most of the strains showed 
significant MTT reduction compared to the negative control after 1 hour of incubation, 
thus demonstrating moderate cytotoxicity, and the absorbance levels for all strains were 
relatively similar, as shown in Figure 3-14. The only exception, however, was strain 1623 
which showed slightly higher cytotoxicity levels compared to the other the strains. All 
strains showed no significant difference in cytotoxicity levels (P < 0.001) compared with 
strain 1623 when analysed by means of one-way ANOVA, followed by multiple 
comparisons with a Dennett’s test.  
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Figure 3-14: Cytotoxicity of A. baumannii strains for 1-hour incubation on the Caco-2 
cell line.  
Most of the strains showed moderate cytotoxicity and there was no significant difference between A. 
baumannii strains when analysed by means of one-way ANOVA, followed by multiple comparisons with a 
Dennett’s test.  
3.3.4. Screening of A. baumannii for virulence factors and antibiotic resistance genes 
3.3.4.1. Virulence factors 
A group of genes of interest in this study were chosen according to the A. baumannii 
virulence factors database (VFDB). These genes were classified into the major virulence 
factors of Acinetobacter, such as Csu fimbrial operon, which plays a vital role in the initial 
steps of biofilm formation and assists in attachment of the cell to biotic and abiotic 
surfaces. The Csu fimbrial operon (csu ABCDE) was noted among all the A. baumannii 
ST113 genomes analysed in this study, however, it was absent in the A. baumannii strain 
belonging to ST193. The biofilm-associated protein (Bap) and operon pgaABCD have 
also been associated with biofilm formation. Genomic analysis revealed that these genes 
were present in all A. baumannii ST113 and ST193 isolates. Other important putative 
virulence-associated genes (VAGs) included those which confer serum resistance (pbpG), 
immune evasion (lpxMBCD), phospholipase (plcD), genes associated with iron 
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acquisition (bauABCDEF - basABCDEFJ –barAB), outer membrane protein A (ompA), 
lipopolysaccharide (LPS) and regulator of a two-component regulatory system (bfmRS) 
were also investigated. The results of the genomic comparison of representative strains 
against the Acinetobacter virulence factors database indicated that all the strains 
belonging to ST113 and ST193 were positive for these virulence genes, as shown in Table 
3-6 With regards to antimicrobial susceptibility and resistance of all representative 
strains, it was found that all strains share some common antibiotic resistance genes, 
such as blaOXA-64, blaADC-25 and blaOXA-51. However, only ST113 strains were found to 
harbour the β-lactam gene blaOXA-23 and the aminoglycoside gene aph(3')-Vla. These 
strains were also found to be highly resistant to all the antibiotics tested, with the 
exception of ciprofloxacin. Among of these, only one strain (strain 1601, belonging to 
ST113) showed susceptibility to the majority of antibiotics tested, even though it was 
found to harbour multiple antibiotic resistance genes. In contrast, only strain 1595 
(ST193) was lacking the antibiotic resistance genes blaOXA-23 and aph(3')-Vla and it was 
also noted that this strain was susceptible to the majority of antibiotics tested. The 
overall antibiotic resistance observed among A. baumannii strains was high and these 
strains encoded a number of different antibiotic resistance genes, as shown in Table 3-
7. Further details regarding these genes are provided in the Discussion (3.4).  
Table 3.8 shows the presence of biofilm associated protein Csu fimbriae genes and a 
correlation between the ability of these isolates to attach to epithelial cells and biofilm 
formation at the initial step of the colonisation process. There was a clear variation 
among the sequenced isolates analysed in the present study. The csu cluster, inclusive 
of csuA, csuB, csuC, csuD, and csuE, was detected in all of the ST113 isolates, with the 
only exception being strain 1595 (ST193), which evidently lacked this cluster. The 
genomic comparison study revealed that all of the sequenced isolates harbouring genes 
of the csu cluster were able to form biofilm and were also able to adhere to the Caco-2 
cell line. Whereas the only non-ST113 strain showed an absence of the csu locus, and 
exhibited a very low amount of biofilm formation and low level of attachment to 
epithelial cells (Table 3-9). Moreover, the results indicate a positive correlation between 
epithelial cell adherence and amounts of biofilm formation (Statistical significance 
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(P ≤ 0.037) was calculated using two-tailed t-test), Figure 3-15 demonstrates this 
correlation and further details will be provided in the Discussion (3.4).  
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Table 3-6: Genomic comparison of representative isolates of ST113 and non-ST113 strains against the Acinetobacter virulence factors database 
(VFDB). 
 
The results indicate that all isolates harboured a number of virulence and antibiotic resistance genes, whilst several genes were notably absent in A. baumannii strain 1595 
belonging to ST193. 
Isolate PT Hospital ST Adherence Regulation Enzyme Immune 
evasion
LPS
Serum 
resistance
Heme 
util ization
Iron uptake (Acinetobactine) Biofilm formation Resistancegenes
ompA Quorum 
sensing
component 
system
plCD lpxMBCD pbpG hemO basA-J bauA-F barAB entE Bap 
protein
Csu
fimbriae
b-(1--)poly-N-acetyl-
D-glucosamine 
(PANG)
A-glycoside Beta-lactam
abaI abaR bfmRS bfmS bapCD csuABCDE pgaABCD aph(3')-Vla blaOXA-23 blaOXA-64 blaADC-25
1591 Ac1 PRH 113 + + + + + + + + + + + + + + + + + + + +
1613 Ac1 PRH 113 + + + + + + + + + + + + + + + + + + + +
1615 Ac1 PRH 113 + + + + + + + + + + + + + + + + + + + +
1618 Ac1 PRH 113 + + + + + + + + + + + + + + + + + + + +
1623 Ac1 PRH 113 + + + + + + + + + + + + + + + + + + + +
1630 Ac1 KAH 113 + + + + + + + + + + + + + + + + + + + +
1601 Ac2 PRH 113 + + + + + + + + + + + + + + + + + + + +
1624 Ac3 PRH 113 + + + + + + + + + + + + + + + + + + + +
1604 Ac4 PRH 113 + + + + + + + + + + + + + + + + + + + +
1595 Ac5 KAH 193 + + + + + + + + + + + + + + - + - - + +
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Table 3-7: comparison of phenotypic and genotypic analysis of A. baumannii strains of ST113 and St193.  
 
The non-ST113 strain 1595 lacked these genes and was found to be susceptible to the majority of antibiotics tested in this study, indicating a correlation between phenotype 
and genotype. Strain 1601 was the exception, belonging to ST113 and harbouring antibiotic resistance genes, but phenotypically sensitive to the majority of antibiotics tested 
in this study. 
 
 
 
Isolate P.T ST Hospital Infant 
age (d)
source Aminoglycoside 
(gene)
Beta-lactam (gene) Antibiogram
aph(3')-Vla blaOXA-23 blaOXA-64 blaADC-25 blaOXA-
51
AUG AP GM MEM IMI CXM CTX CRO CIP C TS
1591 Ac1 113 PRH 14 FM + + + + + R R R R R R R R S R S
1613 Ac1 113 PRH 11 FM + + + + + R R R R R R R R S R S
1615 Ac1 113 PRH 13 BM + + + + + R R R R R R R R S R R
1618 Ac1 113 PRH 14 BM + + + + + R R R R R R R R S R R
1623 Ac1 113 PRH 10 FM + + + + + R R R R R R R R S R S
1630 Ac1 113 KAH 16 BM + + + + + R R R R R R R R S R R
1601 Ac2 113 PRH 12 BM + + + + + R S S S S S S S S R S
1624 Ac3 113 PRH 7 FM + + + + + R R R S S R R R S S R
1604 Ac4 113 PRH 12 FM + + + + + R R R R R R R R S R R
1595 Ac5 193 KAH 8 FM Not found Not found + + + S S S S S S R I S R S
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Table 3-8 A. baumannii strains of ST113 harboured the Csu fimbrial operon (csu ABCDE), which is associated with the ability of bacteria to form 
biofilm and attach to epithelial cells. The non-ST113 strain lacking this operon was a poor biofilm former and also had low attachment to epithelial 
cells. No correlation was observed between this operon and other traits. 
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Figure 3-15: Correlation between amounts of biofilm formation and attachment 
ability among the representative strains of A. baumannii. Statistical significance 
(P ≤ 0.037) was calculated using two-tailed t-test. 
3.4. Discussion 
Bacterial colonisation of infants starts as early as birth. Rapid detection and 
identification of routes of transmission of many bacterial pathogens is very important 
to control and prevent disease and outbreaks. NICUs are more exposed to nosocomial 
microorganisms during hospitalisation of neonates (Mohammed and El Seifi, 2014; 
Legeay et al., 2015; Ramasethu, 2017). Several molecular subtyping methods are 
important tools that allow rapid identification of these microorganisms and their 
sources. Molecular fingerprinting techniques such as PFGE are important in 
epidemiological investigations. PFGE has been applied in several bacterial outbreak 
studies, including A. baumannii, and exhibits high discriminatory power between 
pulsotypes (Villalon et al., 2011). In this study, PFGE has been used to assess the 
genetic diversity of strains and identify whether clonally related strains were isolated 
on different occasions. This technique was also used to determine whether any 
epidemiological relationship exists between pulsotype and clinical presentation.  
Forty-three Acinetobacter baumannii strains were assessed in this project, which were 
isolated from nasogastric enteral feeding tubes from NICUs in Jordan. The strains had 
been collected from two hospitals between 15-07-2011 and 21-12-2011, and PFGE 
was performed in this study using the ApaI restriction enzyme. Representative strains 
were subsequently used to confirm the PFGE profiles using the Ascal restriction 
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enzyme. The combined PFGE profiles for both Apal and Ascal restriction enzymes were 
then considered (Figure 3-2). 
All A. baumannii strains were clustered into five different pulsotypes, with the 
majority of strains clustering with pulsotype Ac1, as showed in Figure 3-1. Interestingly, 
this pulsotype was found across enteral feeding tubes of different infants within the 
same hospital. Furthermore, the same pulsotype was prevalent among strains isolated 
from the two different hospitals (KAH and PRH in Jordan), which was quite unexpected. 
Of particular significance was pulsotype Ac1, which was composed of 38 
indistinguishable strains from 21 neonates, over a six-month period. The first isolate 
was obtained from PRH hospital on 15/07/2011, then after a period of five months, 
strains of the same pulsotype (Ac1) were isolated from both hospitals (KAH and PRH). 
This indicates the ability of these strains to survive and persist for long period of time, 
possibly in both biotic and abiotic environments. 
It is unknown whether there was transfer of neonates or hospital staff between the 
two hospitals. These strains had been isolated from neonates receiving different 
feeding milk, which may rule out the possibility of strains being acquired due to 
sharing the same feeding source. However, several studies have reported that A. 
baumannii isolates had demonstrated long-term persistence in desiccated infant 
formula (Juma et al., 2016; Chapartegui-González et al., 2018). A possible explanation 
for this observation could be contamination of the feeding tubes due to the 
surrounding environment or directly from carers within the NICU. The other possible 
sources might be from the hands of care workers when preparing PIF for infants in the 
NICU. Potential contamination of the fresh feed in the tube lumen may result in 
additional bacterial multiplication. It is therefore reasonable to suggest that 
inappropriate preparation, storage, and handling of powdered infant formula may 
pose a substantial risk to neonates with underdeveloped immune systems as well as 
preterm infants.  
In addition, this study demonstrated that the pulsotypes Ac2, Ac3, and Ac4 comprised 
one unique strain, while pulsotype Ac5 was composed of two strains isolated from 
one neonate on the same day. Pulsotypes Ac2 - Ac5 were less persistent when 
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compared to pulsotype Ac1. This indicates a narrower range of these strains to 
colonise the enteral feeding tubes. Based on these results, one strain was selected as 
representative to study the virulence traits of Acinetobacter pulsotypes Ac2 - Ac5. 
Since the majority of strains clustered with pulsotype Ac1, it was decided to select 
representative strains according to hospital, neonatal sample source, and birth of 
neonate. 
These isolates had been previously identified by the hospital with the API 20E test strip, 
however identification to the species level is often problematic within the 
Acinetobacter genus (Khosravi et al., 2015). Due the importance of these strains in 
hospital infections, precise identification to the species level is important to clarify the 
epidemiology and ecology of these species. Different encoding genes have been used 
to define species within the Acinetobacter genus, such as gyrB, rpoB, and recA (Scola 
et al., 2006; Higgins et al., 2007; T. L. Chen et al., 2014; Khosravi et al., 2015). Among 
these genes, the rpoB gene (350 bp) was used for the identification 
of Acinetobacter isolates due to the variability in its size (zone 1) and because it is 
highly discriminative among the different bacterial species (Gundi et al., 2009; 
Kamolvit et al., 2015). In the current study, the 18 representative strains were 
confirmed as A. baumannii by using whole genome sequencing (WGS). Agreement 
between the rpoB and WGS data in this study suggested that the partial rpoB sequence 
is likely to be a reliable and rapid identification method for Acinetobacter species. This 
is consistent with another study by Gundi et al. (2009) who reported that the method 
for identifying Acinetobacter spp. by rpoB sequencing is target for rapid molecular 
identification. An additional finding was that all isolates were carbapenem-resistant 
and carried the blaOXA-51-like gene. This result is in agreement with another previous 
study which similarly showed that almost all A. baumannii strains possess the blaOXA-
51-like gene. This gene has generally been found to be chromosomally encoded and 
non-transferable. These results provide evidence that detection of blaOXA-51 can be 
used as a simple and reliable method of identifying A. baumannii (Turton et al., 2006). 
Although detection of blaOXA-51 has been suggested to be highly specific for A. 
baumannii, which is in contrast with the results obtained by Teixeira et al. (2013) 
stated that this gene has also been found to be involved in A. nosocomialis. Another 
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study by Leski et al. (2013) showed that this gene can be also found in members of 
the Enterobacteriaceae. 
MLST typing is a method that is often seen as a complementary typing method to PFGE 
(Tomaschek et al., 2016). This study therefore intended to apply the MLST scheme 
database (Institute of Pasteur) to 18 selected isolates among the collected strains of 
Acinetobacter spp. MLST analysis of A. baumannii strains revealed that all of them 
belonged to one of 2 different STs (ST193 and ST113). Seventeen strains belonging to 
pulsotypes Ac1, Ac2, Ac3, and Ac4 were sequence type (ST113).  Amongst these 
fourteen belonging to the same pulsotype Ac1 found in both hospitals. However, the 
other single isolate belonging to pulsotype Ac5 had a unique genotype indicated by 
PFGE as well as MLST (ST193). The A. baumannii ST113 sequence type has been found 
to be the predominant sequence type that was recovered from a large number of 
feeding tubes from the two hospitals. The MLST database contains a total of 19 
isolates belonging to ST113. It was important to note that all of the ST113 isolates in 
the MLST database originated from clinical sample sources (i.e. 22% from CSF, 11% 
from blood, 11% from sputum, 11% from upper respiratory tract, and 5.6 % from 
abdominal and IV catheters). Another interesting observation was the geographic 
spread of these isolates originating from three different countries: Brazil (72%), USA 
(11%), and China (17%), whereas our collection included isolates from two hospitals 
in Jordan, Middle East. A previous study conducted by Bonnin et al. (2013) reported 
that some A. baumannii isolates belonging to ST113 have been recovered from 
hospitals in Kuwait in 2013. More recently, several A. baumannii isolates belonging to 
ST113, recovered from a perineal swab in the intensive care unit of the Minas Gerais 
Hospital, Brazil, was found to be resistant to all β-lactams (Girlich et al., 2014). Based 
on MLST analysis, this strain was typed as ST113, the same ST which was recovered 
from the intensive care unit in Brazil. Considering the geographical separation 
between the two countries (Brazil and Jordan), the evidence indicates there might be 
a wide distribution of these strains throughout the world. In the present study, PFGE 
differentiated 18 isolates into 5 distinct patterns, 14 strains belonged to Ac1 were 
isolated from NICUs in 2 hospitals, over a 5-month period. One strain to each 
pulsotypes Ac2, Ac3 and Ac4 were isolated from the same hospital (PRH) and one 
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strain belonged to Ac5 isolated from KAH hospital. Whereas MLST identified two 
distinct STs among the 18 isolates, suggesting that PFGE is a more discriminatory 
method than MLST for typing these isolates. However, MLST is more efficient to 
improve our understanding of molecular epidemiology within a hospital environment 
or between hospitals and geographic locations (El-Shazly et al., 2015). 
Medical devices, in particular enteral feeding tubes, are frequently used in NICUs for 
feeding the preterm infant or critically ill neonate. A previous study by Hurrell et al. 
(2009), revealed that an important source of bacteria entering neonates is the enteral 
feeding tube, which might act as a place for bacterial colonisation as a biofilm. In the 
last three decades, there has been a rise in the incidence of neonatal infections due 
to A. baumannii (Hsu and Tamma, 2014; Wei et al., 2015). It is widely distributed in 
clinical settings and it is an important problematic opportunistic pathogen. This 
organism has been found to be frequently associated with the surface of medical 
devices, such as catheters and feeding tubes (Tomaras et al., 2003; Pakharukova et al., 
2018). It causes a wide range of infections, including meningitis, bacteraemia, wound 
infections, and UTIs (Antunes et al., 2014; Almasaudi, 2018). Moreover, it is well 
known for its ability to form biofilms and attach to biotic and abiotic surfaces. 
Therefore, biofilms play an important role in the colonisation of microorganisms, 
providing an opportunity for bacteria to be more resistant to environmental stresses. 
In this study, all the representative strains of A. baumannii ST113 and ST193 showed 
the ability to form high amounts of biofilm when compared to the control. Additionally, 
the majority of these isolates were found to produce significantly higher amounts of 
biofilm at 37 °C than at 25 °C (P < 0.05). Only one strain, belonging to ST193, produced 
the lowest amount of biofilm at 25 ºC, which was similar to the control value. The 
effect of temperature on biofilm formation was evident based on this observation. 
The optimum temperature might be linked to the reaction rate of enzymes. Previous 
studies have revealed that several factors affect biofilm formation including, 
temperature, O2 level and pH (Goller, 2008). It is widely accepted as a temperature-
controlled process in living organisms. Thus, the temperature might be an important 
factor for biofilm formation in A. baumannii. Other studies reported that the curli 
fimbriae play an important role in biofilm formation in many species of bacteria, and 
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they help mediate host cell adhesion and invasion (Lasaro et al., 2009; Barnhart and 
Chapman, 2010; Kim et al., 2012; Sharma et al., 2016). In this study, representative 
strains of A. baumannii were characterised on Congo red media to evaluate the 
expression of curli fimbriae. All tested strains expressed red colonies, which indicates 
curli fimbriae as positive colonies for binding to the Congo red dye. However, genome 
comparisons using the Artemis genome browser were carried out to determine the 
presence or absence of the genes of interest, and BLAST search was carried out at the 
nucleotide level for curli fimbriae-associated genes. The investigation confirmed that 
all the analysed genomes of the representative isolates were found to lack the curli 
fimbriae region, thus suggesting that other proteins may be binding to the Congo red 
dye. Another extracellular material produced by bacteria for the formation of biofilm 
is cellulose. It has been shown to play an important role in biofilm formation in 
bacterial cells, structure, and protection in biofilms (Limoli et al., 2015). The same 
authors also reported that the cellulose was produced by many Enterobacteriaceae, 
including S. Typhimurium, S. Enteritidis, Cronobacter species, K. pneumoniae and E. 
coli. Similarly, Re and Ghigo (2006) revealed that cellulose is one of the most important 
components of the biofilm matrix In Salmonella and E. coli. Although the majority of 
the representative strains in this study produced cellulose in different quantities, even 
though ST113 strains showed a higher quantity of biofilm production at 37 °C, no 
correlation was observed between these strains to form biofilm and the amount of 
cellulose produced. 
In addition, this study also revealed that there was no correlation between biofilm 
formation and capsular material produced by all representative strains. Bacterial 
capsule production was determined by colony appearance in two different growth 
media: soya and whey-based infant formula. The strains were unable to produce 
capsule material on both types of media; however, they were able to produce a high 
amount of biofilm on the same media. There are many studies that have found no 
correlation between capsule production and the ability to form biofilm. For example, 
Hurrell et al. (2009a) found that C. sakazakii strains were unable to produce any 
capsular materials, but nevertheless produced more biofilm. Although, the results 
indicate no obvious link between biofilm formation in this strains and capsule 
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production, capsules may provide resistance to desiccation, serum activity and have a 
significant role in avoiding phagocytic killing (Ogrodzki and Forsythe, 2015). Another 
study indicated that capsule production is essential for A. baumannii survival during 
growth in serum and infection (Russo et al., 2010). However, during the current study, 
it was identified that majority of A. baumannii isolated from enteral feeding tubes 
were strains with a high ability to form biofilm on abiotic surfaces. This may explain 
the possibility of biofilm formation inside neonatal feeding tubes, acting as a locus and 
increasing the risk of neonatal infection by the ingestion of these organisms. 
Indeed, biofilm formation is controlled by complex regulatory systems in A. 
baumannii. A recent study by Selasi et al. (2016) showed that several genes are 
reported to be linked with biofilm formation of A. baumannii. For example, the 
csu locus encoding the chaperone usher pili assembly system is required for biofilm 
formation and attachment, and the pgaABCD operon is involved in the synthesis of 
poly-β-(1-6)-N-acetylglucosamine (PNAG) in A. baumannii. It has been described as a 
one of the major components of biofilms in S. aureus. Furthermore, the bap gene 
encoding the surface protein, and ompA encoding the major outer membrane protein, 
demonstrate a key role in biofilm formation (Gaddy et al., 2009; Brossard and 
Campagnari, 2012; Luo et al., 2015; Selasi et al., 2016). Analysing the genomes in the 
current work revealed that all previous genes have been detected in the genomes of 
the tested A. baumannii strains by using genome comparisons. However, only one 
strain (ST193), belonging to pulsotype Ac5, showed a lack of the csu cluster. This 
cluster consists of csuA, csuB, csuC, csuD, and csuE genes, which are essential genes 
involved in the adherence to and biofilm production on abiotic 
surfaces for A. baumannii strains (Bahreini et al., 2014; Luo et al., 2015). One of the 
most interesting observations is strain ST193, which also showed a very low amount 
of biofilm production at 25°C. These findings may suggest a significant correlation 
between the csu cluster and biofilm formation. These results are in agreement with 
the data obtained by Tomaraset al. (2003), who reported that the presence of pili-like 
structures on the surface of A. baumannii leads to the formation of biofilm. The 
disruption of csuE and csuC resulted in non-piliated cells and eliminated biofilm 
formation and cell attachment. This might be because genes that appear to be 
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required for pili formation, result in formation of biofilms and associated attachment 
to plastic surfaces by A. baumannii strains. However, the ability of strains of ST113 to 
form biofilm at 25°C varied, which indicates that some of the genes of the csu locus 
detected might be differentially expressed or influenced by other factors.  Therefore, 
biofilm production of A. baumannii strains could enhance colonisation and 
persistence in enteral feeding tubes and also increase the probability of causing 
nosocomial infections and outbreaks. 
Antimicrobial susceptibility testing in this study was performed for all the 
representative strains of A. baumannii. The results show that the majority of tested 
strains (ST113) were highly resistant to all the antibiotics tested, with the exception of 
ciprofloxacin. These strains were found to harbour β-lactamase genes, such as blaOXA-
23, blaOXA-64, blaADC-25 and blaOXA-51, as well as the aminoglycoside gene (aph (3')-
Vla). In contrast, a single isolate of A. baumannii ST193 showed susceptibility to the 
majority of antibiotics tested, and additionally, the blaOXA-23 and aph(3')-Vla genes 
were not detected. My study showed that the ST113 strains are defined as multidrug-
resistant to different classes of agents and that the blaOXA-23 gene was the most 
frequent carbapenem resistance gene among these strains. One previous study 
carried out in China reported that the most common carbapenem resistance gene is 
blaOXA-23 among A. baumannii (Chang et al., 2015). Another study by Hou and Yang 
(2015) reported that most A. baumannii outbreak strains in ICUs are highly resistant 
to antibiotics. Also, A. baumannii have been reported as a cause of more severe 
diseases among critically ill patients (Almasaudi, 2018). The strains characterised in 
this study showed high resistance to antibiotics, and it can be considered as a risk 
factor to neonates in the ICU who are fed via a nasogastric tube, especially those born 
with low birth weight and undeveloped immune systems.  
In addition, factors other than antibiotic resistance have led to the emergence of A. 
baumannii in the hospital settings as a significant pathogen, including the ability to 
resist desiccation. It has been reported that A. baumannii has the ability to colonise 
and persist in hospital environments for months, surviving in harsh and stressful 
conditions (Espinal et al., 2012; Ryu et al., 2017). A previous study reported that A. 
baumannii can survive for prolonged periods on dry surfaces, such as plastic, glass, 
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and other environmental surfaces implicated as a transmission route in infection and 
outbreaks (Espinall et al., 2012; Gallego et al., 2016). Representative A. baumannii 
strains in the current study were evaluated for their ability to survive desiccation. It 
was revealed that the majority of these organisms have the ability to maintain their 
viability during 14 days of desiccation in infant formula and are able to efficiently 
recover after this period of time. This recovery can be considered as a risk factor to 
the health of neonates in the ICU. Due to the ability of A. baumannii to resist 
desiccation, it is likely that this can contribute to the survival and persistence of this 
organism to maintain its viability under environmental pressures within the hospital. 
This may increase opportunities for transmission between neonates in the ICU, in 
particular those who often require feed via a nasogastric feeding tube. These strains 
also displayed multidrug resistance, which therefore makes them more difficult to 
treat. Consequently, these organisms can be considered as serious concerns and as 
major risk factors to neonates with immune systems that have not fully developed and 
thus, increases the likelihood of infection. 
For pathogenic bacteria to cause infections they require the ability to survive in the 
bloodstream and overcome the defence mechanisms of the host. Resistance to human 
serum is an important factor in bacterial virulence (Russo et al., 2010). Previous 
studies reported that a common trait of organisms causing bacteraemia is the ability 
to resist antimicrobial factors in human serum (Williams et al., 2001). Results obtained 
in the current study demonstrate that all A. baumannii isolates displayed high 
resistance to human serum and revealed significant increases in their initial numbers 
after the third hour of incubation. Indeed, several recent studies have reported the 
involvement of some factors in serum resistance. For instance, Russo et al. (2009) 
reported that the pbpG gene is an encoded virulence factor in A. baumannii and the 
mutant shows reduced growth in human serum. Another report showed 
that phospholipase D (PLD) has been identified as a virulence factor in A. 
baumannii, and disrupting this gene also results in reduced resistance to human 
serum as well as decreased capacity for invading epithelial cells (Jacobs et al., 2010). 
Moreover, it was suggested by Kim et al. (2009) that the OmpA protein contributes to 
the survival of A. baumannii in human serum. OmpA has roles in adherence, invasion 
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of epithelial cells, and binds to factor H in human serum, which may allow A. 
baumannii to survive in blood by avoiding serum-mediated killing. However, pbpG, 
PLD, and ompA genes have been detected in the genomes of the A. baumannii strains 
analysed in this study. Such findings indicating the ability of these strains to survive in 
human serum would increase the clinical concern to neonates in the NICU, especially 
those with compromised immune systems, which are therefore highly susceptible to 
infections.  
In addition to the survival of A. baumannii in human serum, acquisition of iron is 
essential in such environments to help bacteria survive and persist in the host. Iron is 
one of the most important nutrients for the host and pathogenic bacteria alike. 
However, in the human body, iron is rarely found as a free and unbound molecule, 
and is therefore one of the major limiting factors for pathogenic microorganisms. 
(Hasan et al., 2015).  To counter this, pathogenic bacteria use several iron acquisition 
mechanisms to obtain iron from the host (Penwell et al., 2012). The most iron-
chelating molecule found among A. baumannii clinical isolates is called siderophore 
acinetobactin (Mihara et al., 2004; Mortensen and Skaar, 2013). In this study, all A. 
baumannii strains were able to produce siderophores as shown in Table 3-5. This 
suggests that A. baumannii may have the ability of acquiring iron in iron-deficient 
environments. The biosynthesis of acinetobactin is encoded by the operon 
basABCDFGHI and secretion via a siderophore efflux system encoded by genes 
barA and barB. The transport system for acinetobactin is encoded by genes 
bauABCDEF, which are essential for translocation of ferric-acinetobactin complexes 
into bacterial cells, as well as putative binding sites for ferric uptake regulators such 
as entE, basD, and bauF (Penwell et al., 2012; Hasan et al ., 2015). In this study, 
screening for genes encoding iron transport systems and receptors carried out by 
BLAST searches against the virulence factor database (VFDB) confirmed their presence 
in all of the A. baumannii strains in this study. The presence of such genes might enable 
the bacteria to uptake sufficient amounts of iron and survive in the host, which could 
therefore contribute to bacterial pathogenesis. 
Bacterial haemolysins and protease are considered as virulence factors that were 
detected among the tested A. baumannii strains. Such factors are important in 
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contributing to bacterial pathogenesis and disease. The present study showed that the 
majority of A. baumannii isolates were able to lyse the erythrocytes of horse blood. 
The protease enzyme was detected among all tested strains. A previous study by 
Antunes et al. (2011) also reported that clinical isolates of A. baumannii clinical 
demonstrated appreciable amounts of haemolysis in horse blood but not in sheep 
blood. The same authors also reported that the all strains displayed protease activity. 
It is possible that these activities might be an important part of the pathogenic 
mechanisms of these bacteria. These results therefore suggest that the A. baumannii 
strains have the ability to lyse the erythrocytes of horse blood through production of 
β-haemolysis and secreted proteases, which is recognised to interact with host 
systems to promote infection (Tilley et al., 2014). Consequently, the presence of such 
virulence traits is likely to increase the potential risk factors to neonatal health.  
The FAO and WHO (2004 & 2006) risk assessment on the microbiological safety of 
infant formula, identified different microorganisms associated with powdered infant 
formula contamination including Acinetobacter spp. The ingestion of contaminated 
feed containing acid-tolerant bacteria may present the opportunity of bacterial 
colonisation and potentially cause infections in the patients. However, stomach acidity 
would normally provide an important front-line defence against pathogens when 
ingested with food (Martinsen et al., 2005).  In this study, the tolerance of acidic 
conditions was determined by exposure of the A. baumannii strains for 2 hours at pH 
3.5 in infant formula media. All tested strains were able to tolerate the 2 hour 
exposure time at pH 3.5. The protection of these strains from the low pH acidity could 
be because of their ability to form a biofilm. This is in agreement with a previous study 
by McNeill and Hamilton (2003) who showed that biofilm cells of Streptococcus are 
highly resistant to low pH. The survival of these strains in low pH acidity may allow 
them to succeed in causing infection through the route of ingestion, and particularly 
in neonates who feed via nasogastric feeding tubes. Neonates in NICUs are routinely 
fed through a feeding tube at regular period timed between 2 to 3 hours. In this study, 
majority of strains were capable of forming high amounts of biofilm, which also grew 
inside neonatal feeding tubes and were resistant to low pH. This therefore suggests 
that these strains could reach the intestines via ingestion and colonise the neonate’s 
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stomach and cause infection. It’s a potential health risk to neonates, particularly 
among premature babies in NICUs who lack a developed immune system, who are at 
greater risk. 
Another important virulence factor would include the ability of the organisms to 
attach to human epithelial cells during the initial step of the colonisation process 
(Smani et al, 2012).  In this study, attachment ability to human epithelial cells for the 
representative A. baumannii strains was assessed to determine the potential risk of 
infection to neonates in ICUs. Caco-2 monolayer cell line was used as a model of the 
small intestine. It was revealed that A. baumannii isolates possess the ability to adhere 
to the Caco-2 cell line. This shows that the strains might have a high virulence potential. 
Although the levels of adherence varied among the strains, all strains belonging to 
ST113 showed an ability to attach at high and moderate levels. However, several 
studies have shown involvement of the csu locus encoding the chaperone-usher pili 
assembly system in biofilm formation. It has also been involved in attachment to 
abiotic surfaces in A. baumannii strains (Tomaras et al., 2003; Luo et al., 2015; Selasi 
et al., 2016). Interestingly, the csu locus was identified among isolates of ST113 in this 
study, however, only one strain –1595, belonging to ST193 – was lacking the csu locus 
and demonstrated a very low amount of biofilm production and low levels of 
attachment. It can be suggested that the presence of this locus is most likely to be 
associated with the capacity of biofilm formation and attachment ability of this 
isolates. The results of this study agree with a previous study by Tomaras et al. (2003) 
which reported the disruption of the csuE and csuC resulted in non-piliated cells and 
eliminated biofilm formation and cell attachment. This has also has been 
characterised by Pakharukova et al., (2018) Jennifer suggesting that it plays an 
important role in bacterial attachment to biotic and abiotic surfaces and in biofilm 
formation. Similarly, another report suggested that a significant correlation exists 
between the capacity to form biofilms and the expression of the csuC, csuD, and csuE 
genes by carbapenem-resistant A. baumannii (CRAB) (Selasi et al., 2016). Outer 
membrane proteins, such as OmpA, have also been characterised in Acinetobacter, 
which is essential for bacterial attachment to epithelial cells and is involved in the 
development of biofilms on plastic surfaces. For example, Kim et al., (2016) 
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investigated the role of OmpA in the pathogenesis of A. nosocomialis. Their results 
indicated that ompA mutant displayed reduced attachment to A549 human alveolar 
epithelial cells and biofilm formation compared with the wild type. Consistent with 
this, the ompA gene has been detected in the genomes of all A. baumannii strains 
analysed in this study. 
There are several studies which have reported a correlation between resistance to 
antibiotics and the ability to form biofilms. For instance, a recent study by Bardbari et 
al., (2017) found a significant correlation between multidrug-resistant (MDR) A. 
baumannii isolates and biofilm formation.  But correlations between biofilm formation 
and cell adhesion among clinical isolates has been less well studied. The current study 
demonstrates interesting correlations between biofilm formation and the capacity of 
attachment, as shown in Figure 3-15. For example, strain 1595 (ST193) produced a 
very low amount of biofilm and low attachment while strains 1604, 1623, 1524 and 
1591 (all ST113) showed higher levels of biofilm formation and higher levels of 
attachment. Such traits may not only confer persistence and survival of these strains 
in neonatal intensive care units, but also enables growth and colonisation in enteral 
feeding tubes. This could explain the ability of these isolates to successfully colonise 
neonatal feeding tubes and offers the opportunity for these isolates to survive and 
potentially cause subsequent infections in the neonate. It would appear that neonates 
born with low birth weights and undeveloped immune systems in NICUs are at high 
risk, especially those fed via nasogastric tubes. The feeding tube would therefore 
represent an important risk factor in NICU infections. 
Attachment is a very specific process and the initial step in many infections. Once 
pathogenic bacteria adhere to a host surface, they may proceed to invade mammalian 
cells, in some cases. In this study, the gentamicin protection assay was performed to 
determine the ability of strains to invade Caco-2 human epithelial cells. As shown in 
Figure 3-12, most of these strains invaded Caco-2 human epithelial cells at very low 
levels, such as strains 1591, 1595, 1601, 1613, 1615, 1623, and 1630, which belonged 
to different pulsotypes and sequence types. However, strains 1604, 1618, and 1624 
(ST113) showed significantly higher levels of invasion when compared to the other 
strains. When compared to the negative control strain, most of these strains showed 
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no significant difference when analysed by means of one-way ANOVA, followed by 
multiple comparisons with a Dennett’s test. Nevertheless, it was notable that the 
majority of isolates belonging to ST113 revealed significant levels of attachment and 
low levels of invasion, while isolates of ST193 showed lower attachment and invasion 
abilities. This suggested that there was no correlation between the ability to adhere 
and invade for A. baumannii. This demonstrates the virulence potential of A. 
baumannii isolates for neonatal hosts. Although a low ability to invade intestinal cells 
was observed, it may still suggest a potential of pathogenicity in premature babies in 
NICUs who lack a developed immune system.  
After invasion, many bacterial pathogens have the ability to use different strategies 
to survive and replicate in different types of host cells. On the other hand, the innate 
immune system constitutes the first line of host defence against infection. In this 
study, Figure 3-13 shows the A. baumannii strains (n=10) which were investigated for 
their ability to persist in human macrophages, using the U937 macrophage cell line. 
The majority of these strains were able to persist and replicate inside macrophages 
for up to 72 hours of incubation. This could possibly be due to all of these strains 
possessing the pgaABCD genes, which are involved in the synthesis of poly-β-(1-6)-N-
acetylglucosamine (PNAG). PNAG is one of the important polysaccharides, which is 
reported as a virulence factor that protects bacteria against innate host defences, and 
is described as a major component of biofilm formation (Choi et al., 2009). Indeed, 
maintenance of the organism's viability within the macrophage suggests that these 
organisms may be reflective of the levels of pathogenicity in premature babies in 
NICUs. Additionally, these strains were confirmed to show a high level of resistance to 
human serum (Figure 3-5), and such characteristics might enhance the ability of A. 
baumannii strains to evade the host immune response and cause bacteraemia. 
The effect of A. baumannii on the viability of the epithelial Caco-2 cells was also 
assessed by measuring MTT reduction. All strains were moderately cytotoxic to Caco-
2 cells. Amongst the representative isolates tested, strain 1623 was slightly more 
cytotoxic than the other strains, but this difference did not reach statistical 
significance. Cell death has been described in A. baumannii by Choi et al. (2005) to be 
induced by apoptosis as the result of A. baumannii after 12 h, targeting the 
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mitochondria of the human laryngeal epithelial cells (HEp-2). In addition, A. baumannii 
was observed to cause the apoptotic death of A549 human alveolar epithelial cells 
(Gaddy et al., 2009). Cytotoxicity on intestinal epithelial cells might have significant 
implications for the evolution of infections. Due to the ability of these isolates to cause 
a cytotoxic effect and induce cell death, it can be expected that the pathogenic 
potential of A. baumannii could result in infection of neonates in NICUs. 
As classically described, A. baumannii is an important nosocomial pathogen. It is also 
an important pathogen in neonates hospitalised in ICUs, particularly new-born babies 
with very low birth-weights and weakened immune systems (Von-Dolinger et al., 2005; 
Hsu et al., 2014). All isolates in this study were recovered from neonatal feeding tubes 
of 21 neonates in NICUs from two different hospitals. They were defined as multidrug-
resistant and showed the ability to form significant amounts of biofilm. These strains 
also showed the ability to tolerate acidic conditions, desiccation, and survive in human 
serum. Furthermore, other important observations included their ability to attach and 
invade intestinal epithelial cells and persist inside macrophages. These features could 
allow them to survive and facilitate their persistence and transmission in the NICU. 
Additionally, colonised neonatal feeding tubes could serve as reservoirs for 
pathogenic A. baumannii. This strongly indicates a possibility of neonatal infections 
resulting from the persistent exposure by ingestion in hospitals where the neonates 
are at high risk of nosocomial infection in neonatal intensive care units. 
The A. baumannii ST113 sequence type has been found to be the predominant 
sequence type that was recovered from a large number of feeding tubes from the two 
hospitals. Their presence confirms the colonisation of neonatal feeding tubes and 
causes a real concern over risk factors associated with neonatal feeding and infection 
sources. Of particular concern are new-borns with low birth weights who routinely 
feed via a feeding tube. As discussed earlier, the consumption of the feed with bacteria 
colonising the feeding tube could result in the ingestion of high numbers of bacteria. 
After ingestion, these bacteria have the potential to colonise the neonate’s intestine 
and cause infection. This finding warrants due consideration because of the high risk 
of infection associated with premature babies in the NICU. 
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Chapter 4.  Profiling a clinical collection of Enterobacter spp. strains, in 
particular E. hormaechei, isolated from neonatal sepsis cases, 
CSF and nasogastric enteral feeding tubes 
4.1. Introduction 
Neonates in neonatal intensive care units (NICUs) represent highly susceptible 
individuals within the paediatric group, particularly pre-term neonates with low birth-
weight and weak immune systems. The risk of infection to compromised neonates 
increases with prolonged hospitalisation where a wide variety of medical devices are 
used, including enteral feeding tubes, ventilator tubes and catheters. The colonisation 
of nasogastric enteral feeding tubes by opportunistic pathogens, for example, has 
been recognised as a possible source of infectious organisms (Hurrell et al., 2009a). 
The ability of bacteria to attach to medical devices is well known and these bacteria 
are often associated with hospital-acquired infections (Venkateswaran et al., 2016; 
Khelissa et al., 2017). The ability of opportunistic pathogens to form biofilms inside 
neonatal nasogastric feeding tubes has been a cause for concern. It has been reported 
in previous studies that neonatal enteral feeding tubes are prone to rapid colonisation 
by a wide variety of opportunistic pathogens of the Enterobacteriaceae, irrespective 
of feeding regime (Hurrell et al., 2009a; 2009b). In their study, 129 enteral feeding 
tubes collected from NICUs were examined and they showed that 76% of these tubes 
were colonised by microorganisms able to produce biofilms. The most common 
isolates included E. hormaechei, E. cancerogenus, K. pneumoniae, S. marcescens and 
Escherichia coli.  
This colonisation of feeding tubes by pathogenic organisms may cause a serious health 
risk to neonates, particularly those with low birth-weight and premature in the NICU. 
For example, one quarter of all E. hormaechei isolated from neonatal enteral feeding 
tubes by Hurrell were resistant to the 3rd generation cephalosporins, cefotaxime and 
ceftazidime (Hurrell et al., 2009a). This was validated by another study which showed 
that E. coli K1 ST95 strains isolated from neonatal nasogastric feeding tubes possessed 
genes encoding numerous virulence traits associated with neonatal meningitis 
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(Alkeskas et al., 2015). The risk of infection by such bacterial strains is a concern in the 
neonatal unit.  
Enterobacter spp. are one of the most serious ESKAPE pathogens and are a leading 
cause of nosocomial infections throughout the world (Santajit and Indrawattana, 
2016). The ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, 
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and 
Enterobacter spp.) are important causes of nosocomial infection and dissemination of 
multidrug-resistant (MDR) strains (Santajit and Indrawattana, 2016; El-Mahallawy et 
al., 2016; Silva et al., 2017). Chen et al. (2014) reported that Enterobacter spp. were 
important pathogens of nosocomial bacteraemia in paediatric patients at Taipei 
General Hospital, during a 10-year study between 2001 and 2011 to review the clinical 
characteristics of bacteraemia. Enterobacter spp. have also been identified among 
Gram-negative microorganisms as a cause of neonatal sepsis in NICUs (Torkaman et 
al., 2009; Chen et al., 2009; Sharma al., 2013; Arowosegbe et al., 2017). Late-onset 
Enterobacter cloacae sepsis was described by Chen et al. (2009), an infection of very 
low birth-weight neonates admitted to the NICU. E. cloacae was also recognised by 
Weems et al. (2015) as a cause of late-onset sepsis in a preterm infant who was fed 
expressed mother's milk. During the past decade, outbreaks caused by Enterobacter 
spp. have been reported by several studies in hospital settings (Boban et al., 2011; 
Paauw et al., 2010; Stoesser et al., 2015). 
4.1.1. Enterobacter spp.  
Enterobacter spp. are facultative anaerobic Gram-negative rods, motile by means of 
peritrichous flagella. This genus is composed of saprophytic bacteria which are widely 
encountered in nature and commensal in the enteric flora in the human 
gastrointestinal tract. They can also be found in sewage and soil. Currently, six species 
of the genus Enterobacter have been assigned to the E. cloacae complex. These 
members are most frequently isolated from clinical samples (Paauw et al., 2008; 
Morand et al., 2009). The Enterobacter cloacae complex includes E. hormaechei, E. 
cloacae, E. asburiae, E. ludwigii, E. rnimipressuralis and E. kobei. The term E. cloacae 
complex is sometimes used because of difficulties in routine identification methods to 
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distinguish between clinically important species. Phenotypic identification to the 
species level within the complex group has been mostly unreliable. Although their 
identification by 16S rRNA gene is widely used, it is not highly discriminatory between 
members of the Enterobacter genus (Morand et al., 2009). Indeed, molecular 
methods based on single-locus typing sequence analysis of hsp60, fusA, gyrB, or rpoB 
resulted in distinct genetic clusters, but likely not all clusters are able to be assigned 
to a specific species. However, the taxonomy of this complex group is mainly based on 
DNA cross-hybridization (Paauw et al., 2008). 
4.1.2. Enterobacter hormaechei  
E. hormaechei was named as enteric group 75 and first described by the Centers for 
Disease Control and Prevention (CDC) on the basis of 23 isolates which were received 
for identification. The species E. hormaechei was suggested to be negative for 
esculin, melibiose, raffinose and d-sorbitol, and positive for dulcitol 86% of the time. 
Originally, these species were defined by O'Hara as a unique species in 1989 and they 
were found to be associated with bloodstream infections (Hoffmann et al., 2005; 
Morand et al., 2009). E. hormaechei species consists of three different subspecies: E. 
hormaechei subsp. steigerwalti, E. hormaechei subsp. hormaechei and E. hormaechei 
subsp. oharae (Morand et al., 2009). The three subspecies were specified based on 
DNA-DNA hybridization and differentiated on the basis of their biochemical tests and 
particular phenotypic properties (Hoffmann et al., 2005).    
4.1.3. Incidences and Outbreaks 
Over the last decade, members of the Enterobacter cloacae complex have emerged as 
nosocomial pathogens with clinical significance in intensive care units (Hoffmann et 
al., 2005). They can cause numerous infections such as meningitis, septicaemia, 
pneumonia, cerebral abscess, wound infection, urinary tract infection (UTI), as well as 
bloodstream infection. In the United States, between 1992 and 1997, the National 
Nosocomial Infections Surveillance System (NNISS) reported a frequent occurrence of 
Enterobacter infections in intensive care units (ICUs) (Richards et al., 1999). The 
National Healthcare Safety Network (NHSN) reported that Enterobacter spp. 
accounted for nearly 5% of hospital acquired infection cases between 2009 and 2010 
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(Sievert et al., 2013). Sligl et al. (2006) reported that Enterobacter spp. are one of the 
most commonly isolated among nosocomial pathogens. 
The members of the Enterobacter cloacae complex can be considered as nosocomial 
pathogens, and E. hormaechei is generally the most isolated nosocomial pathogen 
within this group (Paauw et al., 2008). An outbreak of E. hormaechei infection and 
colonisation in year 1992 and 1993 was reported by Wenger et al. (1997). This 
outbreak occurred among low birth-weight, premature infants in an NICU at the 
Hospital of Pennsylvania. These organisms have also been reported by Paauw et al. 
(2009), as a result of a nationwide outbreak caused by an E. hormaechei outbreak 
strain in the Netherlands. The study by Paauw and co-authors showed that these 
isolates disseminated throughout hospitals and caused invasive infections in more 
than 100 patients. This species has also been reported in several outbreaks of sepsis 
in NICUs in the USA and in Brazil, where the outbreak originated from contaminated 
parenteral nutrition (Campos et al., 2007). Similarly, sepsis outbreaks in NICUs caused 
by E. cloacae have been reported among new-borns (Kose et al., 2016). Their study 
indicated the source of the sepsis outbreak of E. cloacae is more likely to be the 
contaminated parenteral nutrition solution. 
4.1.4. Potential virulence-associated traits 
E. cloacae complex are well known as human opportunistic pathogens and are most 
frequently isolated from clinical samples (Paauw et al., 2008; Davin-Regli and Pagès. 
2015). They can cause numerous infections and outbreaks among patients who are 
hospitalised for a prolonged period (Paauw et al., 2008). Members of this complex are 
clinically significant, because they usually carry several potential virulence-associated 
genes (VAGs). For example, curli fimbrial genes, csgABCD, are generally known to be 
important for adhesion and binding to hosts tissues. These genes are highly conserved 
within the Enterobacteriaceae family and have a known role in biofilm formation 
(Zogaj et al., 2003; Kim et al., 2012; Smith et al., 2017). The csg operon was detected 
by Kim et al. (2012) in 11 of the 14 of clinical E. cloacae isolates from their study. 
Antimicrobial resistance genes have also been detected in E. cloacae complex strains. 
The fosfomycin gene (fosA), which confers fosfomycin resistance and β-lactam 
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resistance (ACT), was detected in the E. cloacae complex, recovered from the blood of 
a patient with peritonitis (Lin et al., 2017).  
Moreover, multidrug efflux pumps can expel a broad range of antibiotics and also 
drive the acquisition of additional resistance mechanisms. The acrA and tolC efflux 
pump genes were detected among Enterobacter cloacae and were shown to be 
involved in resistance and virulence (Perez et al., 2012). The E. cloacae complex are 
intrinsically resistant to ampicillin, amoxicillin, amoxicillin–clavulanate and first 
generation cephalosporins (Davin-Regli and Pagès. 2015). Resistance to β-lactams is 
due to extended-spectrum β-lactamase production, such as TEM, SHV, CTX-M and VEB 
type enzymes, which can be found in E. hormaechei (Ho et al., 2005; Zhao and Hu, 
2013; Carvalho-Assef et al., 2014). There is therefore a serious concern for increased 
frequency of infection, particularly in low birth-weight and premature infants 
receiving antimicrobial therapy in NICUs. 
Another virulence factor is siderophores. Many pathogenic bacteria release these 
compounds with a high affinity to chelate iron from iron binding proteins. 
Enterobactin and other siderophores were reportedly produced by clinical isolates of 
Enterobacter spp. (Mokracka et al., 2004). Furthermore, attachment to and invasion 
of host cells are required for some bacterial strains to persist in the host and cause 
disease (Pizarro-Cerdá and Cossart, 2006). Krzymińska et al. (2010) reported the ability 
of E. hormaechei and E. cloacae strains isolated from human specimens to adhere and 
invade to human epithelial type 2 (HEp-2) cells. This can be considered as a risk factor 
to neonates in intensive care units, particularly in infants who are already at risk, such 
as those with low birth-weight and immune systems that have not fully developed. 
4.1.5. Aim and objectives  
In the neonatal intensive care unit, Enterobacter spp. have been recognised as a one 
of the most commonly isolated pathogens. Among this group, E. hormaechei is 
commonly isolated as a nosocomial pathogen of clinical significance. As mentioned 
earlier, it has been reported in several outbreaks of sepsis in NICUs. Of particular 
interest in this project were neonates in the intensive care unit which are highly 
susceptible to infection due to their prematurity, particularly of critically-ill neonates, 
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including those with low birth-weight, under-developed immune systems, or various 
other conditions. There are several risk factors to neonatal infection; the most 
important of which would include the use of medical devices such as nasogastric 
enteral feeding tubes (NEFTs). Neonates fed via a nasogastric tube are at increased 
risk with respect to neonatal infections in the NICU. 
The overall aim of the study was to profile a clinical collection of Enterobacter spp., in 
particular E. hormaechei isolated from feeding tubes, CSF and blood samples (sepsis 
cases) of premature babies in NICUs. Additionally, to evaluate these isolates to 
determine important risk factors with respect to neonatal infections in NICUs. The aim 
was to also investigate any unique virulence factors, genetic relatedness, and source 
of these isolates, as the aetiology of neonatal infections is not yet well understood. 
The study of these organisms is very important to improve our understanding of how 
they invade and cause infection. This study also aimed to evaluate the possible 
associations between E. hormaechei isolated from neonatal sepsis cases and neonatal 
feeding tubes and the frequency of virulence genes found in these isolates. To our 
knowledge, there are no known studies investigating the possible correlations 
between E. hormaechei isolated from sepsis and neonatal feeding tubes.  
Specific objectives of this study included: 
• Determining the relatedness of isolated strains from the NICUs of QMC & 
Nottingham City Hospitals by genotyping (i.e. PFG and MLST) isolates over a 
period of time (7 years). 
• Determining physiological attributes of the Enterobacter spp. with respect to 
biofilm formation, capsule production, desiccation tolerance, acid tolerance, 
and serum resistance.  
• A range of phenotyping and genotyping methods and characterisation of 
virulence traits in order to determine the potential infection risk of these 
species to neonates. 
• Evaluating the potential virulence of selected strains using in vitro attachment 
and invasion assays with intestinal and brain cells lines (Caco-2 and human 
brain microvascular endothelial cells; HBMEC) and macrophage survival. 
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• Whole-genome sequencing of selected isolates to detect a range of 
prospective virulence and other relevant genes of interest, such as those 
associated with fimbriae and antimicrobial resistance. 
4.2. Materials and Methods 
The methodology of this chapter is described in detail in Chapter 2 (Section 2). Twenty-
six Enterobacter spp. were selected from the Nottingham Trent University culture 
collection. These strains were isolated from premature babies with sepsis cases and 
CSF at Queen Medical Centre (QMC) and Nottingham City Hospital (NCH). These 
clinical isolates provided by Dr Shiu. The collection were from sporadic cases at either 
NCH or QMC collected during 7 years period (Table 4-1). 
This collection is very unique and has not been studied before. All these isolates were 
evaluated based on PFGE analysis and fusA gene sequence to identify the species 
identity of these Enterobacter isolates. An additional collection had been included in 
this study (2307, 2315, 2316, 2317, 2318, 2319 and 2320), which was recovered from 
sepsis, enteral feeding tubes and faecal samples of low-birth weight neonates from 
the same hospital (QMC). All isolates were subjected to physiological analysis such as 
capsule production, desiccation tolerance, acid tolerance, and serum resistance. Two 
strains were excluded from this investigation: strain 669 because it was identified as 
C. sakazakii by fusA gene sequences and strain 602, which was identified as Serratia 
marcescens by whole-genome sequencing. 
Twenty-three strains were selected and subjected to whole-genome sequencing. 
Twenty-one were identified as E. hormaechei and one strain 602, which was identified 
as Serratia marcescens. While strain 2254 fusA allele 58 as Enterobacter cloacae.  A 
maximum-likelihood phylogeny of these strains was constructed from a core genome 
alignment and their identification was confirmed.  Six E. hormaechei strains were 
identified as E. hormaechei subsp. oharae, 1988, 668, 495, 663, 460 and 665, while 
the rest of the isolates were identified as E. hormaechei subsp. steigerwaltii, as shown 
in Figure 4-9. Pauline Ogrodzki, a member of our research group, carried out the 
whole-genome sequencing and SNP analysis. Twelve representative strains of the 
twenty-one E. hormaechei were selected based on genotype and phenotype, in order 
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to investigate their potential virulence using human intestinal cells Caco-2, brain 
barriers cells HBMEC, testing levels of cytotoxicity and macrophage survival. 
Table 4-1: Enterobacter strains used in this study. 
 
NTU: Nottingham Trent University. *A: Pulsed Field Gel Electrophoresis was performed. *B: 
Physiological characterization was performed.  *C: whole-genome sequencing was performed. *D: 
tissue culture was performed. QMC: Queen Medical Centre. NCH: Nottingham City Hospital. NA: Data 
not available. 
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4.3. Results 
4.3.1. Genotyping Profiles 
4.3.1.1. Partial fusA sequence analysis for Enterobacter genus identification  
Twenty-six Enterobacter spp. were selected from the Nottingham Trent University 
culture collection. These strains were isolated from premature babies with sepsis 
cases at Queen Medical Centre (QMC) and Nottingham City Hospital (NCH). All isolates 
were evaluated based on the fusA gene sequence, to identify the species level identity 
of Enterobacter isolates. The phylogenetic tree, based on the fusA gene sequences, 
showed separation between the Enterobacter isolates. Fourteen strains were found 
to match fusA allele, 55, 56, 57, 75, 131 and 132 (Figure 4-1), identifying them as E. 
hormaechei. Whereas, four strains were found to match fusA allele 101, 130,133 and 
134, and were identified as E. aerogenes. The other 7 strains matching allele 58 and 
76 were not clearly identified and cannot be determined to the species level by fusA. 
Interestingly, one strain found to match fusA allele 1 was identified as C. sakazakii, 
which had been misidentified as E. cloacae by API testing. E. hormaechei was the 
predominant strain among the isolates analysed, as shown in Figure 4-1. 
4.3.1.2. Pulsed Field Gel Electrophoresis (PFGE) 
In this investigation, strain 669 was not included because it was identified as C. 
sakazakii. However, PFGE analysis of the remaining isolates was performed using Xbal 
restriction enzyme (Promega, UK). Twenty-five Enterobacter spp. isolates were 
digested with Xbal restriction enzyme and considered to be non-clonal when they 
have less than 95% band similarity (Tenover et al., 1995). The XbaI restriction enzyme 
separated the collection to unique pulsotypes, indistinguishable strains, and types 
containing bands ranging between 12 to 21 DNA fragments per strain, as shown in 
Figure 4-2. 
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Figure 4-1: Phylogenetic relationships within different Enterobacter spp. 
Twenty-Six Enterobacter spp. were selected from the Nottingham Trent University culture collection. 
Partial fusA gene sequence analysis was used to identify the isolates to species level. The tree was 
generated using MEGA7. 
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Figure 4-2: Xbal PFGE profiles of twenty-five Enterobacter spp. strains isolated from 
premature babies with sepsis at Queen Medical Centre (QMC) and Nottingham City 
Hospital (NCH) 
Dendrogram construction and band assignment was achieved using BioNumerics software version 7.1. 
For cluster analysis, dice coefficient, un-weighted pair group method with arithmetic mean (UPGMA) 
was used. Band similarity of <95% was used to determine whether the isolates are non-clonal. The 
tolerance and optimisation of the bands was 1.5%. 
________________ Strain   Source     Species
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4.3.2. Phenotyping and virulence traits 
Among the twenty-six Enterobacter spp. isolates, strain 669 was not included in this 
investigation because it was identified as C. sakazakii. Also, strain 602 was not included 
and it was identified as Serratia marcescens after whole-genome sequencing, and was 
therefore not determined to the species level by fusA. An additional collection had been 
included in this study, which was recovered from sepsis, enteral feeding tubes, and 
faecal samples of low-birth weight neonates from the same hospital (QMC). This 
collection had been isolated by Pauline Ogrodzki, as part of a parallel PhD study, which 
includes strains numbers, 2307, 2315, 2316, 2317, 2318, 2319 and 2320, resulting in a 
total of 31 isolates.  
4.3.2.1. Biofilm formation 
All strains of Enterobacter spp. (n = 31) were tested for their ability to form a biofilm on 
plastic surfaces at temperatures of 25°C and 37°C and on two types of formula, TSB and 
infant formula (IF). Figure 4.3 and Figure 4.4 show the biofilm formation of the six 
strains of E. cloacae, four strains of E. aerogenes, six strains of E. 
hormaechei subsp. oharae and fifteen strains of E. hormaechei subsp.  steigerwaltii 
isolated from sepsis cases, CFS and NEFTs. All Enterobacter strains showed the ability 
to produce more  biofilm at 37 °C than at 25 °C on infant formula and TSB (p < 0.001) , 
as shown in Figure 4-5. While on TSB, some of the strains produced a higher amount of 
biofilm at 25 °C than at 37 °C, such as strains 663 and 668. 
The highest values were seen by strains 662, 664, 462, 667, 1439, 1977, 2317, 2318 and 
2320 in infant formula and at different temperatures, and majority among these strains 
were E. hormaechei subsp. steigerwaltii. Whereas the strains 604, 1987 and 2307 
showed the lowest amount of biofilm production in same medium at 25 °C, when 
compared to the control. There was a clear variation between all species to form biofilm, 
in particular at 25 °C in TSB media. However, only two out of the thirty-one strains (666 
and 664) were able produce a moderate amount of biofilm on TSB media at different 
temperatures. The majority of strains produced a low amount of biofilm, which was 
close to the control value in this medium, at different temperatures. Regardless of the 
Chapter 4 Profiling a clinical collection of Enterobacter spp. 
 
113 
 
origin of these strains, most E. hormaechei subsp. steigerwaltii isolates showed higher 
biofilm than other strains when compared to the control. 
Biofilm formation in IF was not significantly different between the E. hormaechei subsp.  
steigerwaltii strains 2315, 2318 and 2320 isolated from feeding tubes compared with 
the majority of strains isolated from sepsis and CFS. On the other hand, biofilm 
formation in infant formula was significantly different compared to TSA media, as well 
as higher biofilm formation was observed at 37 °C compared to 25 °C (p < 0.001) , as 
shown in Figure 4-5. Curli genes, csgA, csgB, csgC, and csgD were reported to have an 
important role in the formation of biofilms in clinical E. cloacae isolates (Sung et al., 
2012). Genome screening in this study revealed that all of these genes are present in all 
representative E. hormaechei isolates, as explained later in section 4.3.3. 
 
 
Figure 4-3: Biofilm formation at 25 °C and 37 °C in infant formula 
All strains showed an ability to form more biofilm at 37 °C than at 25 °C on infant formula.Un-inoculated 
infant formula was used as a negative control. Error bars represent the standard deviation of at least two 
independent results.  
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Figure 4-4 Biofilm formation at 25 °C and 37 °C in TSB 
All strains showed an ability to form more biofilm at 37 °C than at 25 °C on TSA. Only strains 663 and 668 
had produced a higher amount of biofilm at 25 °C than at 37 °C. Un-inoculated TSB was used as a negative 
control. Error bars represent the standard deviation of at least two independent results.  
 
 
Figure 4-5 Paired t-test shows E. hormaechei strains form significant more biofilm in IF 
than in TSB (p < 0.001), (A) and also significant more biofilm in IF at 37°C than at 25°C 
(p < 0.001), (B). 
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4.3.2.2. Serum resistance  
To determine serum sensitivity, viability was calculated at four different time points (0h, 
1h, 2h and 3h), using log differentiation between the viable count of bacteria at time 
zero and after 3 hours (Figure 4-6). Enterobacter strains demonstrated a high level of 
resistance to human serum compared with negative and positive controls. Strains 604 
demonstrated intermediate resistance to human serum exposure. While strain 1439 
displayed the lowest serum tolerance with significantly poorer survival than other 
strains after the third hour of incubation (P<0.05). Strain 1977 E. hormaechei subsp. 
steigerwaltii isolated from CFS showed the highest serum tolerance. After the first hour 
of incubation up to 74% of strains revealed an increase in their viable count and 87% 
after the second hour of incubation. However, the majority of the strains from different 
species showed an ability to tolerate human serum for 3 hours. 
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Figure 4-6 Sensitivity of Enterobacter strains (n = 31) to human serum over 3 hours of incubation at 37 °C. 
Enterobacter strains demonstrated a high level of resistance to human serum after 3 hours of incubation. Only strains 1439 and 604 demonstrated intermediate resistance 
to human serum
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4.3.2.3. The iron siderophores 
Pathogenic bacteria require various iron acquisition systems to actively chelate iron 
from the host environment for a variety of metabolic processes. One of the systems is 
where the bacteria secrete siderophores, which are able to extract iron from the host. 
By using CAS agar diffusion assay, all strains examined in the study showed a formation 
of the orange zones around the wells. Production of siderophores was 100% visible in E. 
cloacae, E. aerogenes, E. hormaechei subsp. oharae and E. hormaechei subsp. 
steigerwaltii, as shown in Table 4-2. Most Enterobacteriaceae strains contain genes 
encoding iron uptake systems. Enterobacter has been reported to possess genes for 
enterobactin and aerobactin siderophore biosynthesis (Liu, et al., 2013). In this study, 
the iron siderophores, enterobactin biosynthesis genes (entABCDE) and aerobactin (IucC) 
were detected in all isolates recovered from sepsis cases, feeding tubes and CSF 
specimens. 
4.3.2.4. Haemolysis on blood agar  
Haemolytic activity was demonstrated by thirty-one strains of Enterobacter isolates on 
TSA agar supplemented with 5% horse blood. All Enterobacter strains produced β-
haemolysis on horse blood agar plates by 29 strains (93.5%). Haemolysis was not 
detected in two strains (E. cloacae 661 and E. hormaechei subsp. oharae 460) on TSA 
horse blood agar (Table 4-2). 
4.3.2.5. Cellulose formation  
The expression of cellulose by Enterobacter strains was performed using the calcofluor 
binding assay and visualised by ultra-violet fluorescence. Table 4.2 shows the ability of 
cellulose production by the thirty-one strains of Enterobacter on calcofluor agar medium. 
In general, all strains showed an ability to produced cellulose. Results of this study 
indicated that the ability of cellulose production varies between Enterobacter strains. 
Seven strains, (2 E. cloacae, 3 E. hormaechei subsp. oharae and 2                                    E. 
hormaechei subsp. steigerwaltii) grown on calcofluor agar revealed a strong 
fluorescence, while 15 strains exhibited moderate fluorescence and the remaining 9 
strains showed only weak fluorescence, in particular all E. aerogenes strains. 
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4.3.2.6. Capsule production 
Bacterial capsule production was determined by colony appearance on two different 
infant formula agar media, soya-based infant formula (IF1) and whey-based infant 
formula (IF2). The results were classified into four categories according to the mucosity 
of the colonies: very high, high, medium, low and no capsule production, which are 
represented by ++++, +++, ++, + and – respectively. As shown in Table 4.2, there was a 
clear variation between all Enterobacter strains with regards to production of capsular 
material according to the milk agar composition. Only two strains of E. cloacae (2115 
and 2254) formed high and medium capsular material in whey-based infant formula, 
respectively, whilst formed low capsule on soya-based infant formula. The rest of the 
strains were not able to produce capsular materials on either media (IF1 and IF2). With 
respect to E. aerogenes, all strains were able to produce capsules on two IF agar media 
used. In contrast, 3 out of 6 E. hormaechei subsp. oharae strains, 668, 663 and 1988 
formed capsular material on IF2, but only strain 668 was able to form capsular material 
on IF1. The rest of the stains were not able to produce capsular materials on either 
media. The production of capsular materials by E. hormaechei subsp. steigerwaltii 
strains varied according the growth media. For example, 9 strains showed an ability to 
produce low to medium amounts of capsular material on IF1 and IF2, while strains, 1448 
produced capsular material only on IF2. A very high level of capsular material was 
produced by E. hormaechei subsp. oharae strain 668 on IF2. In general, the majority of 
strains showed an ability to form capsules on whey-based infant formula more so than 
on soya- based infant formula. 
4.3.2.7. Protease production  
Investigations were conducted to determine the protease activity of Enterobacter 
strains. After 72 hours’ incubation on skimmed milk agar at 37 °C, all strains of E. cloacae, 
E. aerogenes, E. hormaechei subsp. oharae and E. hormaechei subsp. steigerwaltii had 
revealed a positive result for production of protease activity (Table 4-2). Protease 
activity is defined as a clear circle on the skimmed milk agar. B. cereus was used as a 
positive control and E. coli NTU 407 was used as a negative control.  
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4.3.2.8. Congo red morphotype  
Curli fimbriae was investigated by using LB agar media supplemented with Congo red. 
The colony morphology determined the formation of the Congo red phenotype. The 
expression of a red colony indicated the ability of the bacterium presumed production 
of curli fimbria, while pink was negative for curli fimbriae. The colony morphology of 
strains of E. cloacae (662, 461 and 2254), all E. aerogenes strains, strains of E. 
hormaechei subsp. oharae (495, 665 and 460), and E. hormaechei subsp. steigerwaltii 
(450, 462 and 1977) were considered as negative colonies for binding to the Congo red 
dye, while the rest of the strains formed red colonies and were therefore presumed 
positive for curli fimbriae (Table 4-2).
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Table 4-2 Capsule production, biofilm formation, curli fimbria, cellulose, siderophore, protease and haemolytic activity among the 31 
Enterobacter strains tested. 
 
β: β-haemolysis γ: γ-haemolysis H.B: horse blood, IF1: infant formula soya based, IF2: infant formula whey-based, +: positive, -: negative, VL= very Low biofilm formation L= 
Low biofilm formation, M = moderate biofilm formation and H = High biofilm formation.  
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4.3.2.9. Acidity  
The ability of E. cloacae, E. aerogenes, E. hormaechei subsp. oharae and E. 
hormaechei subsp. steigerwaltii to tolerate acidic conditions at pH 3.5 was evaluated. 
They were exposed to pre-adjusted infant formula at pH 3.5 for two hours. Figure (4-
7) displays the results for the different strains. In general, the initial viable count for 
all Enterobacter isolates was between 8.2 and 9.5 log10 CFU/ml. All strains were 
clearly resistant to exposure to pH 3.5 for 2 hours. During the first 30 mins of acid 
exposure the viability of all Enterobacter isolates decreased to 0.7-1.6 log cycles. 
After 60 minutes, the viable count cells for all strains tested did not show significant 
reduction. Two out of thirty-one strains showed the most acid sensitivity; strains 
1448 and 664 showed approximately 1.4 to 2.5 log cycle decline over the 2-hour 
incubation period. However, these strains remained viable for 2 hours at pH 3.5 and 
were therefore regarded as acid tolerant. 
  
Figure 4-7 Survival curve of 31 Enterobacter strains in infant formula at pH 3.5. 
Enterobacter strains were assessed for their tolerance to pH 3.5 for two hours. The viable counts were 
determined by the Miles & Misra method. Overall, all strains showed an ability to resist pH 3.5 for the 
total 2 hours. Two strains showed the most acid sensitivity; strains 1448 and 664 showed 
approximately 1.4 to 2.5 log cycle decline over the 2-hour incubation period. The number of survival 
cells in this assays were performed in duplicate in two independent experiments. 
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4.3.2.10. Desiccation 
A total number of 31 Enterobacter strains were evaluated for their desiccation 
survival in infant formula. The first 24h of desiccation caused the viability of the 
majority of Enterobacter strains to slightly decrease by 0.3-1.5 log cfu/ml. The 
majority of viable cells of strains did not appear to be significantly reduced, while 
strains 450, 660 and 2315 were the lowest to persist under desiccated stress during 
24h. The reduction observed over this time ranged between 1.7 and 2.1 5 log cfu/ml. 
However, the reduction observed after the next 14 days ranged between 0.9 and 3.2 
log cfu/ml. There was some variation between all strains in their ability to persist 
under the stress of desiccation. Strains 457, 666, 665, 450, 1439, 660 and 2315 
showed low persistence compared with the other strains, in particular strain 457. The 
reduction of viable cells observed for this strain was 3.2 log cfu/ml, followed by strain 
666 and 665 at 3.1 log cfu/ml. Strain 663 had persisted the longer under desiccation 
stress. Overall, the majority of Enterobacter strains were resistant to desiccation in 
infant formula and remained detectable for the entire 2-week duration of the 
experiment (Figure 4-8). 
4.3.2.11. Antimicrobial Susceptibility 
 Antimicrobial susceptibility was tested using the Kirby-Bauer disk diffusion method, 
as described by the BSAC Methods (2015). As shown in Table 4-3, all Enterobacter 
strains were resistant to ampicillin, cefotaxime, ceftizoxime, ceftriaxone and 
gentamicin. The majority of the isolates were also resistant to imipenem (58%), 
meropenem (19%), ceftazidime + clavulanic acid (51%), cefotaxime + clavulanic acid 
(29%). The effect of the antibiotics tested varied according to the species, as showed 
in Table 4-3. All of the screened strains were found susceptible to tobramycin and 
cefoperazone except strain 1977 was showed resistance to the same antibiotics. Also, 
it was found that ceftazidime + clavulanate (CAZ+CV) and cefotaxime, clavulanate 
(CTX+CV) had effect on the majority of isolates, in particular E. hormaechei subsp. 
oharae. Several studies have reported on the genes implicated in antibiotic resistance 
in Enterobacter spp. (Chollet et al., 2002; Davin-Regli and Pagès. 2015; Ghanavati et 
al., 2015). All E. hormaechei isolates possessed fosfomycin (fosA) and several blaACT 
genes, including blaACT-15 (57%), blaACT-7(33%), blaACT-16 (9.5%) and only one 
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strain, 665, possessed blaTEM-1B. Only strain 1977 E. hormaechei subsp. 
steigerwaltii isolated from CFS had possessed aminoglycoside genes aadA16, aadA2, 
aac(6')lb-cr, aac(3)-lld, macrolide mph(A), sulphonamide sul1(x2), rifampicin ARR-3, 
phenicol catA2 and trimethoprim dfrA2 (Table4-5). 
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Figure 4-8 Survival of Enterobacter strains subjected to desiccation over a period of 2 weeks. 
The figure shows a slight decrease in viability of 0.3-1.5 log cfu/ml, as a result of the first 24h of desiccation, while the reduction observed after 2 weeks ranged between 0.9 
and 3.2 log cfu/ml. Overall, it is clear that the majority of strains were resistant to desiccation in infant formula and remained detectable for the entire duration of the 2-
week experiment 
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Table 4-3 Sensitivity of Enterobacter strains to antibiotic agents. 
 
S: susceptibility. R: resistance. I: intermediate resistance. QMC: Queens Medical Centre Hospital. NCH: Nottingham City Hospital. CTX: cefotaxime. MEM: meropenem. GM: 
gentamicin. CRO: ceftriaxone. AP: ampicillin. IMI: imipenem. ZOX: ceftizoxime. CAZ: ceftazidime. CFP: cefoperazone. TOB: tobramycin. CTX+CV:  cefotaxime + clavulanate. 
CAZ+CV ceftazidime + clavulanate. 
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4.3.3. Genomic studies 
4.3.3.1. Genome sequence and analysis 
Genomic DNA was extracted from twenty-three strains. The Illumina MiSeq reagent 
kit was used for whole-genome sequencing. Strain 602 was identified as Serratia 
marcescens while strain 2254 fusA allele 58 as Enterobacter cloacae. However, Core 
genome alignments were produced for the E. hormaechei strains in order to confirm 
the species identity, and the CSI Phylogeny program were used to identify Single 
Nucleotide Polymorphisms (SNPs). This work was performed by Pauline Ogrodzki. 
Twenty-one E. hormaechei strains were selected and subjected to whole-genome 
sequencing. A maximum-likelihood phylogeny of these strains was constructed from 
a core genome alignment and the identification of these strains was confirmed by 
building a core genome phylogenetic tree. Six E. hormaechei strains were identified 
as E. hormaechei subsp. oharae, 1988, 668, 495, 663, 460 and 665, while, the rest of 
the isolates were identified as E. hormaechei subsp. steigerwaltii, as shown in Figure 
4-9. 
The three E. hormaechei subsp. oharae strains, 668, 495 and 663, formed a single 
cluster isolated from neonatal sepsis cases, and no other clinical details were 
available for these strains. These isolates belong to sequence type (ST) 108, and 
differed from each other by 183–265 SNPs (Figure 4-10). These samples were 
assumed linked in some way, could be the origin for these isolates hospital sources 
environment such as medical devices or carer’s hands. Among the E. hormaechei 
subsp. steigerwaltii, three strains, 2316, 2317 and 2319, were collected from faecal 
samples and three strains, 2315, 2318 and 2320, were from a feeding tube of a 
preterm infant in a NICU over a 1-month period. These isolates belong to ST106 and 
differed from each other by only 13–26 SNPs (Figure 4-10). It can be inferred that the 
small number of SNP differences suggest a common source of origin. On the other 
hand, the rest of the E. hormaechei subsp. Steigerwaltii differed from each other by 
very high numbers of SNPs, up to 66,582 SNPs.  
All strains were obtained between 2009 and 2015. Following the aforementioned 
genomic analysis, twelve representative strains were chosen for further analyses to 
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assess the level of pathogenicity using tissue culture assays (Figure 4-9). This assay 
will be discussed in detail in section 4.3.4. 
 
Figure 4-9 A phylogenetic tree of E. hormaechei strains based on core genome SNP 
analysis. 
The highlighted twelve representative strains were chosen for further analysis to assess their 
pathogenicity using tissue culture assays. 
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Figure 4-10 A heat map illustrating the difference of SNPs between each genome in the alignment. 
The map was generated by Pauline Ogrodzki as part of a parallel PhD study, using the program CSI Phylogeny version 1.4.
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4.3.3.2. Genome screening of E. hormaechei for virulence and physiological 
associated traits  
Genome screening and comparative genomics work for twenty-one E. hormaechei 
strains was performed to examine the presence and absence of selected genes that may 
contribute to virulence or physiological features.  
Table 4-4 shows a list of the proposed virulence genes classified into the major virulence 
factors of E. hormaechei strains, such as genes encoding Csg fimbriae or pili, which play 
a crucial role in adherence and biofilm formation in Gram-negative bacteria (Zogaj et al., 
2003; Kikuchi et al., 2005; Ogasawara et al., 2010; Taylor et al., 2011). Flagellar 
biosynthesis plays a role in colonisation and adhesion, and in pathogenic 
microorganisms are considered as a virulence factor ( Haiko and Wikström, 2013; De 
Maayer and Cowan, 2016). In addition, the role of ompA and ompX genes have been 
described by Mittal and colleagues (2009) in bacterial penetration of the blood-brain 
barrier (BBB). For example, ompA in Cronobacter plays an essential role in invasion of 
human brain microvascular epithelial cells (HBMEC) (Singamsetty et al., 2008). 
Furthermore, the rpoS sigma factor is the master regulator of response to various stress 
conditions in many Gram-negative bacteria ( Stockwell and Loper, 2005; Battesti et al., 
2011; Lago et al., 2017) and iron acquisition system which is mediated through 
siderophore, enterobactin (entABCDE)  and aerobactin (IucC) biosynthesis genes Table 
4-4. All these genes were noted among all E. hormaechei genomes analysed in this study. 
E. hormaechei strains showed a variation in genome size between 4.45 and 5.16 Mb and 
only six strains possessed plasmids (633, 668, 660, 450, 667 and 1977). However, using 
the Center for Genomic Epidemiology database, genome analysis showed all E. 
hormaechei isolates encoded for fosfomycin (fosA), AmpC beta-lactamase and different 
blaACT genes, such as blaACT-15 (11/21), blaACT-7(7/21), blaACT-16 (2/21) and only 
strain 665 possessed blaTEM-1B. Only strain 1977 E. hormaechei subsp. steigerwaltii 
isolated from CFS possessed aminoglycoside genes aadA16, aadA2, aac(6')lb-cr, aac(3)-
lld, macrolide mph(A), sulphonamide sul1(x2), rifampicin ARR-3, phenicol catA2 and 
trimethoprim dfrA27. With regards to the MLST analysis of 21 E. hormaechei isolates, it 
was revealed that a total of 11 STs were present, with 3 strains assigned to unknown 
STs. The most frequent STs of the feeding tube and faeces isolates was ST106 (28%), 
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followed by the sepsis isolates, which were ST108 (14%). However, the MLST sequences 
of the rest of the isolates were unique and were typed as ST134, ST740, ST45, ST133, 
ST102, S7175, ST346, ST50 and ST124. The sequence types obtained for the 21 E. 
hormaechei strains are given in Table 4-5. 
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Table 4-4 shows the results of the genomic comparison of E. hormaechei strains recovered from sepsis, feeding tube and CSF specimens.  
 
The results indicate that all isolates harboured a number of virulence-associated genes. (+) = present, (-) = absent.  
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Table 4-5 shows the results of the genomic comparison of E. hormaechei strains recovered from sepsis cases, feeding tube and CSF specimens. 
 
The results indicate that all isolates harboured a number of virulence-associated and antibiotic resistance genes, (-) = absent. 
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4.3.3.3. Adhesion-associated traits  
Bacterial attachment to the host cell is an important step towards bacterial 
pathogenesis as it facilitates colonisation, and thereby infection. Curli fimbriae play an 
important role in biofilm formation in E. cloacae isolates (Kim et al., 2012) and have been 
attributed a vital role in E. coli and Salmonella adhesion to host cells (Cordeiro et al., 
2016; Tan et al., 2016). Curli fimbrial genes have been detected in the E. hormaechei 
strain in this study (Table 4-3). The CsgA protein is the major subunit of curlin, which has 
possibly been linked with the ability of E. hormaechei to attach to Caco2 cell lines. Figure 
4-11 shows the correlation between CsgA and the adhesion ability of E. hormaechei 
strains. The cluster with high levels of adherence was highlighted in blue and the cluster 
of moderate level of attachment was highlighted in pink, except one strain (668) in this 
cluster which showed high attachment. This strain also showed an ability to produce 
high capsular material in the two infant formula agar media tested, soya-based infant 
formula (IF1) and whey-based infant formula (IF2). Furthermore, this strain produced 
high yields of cellulose, which for this reason, might result in high levels of attachment, 
though further details about this gene will be provided in the discussion section of this 
chapter. 
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Figure 4-11  maximum-likelihood tree for csgA gene sequence. 
 
Positive link between csgA gene and adhesion ability of E. hormaechei strains. The blue highlighted strains 
showed high attachment and pink showed moderate attachment except one strain (668) in this cluster, 
which showed high attachment. The phylogenetic tree was generated by using MEGA-7. 
4.3.3.4. Stress response gene (rpoS) 
The rpoS gene, which encodes the alternative sigma factor S, is the master regulator of 
responses to the various stress conditions in many Gram-negative bacteria (Lago et al., 
2017). In this study, all E. hormaechei strains were screened for the presence of the rpoS 
gene. All E. hormaechei isolates were shown to harbour this gene, as expected. The 
sequences of the rpoS genes of strains 1448 and 664 were shown to cluster separately 
from other rpoS sequences of other strains, indicating the presence of difference in the 
nucleotide sequence. As shown in the phylogenetic tree of Figure 4-12, the blue 
highlighted strains clustered separately and were also the most acid sensitive strains 
over the 2-h incubation period. 
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Figure 4-12 maximum-likelihood tree for rpoS sequence gene. 
All E. hormaechei isolates were shown to harbour the rpoS gene. The blue highlighted strains clustered 
alone and were the most sensitive to acid at pH 3.5 compared with the other strains tested. The 
phylogenetic tree was generated using MEGA-7. 
4.3.4. Assessment of the pathogenicity of E. hormaechei using tissue culture assays 
This part of the study examined the twelve representative strains out of the twenty-one 
of E. hormaechei isolated from sepsis cases, CSF and neonatal feeding tubes. The 
representative strains were chosen based on genotype and phenotype, one strain 
chosen from each cluster based on sequence variation in the core genome as shown in 
the phylogenetic tree (Figure 4-9). Additionally, the strains were chosen based on 
phenotypic traits when they appeared to be more closely related (i.e. clustered 
together). For example, strain 1439 displayed the lowest serum tolerance and strain 664 
showed the most acid sensitivity. Strain 668 showed an ability to produce high capsular 
material in the two infant formula and revealed high yields of cellulose. Also this strain 
produced a higher amount of biofilm on infant formula at temperatures of 25°C and 
37°C among E. hormaechei subsp. oharae. Strains 667 was able to form capsular 
 668 rpoS
 1439 rpoS
 664 rpoS
 1448 rpoS
 450 rpoS RNA
 1977 rpoS
 2307 rpoS
 2315 rpoS
 2318 rpoS
 2320 rpoS
 495 rpoS
 663 RpoS
 460 rpoS
 665 rpoS
 462 rpoS
 660 rpoS
 667 rpoS
 2317 rpoS
 2319 rpoS
 2316 rpoS
 1988 rpoS
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material on both media compared with closely related strain 450 and only strain 460 
showed non-haemolysis on horse blood among of E. hormaechei strains. However, 
strain 1977 E. hormaechei subsp. steigerwaltii was the only strain isolated from CFS and 
2315, 2318 and 2320 strains were isolated from feeding tubes. These strains were 
evaluated for their potential virulence using Caco2 human intestinal cells and HBMEC 
brain endothelial cells to test for cytotoxicity and macrophage survival. 
4.3.4.1. Bacterial attachment on Caco-2 human epithelial cells 
An attachment assay was conducted to evaluate the adherence ability of twelve 
representative E. hormaechei strains to epithelial Caco-2 cells as shown in Figure 31.4 . 
To define the level of attachment achieved by each isolate, the attachment efficiency 
(%) results were classified into three categories according to the observed level of 
attachment on the controls used in this study: high, medium, and low levels of 
attachment. Low attachment was considered to be less than 2% cfu/ml, while 
attachment efficiency of isolates between 2% and 4% cfu/ml was referred to a medium 
level of attachment. Attachment efficiency greater than 4% of recovered cfu/ml was 
considered as a high level of attachment to the Caco-2 human epithelial cells.  It was 
observed that all strains from different sources were able to adhere to this cell line to 
different extents. For example, two strains, 1977 and 664, showed a higher attachment 
rate to Caco-2 than the other bacterial strains compared to the positive control when 
analysed by means of one-way ANOVA statistical testing, followed by multiple 
comparisons with a Dennett’s test (P < 0.001). However, sepsis isolates 1988, 460 and 
2307, exhibited the lowest attachment levels among representative strains when 
compared to the positive control. 
On the other hand, feeding tube strains 2315 and 2320 had similar ability to adhere to 
Caco-2 cells as sepsis isolate 668, and also showed greater adherence to this cell line 
than the sepsis isolates 1988, 460 and 2307. Interestingly, this was also observed by the 
feeding tube strain 2318, as it displayed higher attachment levels compared with sepsis 
strains 668, 1988, 460 and 2307, and similar levels to sepsis isolates 462 and 1439, 
as shown in Figure 4.13. 
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Figure 4-13 Attachment of E. hormaechei strains to the human Caco-2 cell-line. 
The figure shows the differences in attachment levels among E. hormaechei strains to human epithelial 
cell line Caco-2. All strains were able to attach to the epithelial cell-line when compared to E. coli K12, 
which was used as negative control, and. S. Enteritidis, which was used as a positive control. Error bars 
indicate the standard deviation of six data points taken from two independent experiments in triplicate.  
4.3.4.2. Bacterial invasion of Caco-2 human epithelial cells 
The gentamicin protection assay was performed to investigate the capability of E. 
hormaechei strains isolated from different sources to invade the Caco-2 cells. Results 
were classified into three categories according to the percentage of recovered cells after 
invasion. Less than 0.2% recovery was defined as a low level of invasion, 0.2 to 0.4% was 
defined as a medium level, and greater than 0.4% recovery was defined as a high level 
of invasion. All isolates were able to invade human Caco-2 cells, however, the invasion 
rates varied among the examined E. hormaechei strains (Figure 4-14). Strains 1977 and 
668 showed significantly a higher invasion rate than the other strains (P<0.05). 
Strains 664 and 2315 both showed the lowest invasion levels of Caco-2 cells. With regard 
to feeding tube strain 2318, this strain showed the most significant invasion levels 
among the feeding tube strains compared to the negative control. This strain has the 
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ability to invade Caco-2 cells similar to sepsis isolate 462, which also showed an ability 
to invade this cell line more so than the sepsis isolates 664,1439 and 2307. 
 
Figure 4-14 Invasion efficiency of E. hormaechei strains to the mammalian Caco-2 cell 
line. 
The figure shows the differences among E. hormaechei strains with regards to their ability to invade the 
human epithelial cell line Caco-2, by performing the gentamicin protection assay. The majority of strains 
invaded Caco-2 human epithelial cells at moderate levels. S. Enteritidis and E. coli K12 were used as 
positive and negative control strains, respectively.  
4.3.4.3. Attachment to human brain microvascular endothelial cells (HBMEC) 
The ability of the selected E. hormaechei isolates to attach to human brain microvascular 
endothelial cells (HBMEC) are shown in Figure 4-15. In this assay, E. coli K12 was used as 
a negative control, while C. koseri was used as a positive control. All strains were able to 
adhere to this cell-line at different levels. E. hormaechei-steigerwaltii strain 1977 (ST124) 
isolated from CSF showed the highest adherence and invasion capabilities of the HBMEC 
and Caco-2 cell-lines among all of the tested strains. Sepsis strains 462 and 1439 
revealed the ability to adhere to HBMEC cell lines more so than the other sepsis and 
feeding tube strains. On the other hand, feeding tube strain 2318 demonstrated a similar 
level of adhesion to some sepsis strains compared to the C. koseri positive control (P < 
0.001), such as 668, 664 and 667, while displaying a higher adhesion level than other 
sepsis isolates, such as 2307 and 1988. The other feeding tube strains 2315 and 2320 
also revealed an ability to adhere to this cell line, similar to sepsis strains 1988 and 460, 
but less than feeding tube strain 2318. Paired t-test shows no significant deferent               
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(p < 0.573) between sepsis and feeding tube strains compared in the ability to adhere to 
HBMEC cell-line 
 
 
Figure 4-15 Attachment of E. hormaechei strains to HBMEC cell-line. 
The figure shows the differences in attachment levels among E. hormaechei strains to human brain 
microvascular endothelial cells (HBMEC). All strains were able to attach to the HBMEC cell-line when 
compared to E. coli K12, which was used as negative control, and C. koseri, which was used as a positive 
control. Error bars indicate the standard deviation of six data points taken from two independent 
experiments in triplicate.  
4.3.4.4. Invasion of the human brain microvascular endothelial cells (HBMEC) 
With regards to the HBMEC cell line, most of these strains were able to invade the 
human blood brain barrier endothelial cells at low levels when compared to the negative 
control E. coli K12. CSF strain 1977 and sepsis strains 668, 664 and 667, displayed a 
higher invasion level among all of the tested strains (P < 0.05) when compared to the 
negative control. However, feeding tube strains showed a similar level of invasion to 
some sepsis strains compared to the negative control, such as 1439, 2307, 460 and 1988 
(Figure 4-16). These results indicate no correlation observed between attachment and 
invasion with regards to the HBMEC cell line. For example, the sepsis isolate 1439 was 
one of the isolates demonstrating high levels of adhesion, but presented with the lowest 
level of invasion. 
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Figure 4-16 Invasion efficiency of E. hormaechei strains to HBMEC cell line. 
The figure shows the differences among E. hormaechei strains in terms of their ability to invade the human 
blood brain barrier endothelial cells, by performing the gentamicin protection assay. The majority of 
strains invaded HBMECat only low levels. K. koseri and E. coli K12 were used as positive and negative 
control strains, respectively.  
4.3.4.5. Macrophage survival assay 
Twelve representative strains of E. hormaechei were investigated for their ability to 
persist and replicate within human macrophages, represented by the U937 cell-line. The 
NTU collection strain C. koseri 48 was used as a positive control, whilst E. coli K12 strain 
1230 (also from the NTU strain collection) was used as a negative control. All tested 
strains were taken up by macrophage cells. After uptake, most strains persisted in 
macrophages for 72 hours. The majority of them were able to multiply significantly after 
24 hours of incubation, including the positive control C. koseri (P < 0.05). 
Two sepsis strains, 2307 and 1439, displayed a decline in their intracellular survival at 48 
hours of incubation compared to other strains. All strains displayed a slight decrease in 
their intracellular numbers after 72 hours of incubation, whereas strains 460 and 1988 
exhibited a fall in their numbers. CSF strain 1977, with the highest numbers, had 
exhibited the greatest ability to persist and replicate inside the macrophages. The 
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feeding tube strains showed a similar ability to survive and replicate within the U937 
cells compared to some sepsis strains, such as 667 and 668 (Figure 4-17). 
 
Figure 4-17 shows the differences in the ability of E. hormaechei strains to persist in 
U937 macrophage cell lines for 72 hours. 
The majority of the E. hormaechei strains (n = 12) demonstrated an ability to persist and replicate within 
the macr ophage cell-line U937 for up to 72 hours of incubation. The C. koseri 48 strain was used as 
positive control, while E. coli K12 strain 1230 was used as a negative control (both were obtained from 
the NTU strain collection).  
4.3.4.6. Cytotoxicity of E. hormaechei 
The MTT reduction assay was carried out to measure the cytotoxic effect of selected E. 
hormaechei strains on the viability of the epithelial Caco-2 cells. Viable epithelial Caco-
2 cells are able to reduce MTT to its insoluble purple form, known as formazan. An S. 
Enteritis strain, which was used as positive control in this investigation, lowered the 
amount of MTT reduction, thus indicating their high cytotoxic ability. Conversely, Caco-
2 cells in cell culture medium with no bacteria added to the cells was used as a negative 
control, which showed high levels of MTT reduction thus indicating low or non-existent 
cytotoxicity and high cell viability. The results were categorised as low cytotoxicity (OD 
≥ 1), moderate cytotoxicity (OD 0.5 – 1), and high cytotoxicity (OD < 0.5). The results 
from the assay indicated that all of the strains tested were highly cytotoxic. No 
significant difference between strains 1977, 667, 1988 and 462 and the positive control, 
when analysed by means of one-way ANOVA, followed by multiple comparisons with a 
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Dennett’s test. Sepsis strain 462 was the most cytotoxic compared to the other strains. 
Interestingly, feeding tube strains showed a similar level of MTT reduction to some 
sepsis strains such as 2307 and 664 (Figure 4-18). 
 
Figure 4-18 Cytotoxicity of E. hormaechei strains after 1-hour incubation with the Caco-
2 cell line. 
All strains showed high cytotoxicity and no significant difference was observed between strains 1977, 667, 
1988 and 462  compared to the positive control, when analysed by means of one-way ANOVA, followed 
by multiple comparisons with a Dennett’s test.   
4.3.5. Summary of virulence factors for E. Hormaechei 
This part of the study examined the twelve representative strains out of twenty-one E. 
hormaechei isolates from sepsis, CSF and neonatal feeding tube samples. These strains 
were evaluated for their potential virulence using human intestinal cells Caco-2, brain 
endothelial cells HBMEC, as well as an evaluation of cytotoxicity and macrophage 
survival. All results are summarised in Table 4-6. 
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Table 4-6 Results summary of attachment, invasion Caco-2, HBMEC and phagocytosis 
survival of U937 cell lines and cytotoxicity Caco-2 cells. 
 
4.4.  Discussion 
Over the last decade, the incidence of neonatal infections has been increasing due to 
members of the Enterobacteriaceae, including species of the genus Enterobacter, which 
are considered one of the most common opportunistic pathogens (Davin-Regli and 
Pages, 2015). They can cause numerous infections such as meningitis, septicaemia, 
pneumonia, cerebral abscess, wound infection, urinary tract infection, and are also 
associated with bloodstream infections. However, neonates are at high risk of 
nosocomial infection in neonatal intensive care units (NICUs) (Joseph et al., 2012; Basiri 
et al., 2015; Rameshwarnath and Naidoo, 2018). This project concerns the risk 
assessment to neonates, whose immune systems have not fully developed, have low 
birth-weights and are fed via nasogastric feeding tubes. Therefore, this research work 
aimed to profile a diverse clinical collection of Enterobacter species, in particular E. 
hormaechei, by applying a range of phenotyping and genotyping methods to determine 
the potential risk of these species to neonates. Furthermore, this study aimed to 
evaluate the possible correlations between E. hormaechei isolated from sepsis and 
neonatal feeding tubes and the frequency of virulence genes. It is important to improve 
our understanding of the potential risk of E. hormaechei isolated from neonatal feeding 
tubes to neonate in NICUs. Twenty-six Enterobacter spp. were selected from the 
Nottingham Trent University culture collection, which has not previously been studied. 
These strains were isolated from premature babies with sepsis cases and CSF specimens. 
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In addition, 7 strains from sepsis, nasogastric enteral feeding tubes and faeces samples 
from Queen Medical Centre (QMC) in Nottingham were also included in the collection.  
A variety of rapid typing methods include molecular techniques which have been 
developed for the identification of bacterial strains isolated from clinical samples, such 
as PCR-based typing methods, pulsed-field gel electrophoresis (PFGE), and multilocus 
sequence typing (MLST). Such molecular fingerprinting techniques are important 
techniques in epidemiological investigations. These methods are widely used for the 
molecular subtyping of bacteria, including Enterobacter spp. This would assist in 
identifying if the same strains were isolated on different occasions and to determine if 
there is any epidemiological relationship between pulsotype and clinical presentation. 
PFGE analysis was performed for twenty-five strains isolated from premature babies 
with sepsis by using Xbal restriction enzyme to confirm their clonal origin. PFGE profiles 
indicates that all of the Enterobacter strains formed unique pulsotypes of 
distinguishable strains. These sporadic strains were isolated from an NICU during a 7-
year period and were unlikely to be related. 
The similarity of phenotypic of Enterobacter, in particular E. cloacae genomic groups, 
resulted in several problems with their identification. Although phenotypic 
identification of this genus is usually difficult, molecular methods are often used to 
achieve an accurate definition. Multilocus sequence analysis (MLSA), including fusA, was 
shown as an important tool for taxonomic analysis of the Enterobacteriaceae. The 
fusA allele has been reported to be more reliable for identification of Cronobacter from 
non-Cronobacter such as E. hormaechei (Jackson et al., 2015; Ogrodzki and Forsythe, 
2015). 
All isolates in this study was evaluated based on the fusA gene sequence to identify the 
species level identity of Enterobacter spp. According to the phylogenetic tree, the fusA 
gene sequences showed separation between the Enterobacter isolates. Fourteen strains 
were identified as E. hormaechei, four strains identified as E. aerogenes, one strain 
identified as C. sakazakii, and the other 7 strains were not clearly identified and 
clustered within the Enterobacter genus. Interestingly, strain 669 was found to match 
fusA allele 1, identified as C. sakazakii, and as originally identified as E. cloacae by API 
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biochemical profiling in the hospital. Previous studies by Townsend et al. (2008b) also 
reported that the misidentification of E. hormaechei as C. sakazakii isolated from 
neonates during a nosocomial outbreak in a Californian hospital. Similarly,  false 
identifications was reported by Jackson (2015), where patient isolates in a hospital 
outbreak investigation were misidentified as C. sakazakii, then later characterised as 
Enterobacter hormaechei and a species of Enterobacter by using multilocus sequence 
typing. 
Misidentification is problematic issue during clinical infection, particularly in NICUs, 
because it may result in inappropriate treatment of the disease and mislead the 
investigation and attribution of the source. This is also one problem in developed 
countries were most clinical laboratories routinely identify Enterobacteriaceae by semi-
automated systems or commercial kits which limit discrimination of isolates to within 
this group (Jesumirhewe et al., 2016). However, the results of fusA typing did not 
discriminate between the subspecies of E. hormaechei. While the rest of strains 
clustered within the Enterobacter genus through the aforementioned methods were 
strains that did not match or showed ambiguous taxonomy. Similarly, previous Studies 
reported that the sequencing of 16S rRNA and other housekeeping genes such as rpoB, 
hsp60 and gyrB alone is not an appropriate method for determining to the species level 
of the E. cloacae strains (Paauw et al., 2008; Pavlovic et al., 2012). In this study, these 
strains were subjected to whole-genome sequencing to identify the correct species of 
Enterobacter and discriminate between the subspecies of E. hormaechei which isolated 
from several neonatal in QMC. 
Strains had clustered within the Enterobacter genus with deferent alleles and fourteen 
E. hormaechei strains were subjected to whole-genome sequencing. An additional 
collection recovered from sepsis, enteral feeding tubes, and faecal samples of low-birth 
weight neonates from the QMC hospital were also subjected to whole-genome 
sequencing. These selected strains were sequenced using the Illumina MiSeq and it was 
revealed that the majority of strains were identified as E. hormaechei, in particular subsp. 
E h. ssteigerwaltii. However, strain 602 was identified as Serratia marcescens, and thus, 
was not included in this study. In addition, strain 669 also was not included because it 
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was confirmed by fusA gene sequences to be C. sakazakii. All Enterobacter spp. were 
described using a range of phenotyping methods, in order to determine the potential 
infection risk of these species to neonates. However, having evaluated the importance 
of both organisms, I decided to focus on E. hormaechei for genomic and further analyses. 
The reason for this was that although E. hormaechei is associated with severe neonatal 
infections, there have been few in-depth studies in the literature, whereas E.  aerogenes 
and E cloacae have been studied by many research groups. Furthermore, E. hormacechei 
was predominant among the strains collected in this study. 
Formation of biofilms is a one of the important virulence factors, which is a critical 
feature for the development of clinical infection (Wu et al., 2015). It plays a significant 
role in colonisation by microorganisms, providing an opportunity for bacteria to become 
resistant to environmental stresses. In this study, I investigated the biofilm-forming 
potential of Enterobacter strains (n = 31) on plastic surfaces. The two variables used 
were incubation temperature and formula composition. These investigations found that 
the quantity of biofilm was significantly higher (p < 0.05) at 37 °C compared to 25 °C 
among the majority of Enterobacter isolates. It was also noted that the quantity of 
biofilm was higher in infant formula when compared to standard TSB medium under 
similar conditions. These observations indicate that the composition of the medium had 
an influence on the ability of Enterobacter strains to produce biofilm. These findings are 
in agreement with another study by Kadam et al. (2013), who assessed biofilm formation 
of Listeria monocytogenes. Their study showed that biofilm formation was higher in 
nutrient poor medium when compared to nutrient rich medium. Similarly, Allan et al. 
(2002) showed that biofilm formation had been reduced under nutrient limitation. 
The present study also compared the two different incubation temperatures and 
observed a higher quantity of biofilm production at 37 °C compared to 25 °C. This might 
refer to the fast growth rate of the strains tested in this study at higher temperatures. 
Thus, temperature is an important factor for biofilm formation, also the type of nutrient 
is vital for enhancement of biofilm formation. The most notable result was that the same 
quantity of biofilm was formed by E. hormaechei subsp. steigerwaltii isolated from 
feeding tubes when grown in infant formula at 37 °C compared to biofilm formed by E. 
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hormaechei subsp. steigerwaltii isolated from CFS and sepsis cases (Figure 4-3). This 
finding probably indicates the potential risk of neonatal infection by E. 
hormaechei subsp. steigerwaltii isolates from feeding tubes in NICUs. It is well known 
that biofilm protects bacteria during infections (Römling and Balsalobre, 2012). Jamal 
(2018) reported that according to the National Institute of Health, “more than 65% of 
all microbial infections are caused by biofilms”. Another study indicated that the most 
common pathogens in a healthcare setting are found to be biofilm producers, such as 
the ESKAPE pathogen (Bales et al., 2013; Santajit and Indrawattana, 2016; Navidinia, 
2016). 
Previous studies have reported that the curli fimbriae play an important role in biofilm 
formation. For example, a study by Kim et al. (2012) has suggested an association 
between expression of curli genes (csgA & csgD) and the ability of biofilm formation in 
E. cloaca isolates. Although the ability of biofilm formation varies among Enterobacter 
strains, the genome screening shows that these genes are present in all representative 
isolates. This indicates that some of the identified genes may not adequately express 
biofilm or might be influenced by other factors. Another study was carried out by Kim et 
al. (2012), who examined the expression of curli genes and biofilm formation in clinical 
isolates of Enterobacter cloacae by using RT-PCR. They found that curli fimbriae played 
a significant role in biofilm formation in clinical isolates that were tested. Such 
techniques could be used in further studies to determine or confirm whether the same 
phenomenon can be observed in our isolates. 
Curli fimbriae have also been described to contribute to biofilm formation in many 
species of bacteria, and are responsible for mediating host cell adhesion and invasion 
(Barnhart and Chapman, 2006; Kim et al., 2012). Curli fimbriae expression by Salmonella 
strains is also indicated by binding of Congo red dye (Gophna et al., 2001; Uhlich and 
Solomon, 2006; Reichhardt et al., 2015). In this study, Enterobacter isolates were 
characterised on Congo red media to evaluate the expression of curli fimbriae. Red 
colonies would be an indicator presumed of production of curli fimbria as positive 
colonies indicate binding to the Congo red dye. As shown in Table 4-2, not all 
Enterobacter strains were able to bind the Congo red dye. In contrast, all these strains 
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were confirmed to have csgA-G genes. This finding indicated no association between the 
morphology of Enterobacter isolates on Congo red and presumed Curli fimbriae 
expression. Indeed, some bacterial traits can affect biofilm formation, such as capsular 
materials and production of cellulose (Van Houdt and Michiels, 2010; Liu, et al., 2014; 
Wang et al., 2015). In this study, the above traits were investigated to find any 
correlation between these traits and biofilm formation among Enterobacter strains. 
Bacterial capsule production was determined by colony appearance on two types of 
infant formula agar (whey and soya). It is apparent in this study that some strains are 
not able to produce capsular material in both infant formula, while capsules were 
produced by all E. aerogenes strains in both formula used (Tables 4.2). However, in 
general, the majority of Enterobacter species are able to produce capsular material on 
whey rather than soya-based infant formula. This finding may indicate the difference in 
composition of infant formula used possibly affects the production of capsular material. 
It was also noted that there is no correlation between biofilm formation and capsular 
material production. For instance, E. hormaechei subsp. steigerwaltii 1977 and 660 
produced high biofilm in infant formula, as shown in Table 4-2, whilst unable to produce 
capsular materials in both types of infant formula used. Similarly, a previous study by 
Hurrell et al. (2009a) found that C. sakazakii strains were unable to produce any capsular 
materials, but nevertheless produced more biofilm. Although, the results indicate no 
obvious link between biofilm formation and capsule production in these strains, 
capsules may provide resistance to desiccation, serum activity and have a 
significant role in avoiding phagocytic killing (Ogrodzki and Forsythe, 2015). 
Cellulose is another extracellular material identified as one of the major components of 
the biofilm matrix. Its production is a widespread phenomenon by members                                                        
of the Enterobacteriaceae family, including Enterobacter spp. It has been shown to be a 
crucial cause of biofilm formation and protect cells from various environmental stressors 
(Re and Ghigo, 2006, Vu, 2009). Cellulose production was evaluated among Enterobacter 
strains in this study by comparing the visualised fluorescent colonies under UV light. 
All isolates showed differing amounts of cellulose production, although all strains 
showed high quantities of biofilm production. However, there is no obvious correlation 
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of this phenotype with cellulose production. For example, strains 1448, 450 and 495 
produce high biofilm, however these strains had produced lower amounts of cellulose. 
In contrast, strains 988, 460 and 1439 produce high biofilm as well as high 
amounts of cellulose, as shown in Table 4.2. In addition, bcs operon have been reported 
to be associated with the production of cellulose synthase in Enterobacter (Römling and 
Galperin, 2015; Ji et al., 2016). Similarly, cellulose-associated genes bcsA, bcsB and bcsD 
were investigated by Hu et al. (2015) and confirmed that bcsA and bcsB were necessary 
to express cellulose and are involved in biofilm formation in Cronobacter spp. Indeed, 
the BLAST searches were performed to check the presence of cellulose-associated genes 
in the genomes of E. hormaechei strains. It was revealed that all analysed genomes 
possess all of these genes. 
Although biofilm formation has a significant role in the pathogenesis of bacterial 
infection, there are a number of supposed virulence factors that are involved in the 
ability of a bacterial pathogen to cause disease. For example, protease and haemolysins 
were detected among the tested Enterobacter strains. Proteases have a number of key 
roles in the ability of several bacteria to infect the host and cause disease (Gellatly and 
Hancock, 2013; Koziel and Potempa, 2013; Culp and Wright, 2017). Bacterial 
haemolysins are enzymes that destroy red blood cells and they are classified into 
different types of haemolysins including α-haemolysin, β-haemolysin and γ-haemolysin 
(Kong et al., 2016). In the present study, all Enterobacter strains produced β-haemolysis 
on horse blood agar plates, with the exception of two strains, 460 and 661. Previous 
studies have revealed that the β-haemolysin plays a crucial role in the result of group B 
streptococcal sepsis by contributing to liver failure and high mortality (Ring et al., 2002). 
The presence of such virulence traits among the examined Enterobacter strains indicates 
a potentially higher risk to neonatal health in NICUs.      
Other virulence factors would include siderophores, where many pathogenic bacteria 
release these compounds with a high affinity to chelate iron from iron-binding proteins 
(Caza and Kronstad, 2013; Raymond et al., 2015). It is important for these bacteria to 
obtain nutrients such as iron, which is essential for the growth, replication, and survival 
in the host environment and could assist in virulence. The production of siderophores 
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was detected in all tested strains by using the CAS agar diffusion assay. Apart from 
siderophore production, molecular characterisation was also performed. Most 
Enterobacteriaceae strains contain genes encoding iron uptake systems including 
Enterobacter spp., which has been reported to possess genes for enterobactin and 
aerobactin siderophore biosynthesis (Mokracka et al., 2004). In this study, the iron 
siderophores, enterobactin biosynthesis genes (entABCDE) and aerobactin (IucC) were 
detected in all isolates recovered from sepsis, feeding tube and CSF specimens. These 
results suggest that the production of enterobactin and aerobactin siderophores were 
not related to the source of the isolate. However, the detection of entABCDE and IucC 
genes may enhance the ability of pathogenic bacteria to grow in the host in conditions 
of low-level iron and facilitate replication during infections. Therefore, the presence of 
such virulence traits is likely to increase the potential risk factors to neonatal health.  
Resistance to human serum is an important factor in bacterial virulence (Webb and 
Kahler, 2008; Miajlovic and Smith, 2014; Sanchez-Larrayoz et al., 2017). Results obtained 
from the present study demonstrate that all the sporadic isolates of Enterobacter 
demonstrated a high level of resistance to human serum. This finding suggests that 
human serum resistance might be an important determinant of virulence in 
Enterobacter species. A previous study by Townsend et al. (2008b) stated that E. 
hormaechei strains isolated from neonates during a nosocomial outbreak in a California 
hospital were serum-resistant. Figueroa and Densen (1991) reported that a common 
feature of meningococci isolated from CSF or blood is serum-resistant. Similarly, E. 
hormaechei strains were confirmed to be serum-resistant. Such findings may indicate 
the ability of these strains to cause bacteraemia by avoiding or escaping 
human serum killing. Indeed, several studies reported that OmpA contributes to serum 
resistance and mutants of the ompA gene reduce the ability of bacteria to survive in 
human serum (Weiser and Gotschlich, 1991; Lindholm and Oscarsson, 2017). However, 
it was revealed that the ompA gene was detected in all E. hormaechei strains. On the 
other hand, capsular material production could also have a role in serum resistance and 
macrophage evasion (Ogrodzki and Forsythe, 2015). My results showed that not all 
strains were able to produce capsular materials on both media used in this study, 
however, all strains were serum-resistant, therefore suggesting that these strains might 
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be able to escape human serum killing by using different strategies. Indeed, such 
findings suggest that the ability of these strains to survive in human serum would 
increase the clinical concern to neonates in the NICU, especially those with 
compromised immune systems, making them highly susceptible to infections.  
In addition to the survival in human serum, the antibiotic sensitivity test revealed that 
the isolates of Enterobacter were almost 100% resistant to ceftazidime, ampicillin, 
cefotaxime and gentamicin (Table 4-3). Also, some strains were resistant to imipenem, 
meropenem and 3rd generation cephalosporins. These results are consistent with 
Hurrell et al. (2009), who reported that many E. hormaechei strains were found to be 
resistant to the 3rd generation cephalosporins. Torkaman et al. (2009) also suggest that 
Enterobacter spp. is the most common pathogen causing neonatal sepsis in NICUs, 
especially by multiple drug-resistant strains. Antimicrobial resistance genes were 
predicted among all isolates tested, such as fosfomycin (fosA) conferring fosfomycin 
resistance and blaACT β-lactamase. The majority of these isolates investigated in this 
study were resistant to cephalosporins. However, the resistance might be due to the 
presence of the multidrug efflux pump AcrAB-TolC, which was detected among 
examined genomes. It is one of the most important antimicrobial resistance 
mechanisms. Efflux pumps can expel a broad range of antibiotics and also drive the 
acquisition of additional resistance mechanisms. The multidrug efflux system AcrAB has 
been linked with the ability of E. coli to resist ampicillin, chloramphenicol, nalidixic and 
tetracycline (Scatamburlo et al., 2004; Yasufuku et al., 2011; Amábile-Cuevas et al., 2010; 
Kafilzadeh and Farsimadan, 2016). The study by Pérez et al. (2012) found that 
both acrA and tolC genes are key to the fitness of clinical E. cloacae isolates. Similarly, 
another study by Guérin et al. (2016) confirmed the essential role of the AcrAB-TolC 
efflux pump in both virulence and antimicrobial resistance of E. cloacae. Thus, these 
results indicate that there could be serious risk associated with neonates, especially 
those born with low birth-weight. Five strains of E. hormaechei isolates have been found 
to harbour at least one plasmid (Table 4.5), the majority of which belonged to Inc groups, 
for example, strain 667 harboured 3 plasmids IncHI2A, IncN3, IncHI2. Such plasmids may 
able to harbour a variety of resistance genes and additional virulence factors. A study by 
Chen et al. (2016) has shown that IncHI2 was the major plasmid, predominant in 
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antibiotic-resistant Salmonella isolates and contribute to the spread of antibiotic 
resistance among these isolates. 
Among these sporadic isolates, only E. hormaechei subsp. steigerwaltii 1977 isolated 
from CSF showed resistance to all antibiotics used in this study. It had possessed more 
antimicrobial resistance genes, such as macrolide mph(A), sulphonamide sul1, 
rifampicin arr-3, trimethoprim dfrA27 and aminoglycoside genes aadA16, aadA2, 
aac(6')lb-cr and aac(3)-lld. This strain harboured four aminoglycoside genes, which 
might be a serious issue because these resistance genes are generally found on mobile 
genetic elements such as plasmids, integrons or transposons. They can easily be spread 
among other bacteria in the hospital setting (Vaziri et al., 2011). Such isolates raise 
alarms, suggesting that more attention should be given to neonates in NICUs to control 
the spread of these MDR isolates, particularly among preterm and low birth-weight 
infants. Indeed, there are many factors contributing to Enterobacter outbreaks. It was 
noted that human milk can also be involved in outbreaks of infection through milk 
sharing and contamination of equipment used in feed preparation, bottle warmers and 
milk collection equipment. A previous study reported that sepsis outbreaks in NICUs 
caused by Enterobacter cloaceae among new-borns was reported by Kose et al. (2016). 
Their study indicated that the source of the sepsis outbreak of E. cloacae is more likely 
to be the contaminated parenteral nutrition solution. Pulsed-field gel electrophoresis 
(PFGE) analysis revealed the same profile among the isolates identified in the blood 
cultures and samples of the parenteral solutions. Another study by Jackson (2015), 
indicated the first report of an Enterobacter species transmission from powdered infant 
formula (PIF) to patient. These strains were shown to belong to the same pulsotype and 
were characterised using multilocus sequence typing (MLST). 
However, once the pathogenic bacteria are ingested, they are exposed to the acidity of 
the stomach. The ability of bacteria to persist in the human stomach is an opportunity 
that could allow these bacteria to invade the intestine, and consequently this can lead 
to human illness. In this study, all strains were tested under acidic pH conditions similar 
to those present in the gastrointestinal tract. The results showed the survival of these 
isolates and they were clearly resistant to exposure to pH 3.5 for 2 hours. The RpoS 
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sigma factor is the master regulator of the various stress responses in many Gram-
negative bacteria (Lago et al., 2017). It is described by Stasic et al. (2012) to be essential 
to desiccation tolerance among E. coli strains. Similarly, Álvarez-Ordóñez et al. (2012) 
showed that RpoS is required for the tolerance of Cronobacter to osmotic, acidic and 
oxidative stresses. In this work, all E. hormaechei isolates were found to harbour this 
gene. Strain 664 and 1448 were shown to be the most acid-sensitive strains over the 2-
h incubation period. Interestingly, the sequence of rpoS gene for these strains was 
different from other rpoS sequence of E. hormaechei strains. They clustered separately, 
as shown in Figure 4-12, indicating the differences within the rpoS gene. The analysis 
suggested a possibly positive correlation between bacterial acid tolerance and rpoS 
activity. These strains were regarded as acid-tolerant, and this feature will enhance such 
bacteria to pass through the stomach and into the intestines of the neonates. It could 
potentially contribute to an increased risk of these bacteria to colonise and infect the 
infants through toxin productions. As previously mentioned, these bacteria proved to 
have virulence factors such as bacterial haemolysins, protease and serum resistance, 
which may confer a higher potential risk to neonatal health. 
Other factors may contribute to the ability of pathogens to establish persistent 
infections, such as environmental stresses. One of the most significant environmental 
stresses encountered by microorganisms is desiccation. A total number of 31 
Enterobacter strains were evaluated for their desiccation survival in infant formula. The 
majority of these organisms have the ability to maintain their viability during 14 days of 
desiccation in infant formula and are efficiently able to recover after this period of time. 
Resistance to desiccation may contribute to the survival and persistence of this organism 
to maintain its viability under environmental pressure. This can be considered as a risk 
factor to neonates in intensive care units, particularly infants who are already at risk, 
such as those with low birth-weights and immune systems that have not fully developed. 
A previous observation by Barron and Forsythe (2007) showed that the E. cloacae strain 
ATCC 13047T was recoverable after an 8-month survival period of desiccation. This result 
support the potential risk of infecting the neonates through the feeding of milk 
contaminated by Enterobacter strains, as originally proposed by FAO-WHO (2006). 
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Virulence factors such as attachment and invasion are also required for pathogenic 
strains of bacteria to cause disease, which enable the bacteria to colonise and persist in 
host cells (Pizarro-Cerdá and Cossart, 2006; Stones and Krachler, 2016). E. hormaechei 
is an opportunistic pathogen involved in nationwide outbreaks. It has been reported in 
several outbreaks of sepsis in NICUs (Townsend et al., 2008b; Paauw et al., 2009; Ohad 
et al., 2014). Therefore, I have decided to focus on E. hormaechei among strains 
collected as I mentioned previously, although E. hormaechei is associated with severe 
neonatal infections, there have been few in-depth studies published in the literature. 
Furthermore, it is a domain among strains collected in this study. For this reason, 12 of 
21 E. hormaechei isolates from sepsis, CSF and neonatal feeding tubes were assessed for 
their virulence potential using human intestinal and brain barrier cell-lines, Caco-2 and 
HBMEC. This part of the study will lead to the discovery of the potential infection risk of 
E. hormaechei isolated from NEFTs in NICUs, when compared to CSF and sepsis E. 
hormaechei isolates.  
All E. hormaechei strains showed an ability to attach to both Caco-2 and HBMEC cells at 
high and moderate levels indicating their virulence potential. This observation is in 
agreement with the results found by Krzymińska et al. (2010), who reported the ability 
of E. hormaechei and E. cloacae strains isolated from human specimens, which were 
able to adhere to and invade human epithelial type 2 (HEp-2) cells. Another study by a 
previous PhD student at NTU found that E. hormaechei isolated from feeding tubes were 
able to attach to Caco-2, HBMEC and rBCEC4 cells lines (Abudalla, 2014, unpublished 
data). Although some variations were observed among E. hormaechei in this study, it 
was interesting to note that feeding tube isolates showed no significant difference when 
compared with sepsis isolates for their ability to attach to Caco-2 (P < 0.05). Furthermore, 
these strains also showed no significant difference for their ability to attach to HBMEC 
when compared with some sepsis isolates, such as strains 2307, 460 and 1988. 
Adhesion is commonly mediated by fimbriae. Bacterial fimbriae or pili are filamentous 
surface proteins that play a crucial role in the attachment to biotic and abiotic surfaces in 
both Gram-positive and Gram-negative bacteria (Chagnot et al., 2013; Berne et al., 
2015). For example, curli fimbriae have been described to play a vital role in E. coli and 
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Salmonella for adhesion to the host cells. Their presence is linked with severe human 
infections (Cordeiro et al., 2016). In addition, flagellar biosynthesis-related proteins are 
generally recognised to play a role in colonisation and adhesion in pathogenic bacteria 
and are considered to be an important virulence factor (De Maayer and Cowan, 2016). 
A previous study by Du et al. (2016) reported the involvement of two flagellar 
biosynthesis genes (flhA and fliR) in the adhesion of C. sakazakii. These genes have also 
been detected in the genomes of examined E. hormaechei strains in this study.  
Curli fimbriae have been reported to play a vital role in biofilm formation in E. cloacae 
(Kim et al., 2012). Although the role of curli fimbriae among E. hormaechei strains 
remains unclear, it has been suggested that may be have an important role in adhesion 
to host surfaces. Curli fimbrial genes csgABCD have been detected in the assessed E. 
hormaechei strains in this study (Figure 4-11). The CsgA protein is the 
major subunit of curlin, which has been linked to the ability of E. hormaechei to attach 
to Caco2 cell-lines. As shown in Figure 4-13, a positive correlation between csgA and 
adhesion ability of E. hormaechei strains was noted. The sequence analysis of this gene 
presented 2 clusters among E. hormaechei strains; a cluster with high levels of 
adherence and a cluster of moderate levels of attachment. One exception was strain 
668 within the cluster of moderate attachment level which displayed high attachment. 
This might be because of the ability of this strain to produce high capsular material and 
high yields of cellulose, and thus result in high levels of attachment. However, the 
possibility of variations among these strains may explain the other bacterial traits were 
involved with the adhesion activity, or suggest that the expression of fimbrial genes 
were not completely expressed during the adhesion function. This requires further work 
to confirm whether these genes are differentially expressed by transcriptomic analysis 
studies. 
Following attachment, invasion of mammalian cells can be induced by many pathogenic 
bacteria (Ribet and Cossart, 2015). Indeed, the ability of pathogenic bacteria for invasion 
of host cells such as brain endothelial cells is a concern (Townsend et al., 2008a), 
particularly if E. hormaechei strains are found to colonise NEFTs. Therefore, the 
virulence potential of E. hormaechei strains was investigated for their ability to invade 
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the Caco-2 and HBME cell-lines to better understand the pathogenic potential for these 
isolates. 
The gentamicin protection assay showed that the E. hormaechei strains were able to 
invade the two cell-lines, indicating their virulence potential. However, outer membrane 
proteins have been reported to play a vital role in C. sakazakii to invade host eukaryotic 
cells. For instance, deletion mutants of ompX and ompA  of C. sakazakii revealed 
significantly reduced invasion levels of Caco-2 cells (Kim et al., 2010). Another study had 
reported that the ompX deletion mutant in E. coli showed decreased adhesion to 
pulmonary epithelial A549 cells (Kim et al., 2010). These genes were also detected in the 
12 E. hormaechei strains in this study and they may contribute to the invasion ability of 
these isolates. 
Most of the strains tested showed moderate invasion of Caco-2. It was notable that the 
E. hormaechei strains shows higher invasion levels of Caco-2 than HBME cells, suggesting 
that the strains have the tendency to invade epithelial cells (Caco-2) more so than 
endothelial cells (HBMEC). This may indicate why E. hormaechei isolates are frequently 
isolated from blood and associated with sepsis instead of the CSF. The invasion results 
in this research showed lower levels of invasion of Caco-2 cell-lines compared with 
results of the previous study by Townsend et al. (2008b), particularly the E. hormaechei-
steigerwaltii strain isolated from neonatal blood samples. The differences of the 
invasion experiments may be due to the variances in the growth conditions of the strains 
or the passage number of the cell-line used. This variation is not only due to 
experimental differences, but also possibility due to the variability of the demonstration 
and interpretation of the data analysis.  
Some strains, such as 2315 and 664 showed high attachment to Caco-2 cells whilst strain 
1439 showed high attachment to HBMEC cells. However, they demonstrated low 
invasion capabilities of these cell lines. These results suggest that there was no 
correlation between invasion and adhesion among E. hormaechei strains. E. 
hormaechei subsp. steigerwaltii strain 1977 (ST124) isolated from CSF showed the 
highest adherence and invasion of Caco-2 and HBMEC cell-lines among all strains. It may 
be that this strain associated with CSF is expected to have a high virulence potential 
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based on the location of isolation. However, it was notable that strain 2318 from feeding 
tubes revealed high invasion levels to Caco-2 when compared to sepsis isolates, such as 
strains 664, 2307 and 1439. Similarly, this strain also showed high invasion level to 
HBMEC in comparison with sepsis isolate 460 and 1439. Indeed, the ability of E. 
hormaechei subsp. steigerwaltii strain isolated from low birth-weight neonatal feeding 
tubes to adhere to and invade Caco-2 and HBMEC cell-lines may be a cause for concern. 
Particularly among neonates with low birth-weights representing a potential path for 
neonatal infections of the bloodstream following oral ingestion. Certainly, the 
interaction of feeding tube isolates with epithelial cells is an important initial signal for 
neonatal infections. It is believed that the ability of microbes to attach to host epithelial 
and endothelial cells leads to disease in their hosts (Ribet and Cossart, 2015). 
 
This work has shown that feeding tube strains exhibited a similar behaviour to that 
observed in isolates from CSF and sepsis cases, since they have the ability to adhere and 
invade Caco-2 and HBMEC cell-lines and also share the same virulence genes. It is clear 
that they would have the ability to cause infections of neonates in NICUs. It is believed 
that sepsis is associated with Enterobacter spp., for instance, Chen et al. (2014) reported 
that Enterobacter species have appeared as significant pathogens of nosocomial 
bacteraemia in paediatric patients. 
Adhesion is an important step to facilitate pathogens to colonise and cause infection 
(Soto and Hultgren, 1999). In order to get access to the bloodstream, bacteria must 
overcome the host defence system, including macrophages. In the human 
immune system, macrophages are the body’s first line of defence against pathogenic 
bacteria. After invasion, many bacterial pathogens have the ability to use different 
strategies to survive and replicate in host cells (Ribet and Cossart, 2015). In this study, E. 
hormaechei strains (n = 12) were investigated for their ability to persist in human 
macrophages, using the U937 macrophage cell-line. The majority of these strains were 
able to persist and replicate inside macrophages for up to 72 hours of incubation. This 
could possibly be due to all strains possessing the sodA gene. This gene codes for a stress 
protein, which is involved in the protection of bacteria against phagocytosis. For 
example, in C. sakazakii this gene has been reported to be associated with macrophage 
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survival and encodes for superoxide dismutase (Townsend et al., 2007a). Similarly, 
another study revealed that sodA plays a role in the protection and survival 
of Streptococcus agalactiae in murine macrophages (Poyart et al., 2001).  
Another phagocytosis resistance-associated gene mazG has been suggested to be 
essential for the survival of bacteria in macrophages. For example, deletion mutations 
of the mazG gene have reduced survival of Mycobacterium tuberculosis in macrophages, 
as described in a previous study (Lyu et al., 2013). Furthermore, the betaine aldehyde 
dehydrogenase (betB) gene, has also been suggested to affect the phagocytic pathway 
in human phagocytes, which is highly expressed during infections, (Lee et al., 2014). 
BLAST searching indicated that these genes were present in all tested isolates and could 
have a role in persistence and replication inside macrophages. However, in this study 
virulence-associated genes were notably shared by E. hormaechei isolated from sepsis, 
CSF and neonatal feeding tubes. Indeed, maintenance of the organism's viability within 
the macrophage suggests that these organisms may be reflective of the levels of 
pathogenicity in premature babies in NICUs. Although these strains were able to persist 
and replicate inside macrophages, this might induce apoptosis and may be considered 
as a contributing factor in disease development. The ability to survive inside 
macrophages can help bacteria to disseminate through the patient’s body and giving the 
bacteria the opportunity to infect other organs. Thus, the effect of their ability on the 
viability of the epithelial Caco-2 cells was also assessed through mitochondrial activity, 
using the MTT assay. 
This analysis revealed that all strains had demonstrated high cytotoxicity to Caco-2 cells. 
Interestingly, feeding tube strains showed a similar level of MTT reduction to some 
sepsis strains, such as 2307 and 664 (Figure 4-18). Cytotoxicity of intestinal epithelial 
cells may have significant implications for the evolution of infections. Due to the ability 
of feeding tube isolates to cause a cytotoxic effect, it can be expected that the 
pathogenic potential of these isolates would result in infection of neonates. Infants in 
the NICU are known to be at high risk of acquiring sepsis (Joseph et al., 2012; Soni and 
English, 2015; Dobrić et al., 2016). Neonatal sepsis is one of the important causes of 
mortality and morbidity among infants, particularly among low birth-weight and 
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preterm neonates (Cortese et al., 2016). Enterobacter spp. are one of the Gram-negative 
bacteria which play an important role in neonatal sepsis in NICUs (Spironello et al., 2015). 
E. hormaechei, in particular, has been shown to be of clinical significance within the 
genus Enterobacter by causing nosocomial infections, including sepsis (Townsend et al., 
2008b). Furthemore, E. hormaechei is commonly the most isolated nosocomial 
pathogen among Enterobacter spp. (Paauw et al., 2008). In 1996, an outbreak of E. 
hormaechei infection and colonisation was reported by Wenger et al., (1997) where the 
outbreak occurred among low birth-weight premature infants in an NICU at the hospital 
of Pennsylvania. It was also reported by Paauw et al. (2010) that a nationwide outbreak 
occurred with due to an E. hormaechei outbreak strain in The Netherlands. This strain 
disseminated throughout hospitals and caused invasive infections in more than 100 
patients.  
This part of the study was undertaken to investigate the possible correlation between E. 
hormaechei isolated from sepsis and neonatal feeding tubes and how closely related 
they are. Also, it was essential to evaluate the potential risk to neonates acquiring 
organisms from enteral feeding tubes through ingestion of contaminated feed. This 
work has shown that feeding tube strains exhibited a similar behaviour to that observed 
in isolates from CSF and sepsis cases, as they have the ability to adhere and invade Caco-
2 and HBMEC cell lines. It was interesting to note that feeding tube isolates showed no 
significant difference when compared with sepsis isolates for their ability to attach Caco-
2. Also, these strains were able to persist and replicate inside macrophages for up to 72 
hours of incubation and showed a similar level of MTT reduction to some sepsis strains. 
Other important observations included their ability to attach to and invade intestinal 
epithelial cells and persist inside macrophages. Feeding tube strains also shared the 
same virulence genes despite differing from each other by a very high number of SNPs 
(up to 66582 SNPs). It is clear that these strains would have the ability to cause infections 
of neonates in NICUs. In addition, the isolates in this study that were recovered from 
neonatal feeding tubes were defined as multidrug-resistant and showed an ability to 
form significant amounts of biofilm. These strains also showed the ability to tolerate 
acidic conditions, desiccation, and survive in human serum. It can be concluded these 
features could allow them to survive and facilitate their persistence and transmission 
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within the NICU. The results of this study indicate that these bacteria are potentially 
virulent and could present a significant risk to the health of premature neonates in the 
NICU. 
Chapters 3 and 4 provided comprehensive details on the characterisation of the strains 
obtained from different hospitals at Nottingham, UK and Jordan. Different assays 
performed indicated the pathogenic potential of these isolates. The strains were linked 
with sepsis and NEFTs cases, however, these strains only provided the “snapshot” of 
single samples lacking descriptive metadata such as patient information. Furthermore, 
no follow up samples for these isolates were available, and no information regarding the 
persistence of these isolates whether in the NEFTs or intestinal tract of the babies, was 
available. The lack of this information made it extremely difficult to determine whether 
the strains that infected the babies originated from NEFTs. Therefore, in the next 
chapter, bacterial strains have been collected in paired neonatal feeding tubes and 
faeces. Chapter 5 describes a longitudinal study of twin babies with different feeding 
regimes, to compare potentially pathogenic isolates within and between twin pairs over 
time
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Chapter 5.  Longitudinal study in twin babies to compare E. faecium 
isolates within and between the feeding tubes and faeces 
over time. 
5.1. Introduction 
Preterm infants kept in intensive care units (ICUs), are considered as high-risk 
patients due to their increased susceptibility to infections whilst hospitalised 
(Ramasethu, 2017). Early exposure to harmful pathogens during the infant’s 
hospitalisation is likely to influence the microbial colonisation in their gut. 
Commensal bacteria are derived from the surrounding environment such as nursing 
staff, other infants and medical equipment (Guaraldi and Salvator, 2012). The use of 
medical devices is one of the main clinical risk factors in neonatal infection, which 
includes nasogastric enteral feeding tubes (NEFTs). These tubes, which are often 
required to feed new-borns, may also contribute to colonisation by pathogenic 
microorganisms. (Hurrell et al., 2009a; Gómez et al., 2016). 
In addition to contaminated medical equipment, infant feed such as reconstituted 
powdered infant formula (PIF) can also be considered as unsterile and a source of 
infection (Drudy et al., 2006). An example of such outbreaks was reported by Acker 
and colleagues (2001) in an NICU in Belgium, where preterm infants with low birth-
weights were fed infant formula contaminated with Cronobacter spp. Recently, 
another outbreak was reported by the European Centre for Disease Prevention (ECDC) 
and Control and European Food Safety (EFSA) in 2018. This French outbreak affected 
39 neonates and was associated with consumption of infant formula contaminated 
with Salmonella Agona. 
Human milk may also be associated with contamination, although human milk 
provides complete enteral nutrition and contains phagocytes, secretory antibodies, 
and prebiotics which improve gastrointestinal function and host defence. However, 
human milk may also be associated with outbreaks of infection in NICUs through 
collecting, storing and handling or contamination of equipment (Engür et al., 2014; 
Kato et al., 2018). Indeed, the environmental contamination issue may pose a greater 
challenge in the NICU. Equipment and external surfaces in the NICU environment are 
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more likely to harbour a high prevalence of bacteria associated with nosocomial 
infection in neonates (Hewitt et al., 2013). For example, one of the most frequent 
nosocomial infections is neonatal sepsis, which has an increasing incidence in 
neonatal intensive care units, due to long periods of hospitalisation of infants (Polin 
and Saiman, 2003). Cross-transmission among neonates in the NICU may potentially 
occur due to prolonged hospitalisation. Transmission via the contaminated 
equipment play an important role in dissemination of the pathogen. For example. In 
2005, Barwolff and co-workers demonstrated that the transmission rates of 
enterococcal isolates are high among nosocomial patients in ICUs, even higher than 
for E. coli and S. aureus.  The colonisation of the enteral feeding tubes by nosocomial 
bacteria and their impact on earlier gut colonisation of the premature newborn 
babies was investigated in a recent study (Gomez et al., 2016). Their study indicated 
that E. coli, K. pneumoniae, S. aureus, S. epidermidis, Serratia marcescens, E. 
faecium and E. faecalis were the predominant isolates in faeces and milk samples 
amongst 4,000 bacterial strains recovered (Gomez et al.,  2016). Another study by 
Alkeskas et al. (2015) revealed that meningitic E. coli K1 were recovered from 
multiple neonatal enteral feeding tubes from two local hospitals on NICUs, UK. 
Nosocomial infections are caused by many microbes. Bacteria from the ESKAPE group 
are responsible for the majority of nosocomial infections (Navidinia, 2016). 
The ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter 
species) are important causes of nosocomial and multidrug-resistant infections. 
Enterococcus, in particular, have been recognised among the most frequent 
causes of nosocomial infection (Santajit and Indrawattana, 2016; El-Mahallawy et al., 
2016; Zhang et al., 2017a).  
5.1.1. Characteristics of Enterococcus Genus 
Enterococcus faecium and Enterococcus faecalis were split from the genus 
Streptococcus in 1984. The reclassification of this genus resulted in these species 
being assigned to a new genus and renamed to Enterococcus faecium and 
Enterococcus faecalis (Schleifer and Kilpper-Bälz, 1984). Subsequently, more than 
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forty species have been included and classified within the genus Enterococcus after 
the continuous use of new molecular technologies (Lebreton et al., 2014).  
The Enterococcus species, which belong to the family Enterococcaceae, are       
facultatively anaerobic, Gram-positive cocci which grow as single, paired, or grouped 
cocci, or in short chains. They are catalase-negative bacteria that are non-spore 
forming and have a fermentative metabolism. They generally grow at temperatures 
of enterococci between 10 °C and 45 °C, and 37 °C is the optimum growth 
temperature. These bacteria are able to survive when exposed to a high pH, and they 
are highly tolerant to desiccation and can persist on dry surfaces for months 
(Lebreton et al., 2017). Enterococcus have been found to survive in a variety of 
environments and have been isolated from food, water, soil and plants. 
(Byappanahalli et al., 2012; Graves and Weaver, 2010). The Enterococcus genus are 
also commensal bacteria that inhabit the mammalian gut. They have also adapted to 
the oral cavity and vagina of humans (Fisher and Phillips, 2009). 
Enterococcus species also belong to a group of lactic acid bacteria (LAB), which 
produce bacteriocins (Araújo and Ferreira, 2013). Some species have been used as 
probiotics in food and also used as supplement for poultry feed to replace the use of 
sub-lethal antibiotics. For example, Ghareeb et al. (2012) reported that use of 
probiotics, including E. faecium, reduced the colonisation of C. jejuni in broiler 
chickens via drinking water. Because of this, they were thought to be harmless to 
humans for a long time and were initially believed to be medically unimportant 
(Foulquie et al., 2006). Recently however, E. faecium and E. faecalis became the most 
common nosocomial pathogens reported to be associated with many infections and 
also carry antibiotic resistance factors. Various serious diseases can be attributed to 
enterococci such as neonatal infection, bacteraemia and urinary tract infection 
(O’Driscoll and Crank, 2015) 
5.1.2. Clinical importance of Enterococcus faecium  
Enterococcus species are widely spread in various environments and can be 
isolated from different sources, although they are most common among human-
clinical and food isolates. Generally, enterococci are considered to be part of the 
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commensal flora within the gastrointestinal tract of humans and many animals 
(Santagati et al., 2012). Enterococci have emerged as important nosocomial 
pathogens within the past few decades. E. faecium and E. faecalis are recognised as 
important human pathogens and the most predominant enterococcal species 
in humans. These organisms are usually associated with diversity of clinical infections 
including urinary tract infection, intra-abdominal, pelvic, soft tissue infections and 
bacteraemia (Higuita and Huycke, 2014). The pathogenesis of enterococci has 
been attributed to a high degree of multidrug resistance, as well as various virulence 
factors such as adhesion, secreted agents and biofilm formation (Saffari et al., 2017). 
The emergence of multidrug-resistant enterococci poses a problem with regards to 
treatment and is an important challenge for clinicians. The risk of contracting disease, 
such as bacteraemia, is increased by antibiotic-resistant enterococci colonisation 
(Lebreton et al., 2014; Tedim et al., 2015). One of the most common problems in 
hospitals is an increasing presence of vancomycin-resistant Enterococcus 
faecium (VREF) (Özsoy and İlki, 2017). This pathogen is proving problematic for many 
countries worldwide, especially developing countries that are generally associated 
with poor hospital hygiene practice. Furthermore, the ability of these bacteria to 
survive for prolonged periods of time may contribute to cross-contamination 
between patients (Sood et al.,  2008; Lee et al., 2013), particularly in neonatal 
intensive care units (NICUs), where neonates are at high risk of nosocomial infection.  
However, E. faecium clonal complex 17 (CC17) has received more attention as a 
successful nosocomial pathogen and hospital adapted strain. This clone appears to 
be a one of the universally epidemic clones of ampicillin-resistant E. faecium (AREF). 
It is associated with hospital outbreaks and clinical infections and is specified as a 
high risk enterococcal clone. In addition, it can acquire vancomycin resistance genes 
and other virulence factors (Werner et al., 2008; Hollenbeck and Rice, 2012; Garrido 
et al., 2014). A study by Willems (2005) conducted on 411 vancomycin-resistant 
enterococci (VRE) and vancomycin-susceptible E. faecium (VSE) strains, isolated from 
different continents, identified a genetic lineage of E. faecium (CC17). These strains 
were recovered from multiple sources including human, non-human and 
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hospital/clinical samples. This clone is characterised with acquisition of surface 
protein (Esp), which is located in a pathogenicity Island, ampicillin resistance and an 
association with outbreaks in hospitals. Figure 5-1, which was adapted from Top et 
al. (2008), confirms that the infections caused by ampicillin-resistant E. faecium (AREF) 
belonging to clonal complex CC17. The figure shows eBURST clustering of 331 MLST 
profiles representing 855 E. faecium isolates from the MLST database. It indicates the 
sources of specific clusters of STs, including CC17 comprising hospital outbreaks and 
clinical isolates and ST-80 which is the focus of this chapter (see 5.3.3 below). 
 
Figure 5-1 eBURST clustering of 331 MLST profiles including ST-80, representing 855 
 E. faecium isolates from the database (www.mlst.net). 
 Dashed lines indicate the sources of specific clusters of STs, including CC17 comprising hospital 
outbreaks and clinical isolates. Figure adapted from Top et al. (2008). 
 
5.1.3. Virulence Factors in E. faecium 
Several virulence factors exist which contribute to the ability of enterococci to 
persist in the host and cause disease. The most distinguished of the enterococcal 
virulence factors are the surface adhesions proteins such as enterococcal surface 
protein (Esp). This protein has been shown to contribute to adherence and biofilm 
formation in E. faecium. In addition, it was found to be associated with nosocomial 
outbreaks and specifically enriched among hospital associated isolates. (Leavis et al., 
2004; Soares et al., 2014; Biswas et al., 2016). Other virulence factors are the Ebp pili, 
which are important for adherence and play a significant role in biofilm formation. 
Ebp pili are encoded by the ebp operon which consists of ebpA, ebpB and ebpC 
(Sillanpaa et al., 2010; Sillanpaa et al., 2013). Adhesion-associated protein EfaA has 
been also identified in E. faecium, which believed to be involved in cell wall 
adherence (Soheili et al., 2014). Additional virulence genes harboured by E. faecium 
strains are associated with human infections such as gelE, asa1, cylA, and hyl, 
(Ferguson et al., 2016). 
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However, enterococci usually have either intrinsic resistance or acquired resistance 
to multiple antimicrobial agents and most of the antibiotics used in humans (Ünal et 
al., 2017). Indeed, there is concern in hospital settings due to resistance to several 
antimicrobial agents commonly used. Enterococci are resistant to numerous classes 
of antibiotics, including β-lactams and aminoglycosides (Faron et al., 2016). They are 
also able to acquire resistance to vancomycin, which is observed more frequently in 
E. faecium among enterococcal species. 
Vancomycin resistant E. faecium VREfm is an important health concern and is a 
globally disseminated pathogen. Infections caused by vancomycin-resistant 
enterococci (VRE) are associated with higher mortality and there could be limited 
treatment options (DiazGranados and Jernigan, 2005; Cheah et al., 2013). However, 
since the 1980s ampicillin and vancomycin are the most significant resistance traits 
known to have been acquired by E. faecium (Cetinkaya et al., 2000; Arias and Murray, 
2012). Ampicillin-resistant E. faecium isolates have been reported by Lester and 
colleagues in 2008 and that these isolates are increasing in numbers in many 
European hospitals. (Lester et al., 2008). In one study, it was reported that E. 
faecium increased at least from 1.4% in 2001 to 4.3% in 2014 in European hospitals, 
while in the USA the rates also increased from 3.0% in 2001 to 5.4% in 2010 (Mendes 
et al., 2016).  
Premature, low birth weight and immunodeficient infants are usually admitted for 
prolonged periods in the NICU. They are exposed to multidrug-resistant organisms 
that have readily adapted to the healthcare setting and hospital environment. The 
majority of these organisms are high risk clones belonging to the nosocomial ESKAPE 
pathogens group (Santajit and Indrawattana, 2016; Navidinia, 2016). Furthermore, 
these preterm infants are also colonised by pathogenic bacteria recovered from the 
mother and the environment. Sepsis is one of the main causes of death in the NICU; 
risk factors for late-onset sepsis (LOS) include immaturity, mechanical ventilation, 
and intravascular catheters (Dong and Speer, 2015). 
Additionally, nasogastric feeding tubes are reported to act as a locus for bacterial 
attachment and proliferation of several opportunistic pathogens, and this is 
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suggested to be a significant risk factor in the neonatal infections (Hurrell et al., 2009a; 
b). On the other hand, powdered infant formula (PIF) and mother's milk or 
donor human milk may be associated with contamination. For instance, 
Cronobacter species have been recovered from powdered infant formula (PIF), which 
is of serious concern for neonatal health (Craven et al., 2010; Fei et al., 
2017).  Bacteria may contaminate donor human milk due to different means such as 
through storage, during collection, or during processing (Froh et al., 2018). 
Biofilms represent another virulence factor which may contribute to bacterial 
pathogenicity. For instance, adhesion is a necessary step for biofilm formation, which 
allows bacteria to bind to urinary and intravascular catheters and other 
devices. Furthermore, biofilms contribute to bacterial protection from killing by 
antibiotics and phagocytosis. In enterococcal strains, for example, biofilm formation 
is associated with antimicrobial resistance and it is dependent on complex virulence 
factors (Lee, 2017). The ability of the bacteria to form biofilms on medical devices 
including catheters and enteral feeding tubes may result in infection of preterm 
infants in the NICU. Preterm infants are therefore of particular concern, especially 
those born with low birth weight and underdeveloped immune systems fed via a 
nasogastric tube. 
5.1.4. Aim and objectives  
Persistence of bacterial biofilms inside nasogastric feeding tubes has been associated 
with the presence of infectious organisms. Preterm infants are at 
particularly high risk of acquiring infection because their immune systems are 
underdeveloped. In addition, cross-transmission among neonates in the NICU may 
occur due to prolonged hospitalisation. For this reason, it was decided to characterise 
these strains, which have been collected from paired neonatal feeding tubes and 
faeces. The acquisition of the collection of strains assessed in this study represented 
a unique opportunity to investigate pathogens that colonise neonates over time and 
provide answers to some of the key issues that are central to this thesis, to help 
inform and improve pathogen control measures in NICUs in the future. This study is 
focused on longitudinal study for twin babies aimed to compare potentially 
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pathogenic isolates within and between the feeding tubes and faeces of two twin 
babies over time. This will be achieved according to the following objectives: 
- Whole-genome sequencing of E. faecium isolates and SNP analysis based on 
the core genome, in order to determine the relatedness of strains isolated 
from feeding tubes and faeces from both babies over time. Additionally, to 
determine whether some of the strains might have transferred between the 
two babies 
- Genomic analysis of E. faecium isolates to determine the presence or absence 
of virulence and antibiotic resistance genes. 
- Characterisation of a range of physiological traits, such as capsule and biofilm 
formation, serum resistance and acid tolerance to evaluate the possible risk 
to neonates acquiring these organisms through feeding tubes. 
- In vitro virulence characterisation of E. faecium isolates using epithelial cell 
line Caco-2, to determine bacterial attachment and invasion abilities. 
5.2. Materials and Methods 
The methodology of this chapter is described in detail in Chapter 2 (Section 2). The 
samples had been collected by Pauline Ogrodzki from two premature babies (twins) 
from the neonatal intensive care unit of Queens Medical Centre (Table 5-1). The 
patients were born premature at 25 weeks and 5 days gestation. The first patient was 
a low-birth weight (660 g) preterm male neonate and the second preterm male was 
also low-birth weight (880 g). The samples were collected from feeding tubes and 
faecal samples from both neonates at different times. The first sample was collected 
at 4 weeks of age and the last sample was collected at 13 weeks. The neonates had 
been fed breast milk, fortified and pre-med formula during this period of time. 
However, because of the ethical considerations, storage of the original faecal 
material collected from the two premature babies was not permitted. Therefore, 
feeding tube and faeces samples were incubated in Brain Heart Infusion (BHI) growth 
medium at 37 °C for 24h. The samples were then mixed with 20% glycerol and stored 
in 1.5 ml aliquots at -80°C until required for analysis. Differential media were used in 
the present study for identification of these isolates, in order to distinguish between 
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isolates as an initial presumptive identification. Brain heart infusion agar (BHIA) was 
used for general bacteria and Violet Red Bile Glucose Agar (VRBGA) for 
Enterobacteriaceae. In addition, De Man, Rogosa, Sharpe Agar (MRSA) and Bifidus 
Selective Media Agar (BSMA) were used for Lactic acid bacteria and Bifidobacteria.  
The provisional identification was performed according to their morphological 
appearance, Gram stain, catalase and oxidase reactions. The isolated organisms            
were identified using 16S rRNA sequencing. However, among these isolates, a total 
of 24 E. faecium isolates were used in this study, as shown in Table 5.1, selected as 
representative strains and subjected to whole-genome sequencing by Pauline 
Ogrodzki using the Illumina MiSeq sequencer. All these isolates were analysed to 
identify the presence and absence of different virulence genes potentially associated 
with colonising the host. Furthermore, a range of phenotyping methods were applied 
such as those for biofilm formation, capsule production, acid tolerance, and serum 
resistance. Moreover, evaluating the potential virulence of these strains using in vitro 
attachment and invasion assays with intestinal cells lines (Caco-2).   
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Table 5-1 E. faecium strains used in this study. 
 
 
 
5.3. Results 
5.3.1. Isolation and identification of bacterial strains 
In general, samples were streaked onto differential media to give an initial 
presumptive identification by distinguishing visually by the appearance of the colony. 
The majority of these isolates were revealed as Gram-positive cocci and few isolates 
were identified as Gram-negative. These isolates were subjected to 16S rRNA 
sequencing and were identified as E. faecium, S. aureus, E. faecalis, S. haemolyticus, 
S. epidermidis, Streptococcus, K. pneumoniae and K. oxytoca as shown in Table 5-2. 
The most common species among the isolated strains was E. faecium. This species 
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represented 30% of isolates, which were recovered from feeding tubes (n=10) and 
from faecal samples (n=14). S. aureus was the next most common species at 20% (9 
isolates were recovered from feeding tubes and 7 isolates from faecal samples). E. 
faecalis was also identified among the isolates at 15% prevalence; 7 strains were 
recovered from feeding tubes and 5 strains from faecal samples. In addition, 11.3% 
S. haemolyticus (n=9), 10% S. epidermidis (n=8), 7.5% Streptococcus (n=6), 3.8% K. 
pneumoniae (n=2) and 2.5% K. oxytoca (n=2) were also identified (Figure 5-2). 
 
Figure 5-2 Species identity of clinical strains collected from neonatal gastric feeding 
tubes and faecal samples, expressed as the total number strains identified at each 
site. The most commonly isolated species was E. faecium. 
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Table 5-2 Biochemical tests and 16S rRNA of E. faecium strains 
 
 
Genomic DNA was extracted from these isolates using the GenElute™ Bacterial 
Genomic DNA Kit (Sigma Aldrich). The Illumina Miseq reagent kit was used for Whole-
genome sequencing. A core-genome alignment was constructed and the CSI 
Phylogeny program was used to identify Single nucleotide polymorphisms (SNPs) to 
confirm the speciation of the E. faecium strains (Figure 5-3).  As mentioned in an 
earlier chapter, Pauline Ogrodzki (a member of our research group at NTU), carried 
out the whole-genome sequencing and SNP analysis.  
5.3.1.1. Multi locus sequence typing (MLST) 
Traditionally, MLST was achieved by PCR amplification of seven housekeeping genes 
based on the MLST scheme database and followed by Sanger sequencing. In the 
present study, the genetic diversity of different sequence types (ST) of E. faecium 
strains was analysed to compare the isolates obtained from different sites. These 
strains were isolated from feeding tubes and faecal samples during a 3-month period 
collected from two premature babies in the NICU. The sequence types were 
identified using whole-genome sequence (WGS) data and the MLST web-based 
Strain Neonate Collection date Sample source Gram stain Oxidase Catalase 16S rRNA Feeding regime
2367 1 23/07/15 Faecal G +ve - ve -ve E. faecium
2368 1 10/08/15 Faecal G +ve - ve -ve E. faecium
2372 1 24/08/15 Faecal G +ve - ve -ve E. faecium
2375 1 15/09/15 Faecal G +ve - ve -ve E. faecium
2376 1 24/09/15 Faecal G +ve - ve -ve E. faecium
2379 1 20/10/15 Faecal G +ve - ve -ve E. faecium
2382 1 22/10/15 Faecal G +ve - ve -ve E. faecium pre-made formula
2393 1 10/08/15 NG tube G +ve - ve -ve E. faecium +
2395 1 19/08/15 NG tube G +ve - ve -ve E. faecium breast milk
2397 1 08/09/15 NG tube G +ve - ve -ve E. faecium +
2399 1 27/09/15 NG tube G +ve - ve -ve E. faecium fortifier
2401 1 01/10/15 NG tube G +ve - ve -ve E. faecium
2407 2 31/07/15 Faecal G +ve - ve -ve E. faecium
2409 2 16/08/15 Faecal G +ve - ve -ve E. faecium
2410 2 20/08/15 Faecal G +ve - ve -ve E. faecium
2413 2 10/09/15 Faecal G +ve - ve -ve E. faecium
2417 2 30/09/15 Faecal G +ve - ve -ve E. faecium
2418 2 16/10/15 Faecal G +ve - ve -ve E. faecium
2425 2 20/10/15 Faecal G +ve - ve -ve E. faecium
2430 2 16/07/15 NG tube G +ve - ve -ve E. faecium
2433 2 17/08/15 NG tube G +ve - ve -ve E. faecium
2436 2 08/09/15 NG tube G +ve - ve -ve E. faecium
2439 2 11/10/15 NG tube G +ve - ve -ve E. faecium
2462 2 12/10/15 NG tube G +ve - ve -ve E. faecium
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service of the Center for Genomic Epidemiology. The database showed fragments of 
seven housekeeping genes for twenty-four E. faecium strains were unique and they 
all belonged to the same ST-80, as shown in Table 5-3. However, all strains were typed 
as ST80 belonging to clonal complex (CC17). These results indicate that these isolates 
from different sites are clonally identical and transfer between two premature 
neonates in the NICU may have occurred. 
Table 5-3 MLST profile of 24 representative strains of E. faecium isolated from feeding 
tubes and faecal samples from two premature babies in an NICU. The results indicate 
that all isolates were ST-80 and belonged to clonal complex (CC17). 
 
 
The MLST scheme is based on seven housekeeping genes - adenylate kinase (adk), ATP synthase alpha 
subunit (atpA), D-alanine:D-alanine ligase (ddl), glyceraldehyde-3-phosphate dehydrogenase 
(gyd), glucose-6 phosphate dehydrogenase (gdh), phosphor ribosyl aminoimidazol carboxylase ATPase 
subunit (purK),and phosphate ATP-binding cassette transporter (pstS).  
5.3.1.2. Core genome phylogenetic analysis of E. faecium  
Whole-genome sequencing of E. faecium isolates was performed using the Illumina 
Miseq as mentioned earlier and a maximum likelihood phylogeny of the 24 E. faecium 
strains was constructed from a core genome alignment. The CSI Phylogeny program 
was used to identify SNPs. In the present study, twenty-four E. faecium isolates were 
Isolate Neonate Sample 
Source 
Isolation 
date
adk atpa addi gdh gyd psts purk Sequence
Type 
Clonal   
complex
2367
1
Faecal
23/07/15 1 9 1 1 12 1 1 ST-80 CC17
2368 10/8/2015 1 9 1 1 12 1 1 ST-80 CC17
2372 24/08/15 1 9 1 1 12 1 1 ST-80 CC17
2375 15/09/15 1 9 1 1 12 1 1 ST-80 CC17
2376 24/09/15 1 9 1 1 12 1 1 ST-80 CC17
2379 20/10/15 1 9 1 1 12 1 1 ST-80 CC17
2382 22/10/15 1 9 1 1 12 1 1 ST-80 CC17
2393
NG tube
12/08/15 1 9 1 1 12 1 1 ST-80 CC17
2395 20/08/15 1 9 1 1 12 1 1 ST-80 CC17
2397 08/09/15 1 9 1 1 12 1 1 ST-80 CC17
2399 01/10/15 1 9 1 1 12 1 1 ST-80 CC17
2401 1/10/15 1 9 1 1 12 1 1 ST-80 CC17
2407
2
Faecal
31/07/15 1 9 1 1 12 1 1 ST-80 CC17
2409 16/08/15 1 9 1 1 12 1 1 ST-80 CC17
2410 20/08/15 1 9 1 1 12 1 1 ST-80 CC17
2413 10/9/2015 1 9 1 1 12 1 1 ST-80 CC17
2417 30/09/15 1 9 1 1 12 1 1 ST-80 CC17
2418 16/10/15 1 9 1 1 12 1 1 ST-80 CC17
2425 20/10/15 1 9 1 1 12 1 1 ST-80 CC17
2430
NG tube
19/07/15 1 9 1 1 12 1 1 ST-80 CC17
2433 20/08/15 1 9 1 1 12 1 1 ST-80 CC17
2436 10/09/15 1 9 1 1 12 1 1 ST-80 CC17
2439 12/10/15 1 9 1 1 12 1 1 ST-80 CC17
2462 11/10/15 1 9 1 1 12 1 1 ST-80 CC17
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analysed based on core genome (Figure 5-3). All of these isolates belong to ST80 
based on sequences of the conserved regions of the seven housekeeping genes of E. 
faecium MLST scheme. 
Whole genome sequence data revealed a number of SNP differences ranging from 12 
to 287 SNPs between the isolates from the two premature twin babies in the NICU. 
For instance, strain 2393 was distant to the strain 2397 by 75 SNPs, both strains were 
isolated from baby 1 from feeding tube samples taken four weeks apart. Whereas, 
the two isolates 2433 and 2395 differed from each other by a very small of SNPs (12), 
and these 2 strains were isolated from feeding tubes from neonates 1 and 2 at 
different time points 3 days apart. This might be explained by the transfer of the 
strain from baby 2 to baby 1. Similarly, strain 2425 and 2367 from faecal samples 
from different neonates, with 15 SNPs difference across a 12- weeks time period. 
Strains 2436 and 2417 which differed by only 21 SNPs, were isolated from infant 2 at 
different neonatal sites, feeding tube and faecal sample during a 3-week period. The 
interesting observation that the first strain 2430 isolated from baby 2 feeding tube 
on 16-07-2015 differed from the last isolate 2425 by 23 SNPs collected on 20-10-2015 
from baby 2 faecal sample. This may indicate that the same strain could persist in the 
baby’s intestinal tract over this time. Another important observation is that the same 
strain 2430 differed from strain 2439 by 23 SNPs, which was isolated after at least 11 
weeks. The other two isolates 2413 and 2425 were obtained from neonate 2 faecal 
sample at 5 weeks. These strains had a maximum of 17 SNPs difference. The outlying 
single isolate 2409 clustered alone with a high SNPs difference of 287 SNPs compared 
with strain 2376. Suggesting that they were acquired independently of each other. 
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Figure 5-3 Single nucleotide polymorphism analysis tree of E. faecium isolates 
E. faecium isolates collected from feeding tubes and faecal samples from twins in the NICU of QMC during different time periods are represented in different colours. Yellow 
indicates baby 1, orange colour indicates baby 2, while green indicates bacteria detected in feeding tubes and blue represents bacteria detected in faeces of the infant. 
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5.3.1.3. 5.3.5 Screening of E. faecium for virulence factors 
Genome screening was performed to examine the presence and absence of selected 
genes that may contribute to virulence or physiological features. Table 5-4 shows a list 
of the proposed virulence genes classified into the major virulence factors of E. faecium 
strains, including a gene encoding enterococcal surface protein (Esp), which is located 
on a pathogenicity island and is involved in biofilm formation and contributes to 
pathogenesis (Top et al., 2013; Zou and Shankar, 2016; ). Gene gltK, encoding a putative 
glutamate transport system permease protein, was identified in high prevalence and 
may contribute to bile resistance in E. faecium (Zhang et al., 2013b). It well known that 
bacteria that colonise the human intestinal tract must be able to tolerate bile in order 
to survive. However, other virulence genes were also noted in this strain such as the 
acm gene, which confers collagen-binding adhesin properties of E. faecium and 
contributes to the pathogenesis in experimental endocarditis. In addition, EcbA, E. 
faecium collagen-binding protein A, encodes for fibrinogen and recognises adhesive 
matrix molecules. Furthermore, the efaA gene was hypothesised and believed to be 
involved in cell wall adherence (Sava et al., 2010; Soheili et al., 2014; Yang et al., 2016). 
Additionally, other virulence genes were observed among E. faecium strains, as shown 
in Table 5-4. Further details regarding these genes are provided in the Discussion section 
(5.4).  
5.3.1.4. 5.3.6 Plasmids and resistance genes 
All isolates were screened for identifying plasmids among 24 E. faecium isolated from 
feeding tubes and faecal samples from two premature babies in the NICU. These isolates 
were analysed using the PlasmidFinder database and were BLAST’d against the 
assembled genomes. All these strains were found to carry multiple plasmids. Six 
different rep-family plasmids were detected among 24 E. faecium isolates (repUS15, 
rep11, rep17, rep2, rep1 and rep21). The predominant rep-family, repUS15 and rep2 
were identified in all E. faecium isolated in this study. Other rep-families, rep11 and 
rep17, were also observed among all E. faecium isolates except strain 2372 isolated from 
infant 1, which do not carry rep17. rep11 was not detected only in strain 2409 isolated 
from infant 2. In contrast, rep1 and rep21 are rare plasmids found among E. faecium 
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isolates. rep21 was detected only in two isolates 2425 and 2436 were isolated from 
infant 2. rep1 was found only in three other strains, 2395 isolated from infant 1 and 
strains 2410 and 2433 isolated from infant 2 (Table 5-5). 
However, all of these E. faecium isolates were also investigated for the presence of the 
antimicrobial resistance genes. The antibiotic resistance genes were identified using 
ResFinder 2.1 software by the Center for Genomic Epidemiology website 
(https://cge.cbs.dtu.dk/services/ResFinder/). Two genes encoding resistance to 
aminoglycosides were identified among all E. faecium isolated. For instance, 
aminoglycoside resistance gene, aph(3′)-III ant(6)-Ia was shared among all of E. faecium 
isolates, the exception was strain 2417 which lacked this particular resistance gene. In 
contrast, only two strains 2410 and 2433 isolated from infant 2 were found to harbour 
the second aminoglycoside gene aac(6′)-aph(2′′). The other four encountered genes, 
coding for macrolide resistance - that is, msr(C) and erm(B) - all isolates possessed these 
genes except for strain 2417 which lacked erm(B). While mph(C) and vat(B) were not 
detected among all isolates evaluated, this excluded strain 2433, which was positive for 
mph(C) and only strain 2436 was positive for vat(B). Both these strains were isolated 
from the feeding tube from infant 2 after a 3-week period. However, tetracycline 
resistance gene tet(S) was present in all isolates and fluoroquinolone nor(A) was 
harboured by only two strains 2462, which was isolated from the feeding tube of infant 
2 and strain 2375 isolated from infant 1 faecal sample, as shown in Table 5-5. 
5.3.2. Antimicrobial Susceptibility  
Antibiotic susceptibility profiles were determined for the 24 E. faecium strains. This 
involved screening the sensitivity to 9 different antibiotic groups: penicillins, 
aminoglycosides, carbapenems, cephalosporins, chloramphenicol, tetracycline, 
macrolide, glycopeptides and trimethoprim. The antibiogram (Table 5-6) was generated 
using the Kirby-Bauer disk diffusion method. All 24 E. faecium isolates were susceptible 
to vancomycin, gentamicin and doxycycline, but were found to be highly resistant to 
most antibiotics tested in this study. This study determines that all of the E. 
faecium isolates were multidrug resistant and exhibited similar levels of resistance 
Chapter 5 Longitudinal study for E. faecium within twin babies  
 
178 
 
relative to each other. Among the 24 E. faecium isolates, 9 different antibiotic resistance 
genes were detected including aminoglycoside, macrolide tetracycline resistance genes.
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Table 5-4 shows the results of the genomic comparison of 24 E. faecium strains recovered from feeding tubes and faecal samples from two 
premature babies in NICU. 
 
The results indicate that all isolates harboured a number of virulence-associated genes. (+) = present, (-) = absent.                           
Virulence genes
Isolate Neonate Sample 
Source 
Isolation 
date acm ebpA ebpB ebpC srtC ecbA efaA esp sqrA manY_2 pyrF purD pyrF pyrK_2 Cyl1,2 cylABM gltK
2372 1 Faecal 24/08/15 + + + + + + + + + - + + + + - - +
2397 1 NG tube 08/09/15 + + + + + + + + + - + + + + - - +
2393 1 NG tube 12/08/15 + + + + + + + + + - + + + + - - +
2430 2 NG tube 16/07/15 + + + + + + + + + - + + + + - - +
2410 2 Faecal 20/08/15 + + + + + + + + + - + + + + - - +
2395 1 NG tube 19/08/15 + + + + + + + + + - + + + + - - +
2433 2 NG tube 17/08/15 + + + + + + + + + - + + + + - - +
2382 1 Faecal 22/10/15 + + + + + + + + + - + + + + - - +
2379 1 Faecal 20/10/15 + + + + + + + + + - + + + + - - +
2375 1 Faecal 15/09/15 + + + + + + + + + - + + + + - - +
2407 2 Faecal 31/09/15 + + + + + + + + + - + + + + - - +
2462 2 NG tube 11/10/15 + + + + + + + + + - + + + + - - +
2439 2 NG tube 12/10/15 + + + + + + + + + - + + + + - - +
2399 1 NG tube 27/09/15 + + + + + + + + + - + + + + - - +
2401 1 NG tube 01/10/15 + + + + + + + + + - + + + + - - +
2417 2 Faecal 30/09/15 + + + + + + + + + - + + + + - - +
2436 2 NG tube 08/09/15 + + + + + + + + + - + + + + - - +
2368 1 Faecal 10/8/2015 + + + + + + + + + - + + + + - - +
2418 2 Faecal 16/10/15 + + + + + + + + + - + + + + - - +
2409 2 Faecal 16/08/15 + + + + + + + + + - + + + + - - +
2376 1 Faecal 24/09/15 + + + + + + + + + - + + + + - - +
2413 2 Faecal 10/9/2015 + + + + + + + + + - + + + + - - +
2425 2 Faecal 20/10/15 + + + + + + + + + - + + + + - - +
2367 1 Faecal 23/07/15 + + + + + + + + + - + + + + - - +
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Table 5-5 shows the results of plasmids and antibiotic resistance gene profiles of 24 E. faecium strains recovered feeding tubes and faecal samples 
from twines in NICU at QMC. 
 
(+) = present, (-) = absent.
Isolate Neonate
Sample 
Source 
Isolation 
date
Plasmid Beta-
lactam
Aminoglycoside MLS - Macrolide
Tetracy-
cline
Fluoroqu-
inolone
repUS15 Rep11 Rep17 Rep2 Rep1 Rep21 blaZ aac(6')-
aph(2'')
aph(3')-III
ant(6)-Ia
msr(C) erm(B) mph(C) vat(B) tet(S) norA
2372 1 Faecal 24/08/15 + + - + - - - - + + + - - + -
2397 1 NG tube 08/09/15 + + + + - - - - + + + - - + -
2393 1 NG tube 12/08/15 + + + + - - - - + + + - - + -
2430 2 NG tube 16/07/15 + + + + - - - - + + + - - + -
2410 2 Faecal 20/08/15 + + + + + - - + + + + - - + -
2395 1 NG tube 19/08/15 + + + + + - - - + + + - - + -
2433 2 NG tube 17/08/15 + + + + + - + + + + + + - + -
2382 1 Faecal 22/10/15 + + + + - - - - + + + - - + -
2379 1 Faecal 20/10/15 + + + + - - - - + + + - - + -
2375 1 Faecal 15/09/15 + + + + - - - - + + + - - + +
2407 2 Faecal 31/09/15 + + + + - - - - + + + - - + -
2462 2 NG tube 11/10/15 + + + + - - + - + + + - - + +
2439 2 NG tube 12/10/15 + + + + - - - - + + + - - + -
2399 1 NG tube 27/09/15 + + + + - - - - + + + - - + -
2401 1 NG tube 01/10/15 + + + + - - - - + + + - - + -
2417 2 Faecal 30/09/15 + + + + - - - - - + - - - + -
2436 2 NG tube 08/09/15 + + + + - + - - + + + - + + -
2368 1 Faecal 10/8/2015 + + + + - - - - + + + - + -
2418 2 Faecal 16/10/15 + + + + - - - - + + + - - + -
2409 2 Faecal 16/08/15 + - + + - - - - + + + - - + -
2376 1 Faecal 24/09/15 + + + + - - - - + + + - - + -
2413 2 Faecal 10/9/2015 + + + + - - - - + + + - - + -
2425 2 Faecal 20/10/15 + + + + - + - - + + + - - + -
2367 1 Faecal 23/07/15 + + + + - - + - + + + - - + -
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Table 5-6 Sensitivity for E. faecium strains to antibiotic agents. 
 
Table 5-6 R= resistant, S= susceptible, Imipenem (IMI), Meropenem (MEM), ceftizoxime (ZOX), Ceftazidime (CAZ), Ceftriaxone (CRO), Cefoperazone (CFP), clarithromycin 
(CLR), doxycycline (DO), Ampicillin (AMP), Ciprofloxacin (CIP), Vancomycin (VA), Tobramycin (TOB) and Gentamicin (CN), Ceftazidime + Clavulanic acid (CAZ+CV), Cefotaxime 
+ Clavulanic acid (CTX+CV), Fluroqu= Fluoroquinolone, Tetra= tetracycline, Glycope= glycopeptide.
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5.3.3. Biofilm formation 
Biofilm formation is recognised as an important virulence factor and has been related to 
colonisation of medical equipment, such as catheters and feeding tubes and is linked to 
various human diseases. In this study, the ability of E. faecium isolates to produce 
biofilms was studied on plastic surfaces at different temperatures (Figure 5-4).    
All these strains demonstrated the ability to form high amounts of biofilms at 37 °C in 
infant formula. On the other hand, a low amount of biofilm formation at 25 °C was 
observed in the same formula. Paired t-test showed that E. faecium strains formed 
significantly more biofilm in PIF at 37 °C than at 25 °C (p < 0.0001), as shown in Figure 5-
5.  The highest amount of biofilm formation was observed in strain 2409 at 37 °C, which 
was isolated from the faecal sample from neonate 2. However, no significant differences 
(p < 0.0001) were noted between the isolates; e.g. 2368, 2401, 2407, 2410, 2417 and 
2430 when compared to strain 2409. These strains were considerably higher producers 
of biofilm when compared with other isolates from both neonates. Conversely, the 
lowest amount of biofilm formation was observed in strains 2393, 2413, 2425 and 2397 
when compared to the highest biofilm producer, strain 2409. They showed a statistically 
significant difference when analysed by means of one-way ANOVA followed by multiple 
comparisons with a Dennett’s test. Of note, none of the E. faecium isolates produced  
statistically significant biofilm at 25 °C when compared to the negative control, except 
for strain 2401 (Figure 5-4).   
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Figure 5-4 Biofilm formation at 25 °C and 37 °C in infant formula using the crystal violet 
adsorption assay. 
All strains showed an ability to form more biofilm at 37 °C than at 25 °C in infant formula. The highest 
amount of biofilm formation was observed in strain 2409 at 37 °C, while at 25 °C the highest amount was 
observed in strain 2401 when compared to the negative control. 
 
 
Figure 5-5 Paired t-test shows E. faecium strains form significantly more biofilm in PIF 
at 37°C than at 25°C (p < 0.0001). 
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5.3.4. Acid resistance 
The main route of bacteria colonising the human intestine is via oral ingestion.  Bacteria 
need to survive and grow in the high acidic conditions of the stomach, in order to cause 
infection. Acid tolerance is therefore one of the important virulence factors, and in this 
study, the ability of 24 E. faecium isolates to survive and grow under highly acidic 
conditions were investigated. These strains were exposed to pre-adjusted infant 
formula at pH 3.5 for two hours and the results are presented in Figure 5-6. All E. 
faecium strains were clearly resistant to exposure to low acidity for 2 hours. The viability 
of all these isolates decreased to 0.3-0.5 log cycles during the first 30 mins of acid 
exposure. From 30 mins to 120 minutes, the viable count cells for all strains tested did 
not show significant reduction, revealing a 0.2-0.3 log cycle decline during this period. 
No significant variation was observed between strains isolated from feeding tubes and 
faecal samples from the two premature babies. It is therefore likely that the same clone 
of bacteria has colonised the feeding tubes during the three-month period and has 
transferred between the twins.  
 
 
Figure 5-6 Survival curve of 24 E. faecium strains in infant formula at pH 3.5. 
E. faecium strains (n=24) were assessed for their tolerance to pH 3.5 for two hours. The viable counts were 
determined by the Miles & Misra method. All strains showed an ability to resist pH 3.5 for the total 2 
hours. No significant variation was observed between strains isolated from feeding tubes and faecal 
samples from two premature babies. 
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5.3.5. Heat tolerance 
Heat resistance is an essential bacterial virulence factor for survival of microorganisms in 
different environmental stresses. It could pose a risk to the human health when bacteria 
become resistant to heat treatment, especially in PIF. In the present study, 24 E. 
faecium isolates were investigated to determine their ability to tolerate heat at 55 °C. 
D-values were determined at the time required to drop 1 log cycle in the viable cell count 
at 55 °C. D-values were quantified by linear regressions (−1/slope of the regression line) 
from the linear of the bacterial survival curves, and categorised as following: strain to 
heat tolerance (D55 = ≤5), moderate strain to heat tolerance (D55= >5 & ≤10) and 
resistant strain to heat tolerance (D55 = >10). All E. faecium isolates (n=24) showed a 
high level of heat resistance as shown in Figure 5-7, the D-values ranged from 15.7 to 
24.5 min (Table 5-7). However, some levels of variation in thermo-tolerance were 
observed between the strains. For example, strain 2401 had showed high heat 
resistance, with D55 of 24.5 minutes at 55 °C. While strain 2413 showed lower heat-
resistance compared with other isolates, D55 of 15.7minutes at 55 °C (Table 5-7). 
 
Figure 5-7 Survival of E. faecium isolates (n=24) in liquid infant formula at 55°C. 
E. faecium strains (n=24) were assessed for their tolerance to heat resistance during their growth in liquid 
infant formula at 55 °C. The viable counts were determined by the Miles & Misra method. All strains 
showed an ability to a high level of heat resistance. 
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Table 5-7 D-values for E. faecium isolates (n=24) in liquid infant formula at 55°C.   
 
5.3.6. Human serum 
Once pathogenic bacteria succeed in passing through the membrane epithelial barrier, 
cells must be able to evade host defence mechanisms, such as serum bactericidal 
activities and macrophages. In this study, bactericidal assays were conducted on 24 E. 
faecium isolates exposed to human serum for three hours. As a positive control, S. 
Enteritidis was used, whilst E. coli K12 was used as a negative control. The results of this 
experiment are shown in Figure 5-8. All these strains demonstrated a high level of 
resistance to human serum when compared with negative and positive controls. It was 
revealed that an increase in cell numbers occurred after 3-hours incubation. There was 
a slight variation between E. faecium strains in their response to the human serum. 
Differentiation between the viable counts of bacteria at time zero could be a possible 
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reason of the variations among these strains.  These strains showed an increase in their 
numbers after the first hour of incubation with human serum. While strain 2367 isolated 
from the faecal sample from neonate 1, showed a decrease of recovered viable cell 
numbers at the first hour of incubation. However, all of the strains isolated from the 
twin infants showed an ability to tolerate human serum after the final time point. This 
explain why such bacteria could survive and travel through the bloodstream and infect 
different host organs such as brain. 
 
Figure 5-8 Sensitivity of 24 E. faecium to human serum over 3 hours of incubation at 
37 °C. 
All 24 E. faecium strains isolated from twin infants at different neonatal sites, showed an ability to tolerate 
human serum after the final time point. 
5.3.7. Blood haemolysis 
Haemolysing blood cells is an important virulence factor and is recognised as an 
important mechanism for many pathogenic bacteria to lyse red blood cells. The 
production of haemolysin was determined by streaking bacterial cultures on TSA agar 
supplemented with 5% horse blood. Haemolytic activity of the twenty-four E. 
faecium strains isolated from feeding tubes and faecal samples from two premature 
babies in an NICU was investigated. All isolates were able to induce α haemolysis on 
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horse blood (Table 5-8). The haemolysis activity expressed by these strains to lyse red 
blood cells might be one of the important key virulence in persistence of these isolates 
in bloodstream and causing sepsis. 
5.3.8. Protease production 
Protease activity by pathogens are well known as a virulence factor that plays an 
important role in pathogenesis, by contributing to immune evasion of many pathogens. 
In this study, the protease activity assay was performed to determine the expression of 
protease on skimmed milk at 37 °C for 72 hours. The results indicated that all E. 
faecium strains (n = 24) had revealed a positive result for production of protease activity 
(Table 5-8). Protease activity is defined as a clear circle on the skimmed milk agar. B. 
cereus was used as a positive control and E. coli NTU 407 was used as a negative control. 
5.3.9. Lipase 
Lipase activity was assessed by using tributyrin agar media, according to the 
methodology described in detail in Chapter 2 (Section 2). A clear halo around the 
colonies indicates a positive reaction by the tested strain. Lipase activity was observed 
amongst all strains (n = 24) collected from two premature babies in this study, as shown 
in the Table 5-8. 
5.3.10. Capsule production  
Table 5-8 shows the results of capsule production in two different infant formula agar 
media, soya-based infant formula (IF1) and whey -based infant formula (IF2). All of 
twenty-four E. faecium strains were negative for capsule production on both media.  
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Table 5-8 Results summary of biofilm formation, capsule production on milk agar, acid 
resistance, haemolysins, protease and lipase, among E. faecium strains (n=24). 
 
5.3.11. Assessment of the pathogenicity of E. faecium using tissue culture  
5.3.11.1. Attachment to Caco-2 Intestinal Epithelial Cells  
There are a number of virulence factors which enable bacteria to cause infections such 
as attachment and invasion. In this chapter, the potential virulence of 24 E. 
faecium isolates was investigated to assess the ability of these strains to attach and 
invade epithelial Caco-2 cells. E. coli K12 and S. Enteritidis were used as negative and 
positive controls (Figure 5-9). All strains from different sources were able to adhere to 
the Caco-2 cell line. These isolates were significantly higher than that of the negative 
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control strain E. coli 1230. However, there were some different levels of adherence to 
Caco-2 cells among strains. Strain 2309, isolated from neonate 2 faecal sample, was the 
strain with the highest adhesion potential among all tested strains, although there was 
no significant difference in attachment levels among strains when compared to the most 
adhesive strain 2309. Some observable differences were noted between strains 2372, 
2401, 2417 and 2462 when compared with the positive control. An unpaired t-test 
shows no significant difference in the ability of the bacteria to adhere to Caco-2 between 
all strains isolated from baby 1 and with baby 2 (p = 0.6048). Also, no significant 
difference was observed between all strains isolated from feeding tubes from both 
babies compared with the faeces sample from both babies (p = 0.2073). 
 
Figure 5-9 Attachment of E. faecium strains to the human Caco-2 cell line. 
The figure shows the differences in attachment levels to the human epithelial cell line Caco-2 among E. 
faecium strains. All strains were able to attach to the epithelial cell line when compared to E. coli 1230, 
which was used as the negative control, and S. Enteritidis 358, which was used as the positive control.  
5.3.11.2. Bacterial invasion of Caco-2 human epithelial cells 
The gentamicin protection assay was employed in order to determine the ability of E. 
faecium strains to invade the Caco-2 cells. All strains were able to invade the Caco-2 cells 
at a low level; however, there was a variation amongst E. faecium isolates in their ability 
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to invade this cell line (Figure 5-10). The highest invasion efficiency was achieved by 
strains 2399, 2372, 2433,2393, 2367 and 2462, conversely, strain 2417 and 2418 showed 
the lowest invasion levels among the isolates tested. Although there was slight variation 
among E. faecium isolates in their ability to invade Caco-2 cells, there was no significant 
difference in invasion levels when analysed by means of one-way ANOVA (P < 
0.001), followed by multiple comparisons with a Dennett’s test. Unpaired t-test also 
shows no significant difference in the ability to invade to Caco-2 between all strains 
isolated from baby 1 and compered with baby 2 (p = 0.0533). Also no significant 
difference was observed between all strains isolated from feeding tubes from both 
babies compared with faecal samples from both babies (p = 0.2073). 
 
 
Figure 5-10 Invasion efficiency of E. faecium strains to the mammalian Caco-2 cell line. 
The bar chart shows the differences among E. faecium strains with regards to their ability to invade the 
human epithelial cell line Caco-2, by performing the gentamicin protection assay. All of strains were able 
to invade the Caco-2 cells by low level. S. Enteritidis 358 and E. coli 1230 were used as positive and 
negative control strains, respectively. 
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5.4. Discussion 
Enterococci are one of the leading causes of nosocomial infection in the hospital setting, 
particularly in Neonatal Intensive Care Units (NICU). Most enterococcal infections are 
known to be caused by E. faecalis and E. faecium among various species of Enterococcus 
(Sood et al., 2008; Mutters et al., 2013; Abamecha et al., 2015; Adesida et al., 2017). 
Multidrug-resistant enterococci are a major concern in hospitals. They are most 
commonly recovered in NICUs (Moemen et al., 2015; Wassilew et al., 2018). The ability 
of enterococci to survive for prolonged periods of time may contribute to cross-
contamination, through healthcare workers' hands, surfaces or medical devices. The use 
of medical devices is one of the main clinical risk factors in neonatal infection including 
nasogastric enteral feeding tubes (NEFTs). These tubes may also contribute to the 
colonisation by pathogenic microorganisms which are often required for feeding new-
borns (Gómez et al., 2016). Furthermore, preterm infants in Intensive Care Units (ICUs) 
are high-risk patients, due to their increased susceptibility to infections during 
hospitalisation (Christina et al., 2015; Ramasethu, 2017). Their exposure to pathogens 
from the surrounding environment may result in a potential infection. In addition, cross-
transmission among neonates in the NICU may potentially occur due to prolonged 
hospitalisation. The colonisation of the enteral feeding tubes by nosocomial bacteria 
and their impact on earlier gut colonisation of the premature newborn babies was 
investigated in a recent study (Gomez et al., 2016). Their study indicated that E. coli, K. 
pneumoniae, S. aureus, S. epidermidis, Serratia marcescens, E. faecium and E. 
faecalis were the predominant isolates in faeces and milk samples amongst 4,000 
bacterial strains recovered (Gomez et al., 2016).  The findings of present study have 
striking similarities with Gomez, 2016.  
Therefore, the present longitudinal study was aimed to compare potentially pathogenic 
isolates within and between the feeding tubes and faeces of two twin babies in the NICU 
over time. Subsequently, feeding tubes and faecal samples were collected from two 
premature babies (twins) in the NICU of Queen Medical Centre (QMC). The first patient 
was a low-birth weight (660 g) preterm male neonate and the second preterm male was 
also low-birth weight (880 g).  Both neonates received antibiotics, and were initially fed 
with breast milk, fortifier and followed by pre-made formula.  
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Accurate identification of bacterial isolates is significant, particularly in the clinical field. 
For instance, correct identification of species and sub-species groups may be essential 
to selecting the appropriate choice of antibiotic therapy. The isolates collected from two 
premature babies were identified using 16S rRNA sequencing. Indeed, it is difficult to 
distinguish among closely related species by using 16S rRNA gene as the limited 
resolution of this method. A recent study by Ogrodzki et al. (2017) indicated that the 
strains isolated from 2 different feeding tubes of the same neonate were identified as E. 
faecalis by using 16S rRNA gene. However, the genomic profiling of E. faecalis confirmed 
these strains formed two distinct clusters according to their sequence type. For this 
reason, representative strains in this study were later confirmed by Whole-genome 
sequencing (WGS) to help provide a complete picture. These isolates were revealed to 
be Gram-positive cocci while few isolates were identified as Gram-negative. In the 
current study, it was revealed that E. faecium was the predominant species isolated from 
feeding tubes and faecal samples that persisted unaffected by antibiotics and other 
factors in the NICU (Figure 5-2). E. faecium, S. aureus and E. faecalis showed higher 
prevalence compared to Gram-negative K. pneumoniae and K. oxytoca during the three-
month period. 
Despite different bacterial cultures being used, my sample collection was characterised 
by a lack of detectable Bifidobacterium spp., in addition to low levels of Gram-negative 
isolates. It may be possible that those premature neonates received antibiotics during 
hospitalisation. This may prevent or affect these bacteria from colonising and also 
reduce the level of Gram-negative strains. A previous studies showed that the reduced 
Bifidobacterium colonised preterm infants who treated with antibiotics (Hussey et al., 
2011; Barrett et al., 2013). The early exposure to antibiotics can be considered as a 
possible explanation for the low percentage of bacterial species in the feeding tubes and 
faecal samples. This observation is in agreement with Ubeda et al. (2010), who revealed 
that bacteria associated with hospital-acquired infections can become one of the most 
dominant in the gut microbiota as a result of antibiotic therapy. 
However, among the most common species isolated from feeding tubes and faecal 
samples from the two premature babies in the NICU, E. faecium showed the highest 
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percentage prevalence. For this reason, twenty-four E. faecium isolates were selected 
as representative strains in this study and were subjected to whole-genome sequencing. 
Traditionally E. faecium have been observed as low-grade pathogens, however, in the 
last two decades enterococci have emerged as an increasingly important cause of 
nosocomial infections. In addition, they have been identified to be responsible for the 
majority of healthcare-associated enterococcal infections. This is attributed to their 
ability to acquire resistance to various antibiotics, to receive foreign genetic material or 
undergo mutation due the transfer of transposons and plasmids. (Simjee et al., 2002; 
Sood et al., 2008; Palmer et al., 2011; Arias and Murray, 2012). 
However, previous epidemiological studies of E. faecium using multilocus sequence 
typing (MLST), revealed that the clonal complex lineage CC17 are considered a high-risk 
clonal group. This clonal associated with hospital outbreaks, recovered frequently from 
hospitalised patients has become endemic in most countries. At the same time, this 
clone is characterised by susceptibility to ampicillin and carriage of the esp gene, 
indicating presence of a putative pathogenicity island (Deplano et al., 2007; Top et al., 
2008; Lester et al., 2008). The present study exploited this opportunity, and MLST 
analysis of E. faecium isolates was performed to determine whether these isolates 
belong to CC17 or not. 
It was found that all strains were typed as ST80, belonging to clonal complex (CC17). 
Furthermore, they were resistant to ampicillin and were found to carry the virulence-
associated gene esp. My results are supported by previous studies which stated that the 
CC17 lineage is largely characterised by resistance to ampicillin and possess the 
virulence gene esp. (Deplano et al., 2007; Top et al., 2008; Kwon et al., 2012). 
Despite the high percentage of E. faecium isolates recovered during the NICU stay, no 
genetic diversity was observed, and the ST80 clone persisted throughout most of the 
studied period. These results led to the conclusion that these isolates from different 
sites are same clone and are able to persist and be transferred between the two 
premature neonates in the NICU (Table 5-3). Based on MLST and phylogenetic analysis 
of whole genome sequences, the isolates recovered from feeding tubes and faeces 
samples of the two neonates are likely derived from the same local source. Nevertheless, 
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the ampicillin resistant E. faecium isolates are an increasing problem in NICUs. The 
treatment of the two premature babies with vancomycin and gentamicin may have 
created selective antibiotic pressures, contributing to the presence of vancomycin-
resistant E. faecium (VREF) through mutation. Furthermore, Enterococci have the ability 
to acquire antimicrobial resistance via horizontal transfer of mobile genetic elements 
(Palmer et al., 2011). Previous studies have shown that within enterococci, vancomycin 
resistance possibly spreads through genetic mobile elements such as the vanA type 
frequently found on mobilisable or conjugative plasmids (Migura et al., 2007; Sletvold 
et al., 2010; Hegstad et al., 2010). 
Significant rates of antimicrobial resistance was observed for E. faecium isolates, not 
only for ampicillin resistance, but resistance to multiple antimicrobial drugs, such as 
imipenem, meropenem, ceftizoxime, ceftazidime, ceftriaxone, cefoperazone, 
clarithromycin, ciprofloxacin, tobramycin and also to ESBLs, ceftazidime + clavulanic acid 
and cefotaxime + clavulanic acid. Some drug susceptibility was reported to vancomycin, 
gentamicin and doxycycline. Overall, feeding tubes and faecal isolates from both 
neonates had displayed the similar patterns of antibiotic resistance. However, several 
previous studies have identified multidrug-resistant E. faecium in NICUs, especially 
vancomycin resistant strains (Hufnagel et al., 2007; Cilo et al., 2014; Shantala et al., 
2014). 
The persistence of antibiotic-resistant E. faecium acquired by premature infants during 
hospitalisation in the NICU may lead to an increased risk among these neonates. The gut 
microbiota composition during the first 3 months may have important health 
consequences and may be linked to numerous problems later in life, particularly those 
associated with development of the immune system. (Cahenzli et al., 2013; Tanaka and 
Nakayama, 2017). For example the genus Bifidobacterium is considered to be good for 
health, however my collection in this study showed a lack of this genus, which might be 
a result of antibiotics used during hospitalisation as I mentioned previously. Indeed, the 
persistence of multidrug-resistant strains among neonates may pose a risk to other 
neonates acquiring these organisms in the NICU, particularly preterm infants with very 
low birthweight. 
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Enterococci are clinically significant pathogens and are considered to be a major 
concern and are able to acquire resistance to many antibiotics (Billington et al., 2014; 
Daniel et al., 2015). All E. faecium isolates were investigated for the presence of the 
antimicrobial resistance genes in this study. Aminoglycoside resistance gene aph(3′)-III 
ant(6)-Ia were detected among all isolates except strain 2417. These isolates were found 
to be highly resistant to tobramycin and it is primarily due to the acquisition of this 
resistance gene. I presume the resistance of strain 2417 to tobramycin and lack of 
aminoglycoside resistance gene may be due to the action of other resistance 
mechanisms. Furthermore, all isolates were observed to be phenotypically susceptible 
towards gentamicin, and lacking the aminoglycoside gene aac(6′)-aph(2′′), except for 
two strains 2410 and 2433, which carried this gene but without resistance to gentamicin. 
Indeed, this gene is well known to play a significant role in mediating high-level 
gentamicin-resistance among strains (Behnood et al., 2013). These results suggest that 
the susceptibility observed among these strains may be caused by inactive gene 
products or by low levels of genes expression (Table 5-5). Another important 
observation in this study was that all isolates were found to carry genes coding for 
macrolide resistance msr(C), erm(B) and tetracycline resistance gene tet(S). These genes 
were identified in this study are similar to those reported by previous studies were 
isolated from diverse samples: clinical isolates, animals and food (Cauwerts et al., 2007; 
Thumu and Halami, 2014; Beukers et al., 2015). Macrolide resistance conferred by the 
erm (B) gene has spread in different parts of the world (Qin et al., 2012; Lam et al., 2013; 
Szakacs et al., 2014; El Ashkar et al., 2017).  
Moreover, other antimicrobial resistance genes were harboured among few of the E. 
faecium strains. For example, only strain 2433 was positive for the macrolide resistance 
gene mph(C) and strain 2436 was positive for vat(B). Fluoroquinolone resistance gene 
nor(A) was harboured by only two strains (2375 and 2462) and the Beta-lactam blaZ was 
harboured by 3 strains, 2367, 2433 and 2462 (Table 5-5). This is not surprising as E. 
faecium can more easily acquire antibiotic resistance (Hollenbeck and Rice, 2012; 
Cattoir and Giard, 2014) and are believed to be highly transferable plasmids or 
transposons. An important observation in this study was that these isolates were found 
to carry multiple plasmids. Six different rep-family plasmids were detected among 24 E. 
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faecium isolates (rep15, rep11, rep17, rep1, rep2 and rep21) as shown in Table 5-5. This 
finding is consistent with the fact that clinical enterococcal isolates often harbour 
several types of plasmids (Migura et al., 2007; Rosvoll et al., 2010; Zhu et al., 2010; 
Rosvoll et al., 2012). Additionally, this is in agreement with previous studies, which have 
described the rep17, rep1 and rep2 plasmids in E. faecium clinical isolates (Mikalsen et 
al., 2015; Freitas et al., 2016). It is possible that plasmids could be a potential source of 
transferable antimicrobial resistance. The rise of drug resistance in E. faecium strains is 
a serious problem for treatment and control, especially among neonates in NICUs. It 
would appear that neonates born with low birth weights and underdeveloped immune 
systems in NICUs are at high risk, particularly those fed via nasogastric tubes. It was 
interesting to note that E. faecium was revealed to be the most predominant species 
isolated as well as the species persisting during the studied period. This is also why it 
was decided to characterise and type the isolates obtained from feeding tubes and 
faecal samples from the two premature babies. 
Pathogen typing is essential to identify and trace the epidemic and phylogenetic 
relationships among the isolates that have common origins. Also, it is important in 
clinical settings for patient diagnosis, treatment and helps in tracing contaminants to 
their original source. (Squires et al. 2015). Although PFGE is the most commonly 
used method for typing and outbreak tracking, there are limitations of PFGE to 
resolve bands; they could be obscured by bands of similar or nearly identical size (Davis 
et al., 2003). However, the SNP-based typing assay has proven to be more 
discriminatory and has been employed to infer the evolution of outbreak isolates which 
show too little sequence diversity (Turabelidze et al., 2013). In the present study, whole-
genome sequencing of isolates was performed, and a maximum likelihood phylogeny of 
the 24 E. faecium isolates was constructed from a core genome alignment. The SNP 
analysis was undertaken in order to observe the relatedness of E. faecium strains 
recovered from the feeding tubes and faecal samples among two premature babies over 
time. Isolate 2425 was used as the reference for SNP comparisons within this collection, 
which was isolated on 20/10/2015 from neonate 2. 
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However, strain 2372 clustered alone with high SNP differences of 211 SNPs when 
compared with reference strain 2425. Both isolates were recovered from faecal samples 
from baby 1 at different time points, suggesting that they were acquired independently 
of each other. The interesting observation is that of the numbers of SNP was very small 
(12 SNPs) between strains 2433 isolated from feeding tube neonate 2 and strain 2395 
isolated from feeding tube neonate 1 after 2 days (Figure 5-3). This observation suggests 
that possible cross contamination and transfer by this organism from neonate 2 to 
neonate 1. Also, SNP-based analysis of the strain 2433 isolated from feeding tube 
displayed related close phylogenetic relation to strain 2410 isolated 3 days later from 
the faecal sample of the same neonate 2. Only 13 SNPs were identified between them, 
which confirms the source of this strain to be ingested by the neonate through the 
feeding tube. 
In addition, strain 2433 and 2395, also isolated from feeding tubes from both neonates, 
was shown by the small number of SNP differences (12 SNPs). This finding can be 
explained by the transfer of the strain from baby 2 to baby 1. Another important 
observation in this study was that strain 2413 and 2425 were obtained from the same 
infant 2 from faecal samples during a 5-week period (Figure 5-3). These isolates differed 
from each other by 17 SNPs difference between them, indicating the same strain could 
persist in the baby’s intestinal tract over this period of time. Furthermore, strain 2367 
isolated from neonate 1 was highly identical to strain 2425 (only 15 SNPs difference), 
which were recovered after nearly 3 months from baby 2. This observation led to the 
conclusion that the same clone has persisted among two neonates during the majority 
of the study period. The SNP typing of the isolates were highly similar, as well as the 
MLST profile also indicated all of these isolates were typed as ST80 belonging to clonal 
complex (CC17). The last isolate 2382 from neonate 1 is virtually identical to the original 
isolate 2430 from neonate 2, which was isolated after 3 months and had only 24 SNP 
differences. This confirms the circulation of the E. faecium ST80 clone between the twin 
babies within the NICU. The SNP typing suggested that strains had as little as 12 to 27 
SNPs difference from each other, thus revealing a remarkable degree of homology 
between these strains. The SNP differences observed between strains might be the 
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result of microevolution and adaptation to two different niches (i.e. the gut flora and 
the feeding tube), as they are two different environments.  
The small number of SNP differences suggest a common source of origin. It might be 
that the potential source of contamination could be the mother’s milk or it could either 
be PIF itself, in addition, the tools used to prepare formula or the carer’s hands. However, 
a current limitation of my study is the lack of environmental/carer samples or samples 
of mother’s milk and PIF, which have not been screened to compare with feeding tubes 
and faecal isolates. For this reason, it is not possible to determine the source of the E. 
faecalis strains that colonised the infants and their feeding tubes. The ability of this clone 
to colonise and persist in feeding tubes and faecal samples among two neonates for 
three months has been demonstrated in this study, and this could be explained by their 
possession of essential bacterial virulence factors such as the ability to form biofilm. 
Biofilm formation is one of important factors reported as a virulence-associated trait, by 
helping to maintain cell survival on biotic and abiotic surfaces (Tomaras et al., 2003). For 
example, a study by Ogrodzki et al. (2017) reported that bacterial biofilms distributed 
inside the nasogastric feeding tube was visualised using optical coherence tomography. 
Indeed, the ability of bacteria to form biofilms inside feeding tubes are a major concern. 
It is believed that bacterial biofilms would be capable to develop on medical device 
surfaces and are an important risk factor for microbial spreading within the host and 
increased chance of disease (Perciva et al., 2015). In this study, the ability of E. 
faecium isolates to produce biofilms was studied on plastic surfaces using two 
temperatures, 25 °C and 37 °C. All strains demonstrated the ability to form high amounts 
of biofilm in infant formula at 37 °C when compared with at 25°C. 
There was no significant difference (p > 0.05) among all isolates in the capacity of biofilm 
formation at 25 °C, except for strain 2401, which showed the highest amount of biofilm 
formation. The reason for the difference in capacity of biofilm formation might be 
influenced by gene expression. Although there are some differences among all strains 
with their capacity to form biofilm at 37 °C, all strains demonstrated the ability to form 
high amounts of biofilms in infant formula at this temperature. Indeed, numerous genes 
have been reported by several earlier studies to be associated with biofilm production, 
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particularly the presence of esp gene. This gene encodes the enterococcal surface 
protein (Esp), which is located on a pathogenicity island (Leavis et al., 2004; Van Schaik 
et al., 2010). This gene is also predominantly present in hospital acquired isolates, which 
has a role in biofilm formation and contributes to pathogenesis (Heikens et al., 2007; 
Top et al., 2013). In this study, the results indicate that the analysed genomes of the 24 
E. faecium isolates were found to harbour the esp gene. Additionally, these strains 
revealed high amounts of biofilm production at 37 °C compared to at 25 °C as mentioned 
earlier. 
This finding was in agreement with previous study by Van Wamel et al. (2007). Who 
reported that esp-positive E. faecium strains showed significantly increased levels to 
binding of polystyrene and biofilm development when grown at 37 °C compared to 21 °C. 
This result may suggest a correlation between the esp gene and biofilm formation. 
However, there is conflict regarding the role of the esp gene in biofilm development. 
Some studies have suggested that the esp gene plays an important role in biofilm 
formation. (Heikens et al., 2007). While other studies have reported that it is not 
necessarily required to produce biofilm (Kafil and Mobarez, 2015; Garg et al., 2017). 
So far, several virulence genes have been reported to be involved in biofilm formation 
by E. faecium. For instance, the sgrA gene, which binds to extracellular matrix proteins 
and is implicated in biofilm development (Hendrick et al., 2009). Locus ebpABC, which 
are putative major pilus subunits are also important for the cell’s ability to form biofilm 
(Sillanpaa et al., 2010). However, analysing the genomes in the current work revealed 
that the sgrA gene and ebpABC locus have been detected in the genomes of the tested 
E. faecium. Therefore, biofilm production in E. faecium strains belonging to clonal 
complex (CC17) could enhance colonisation and persistence in enteral feeding tubes, 
and also increase the probability of causing nosocomial infections and outbreaks.  
Translocation of E. faecium from the gut into the bloodstream can cause serious 
bloodstream infections (Arias and Murray, 2012), and additionally, they are able to resist 
the host immune response (Wilson et al., 2002). In this study, a bactericidal assay was 
conducted on the 24 E. faecium isolates by exposing them to human serum for three 
hours. All strains demonstrated a high level of resistance to human serum when 
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compared to the negative and positive controls. There was a slight variation between E. 
faecium strains in their response to the human serum. Differences between the viable 
counts of bacteria at time zero could be a possible reason for the variation observed 
between these strains. However, all strains isolated from the feeding tubes and faeces 
of the twin infants showed an ability to tolerate human serum after the final time point. 
This would indicate that these bacteria could survive and travel in the bloodstream, 
which may lead to infection of different host organs, such as the brain. A recent study 
by Zhang et al. (2017b) identified genes required for the growth of E. faecium E745 in 
human serum. These genes, pyr K_2, pyrF, purD, and purH, are involved in nucleotide 
biosynthesis and manY_2 encoding a phosphotransferase system subunit. The study 
showed that these genes are crucial for the growth of E. faecium E745 in human serum 
and contributes to the pathogenesis of this strain. The pyrK_2, pyrF, purD and purH 
genes have been detected in all E. faecium genomes in this study, while the manY_2 
gene was not detected in the genomes analysed. The results of the current analysis 
might explain that the genes detected are associated with the ability of these strains to 
survive in human serum. These findings increase the clinical concern to neonates with 
compromised immune systems in the NICU, which are highly susceptible to infections.  
Other virulence factors such as haemolysin which were detected among the tested E. 
faecium strains. The present study showed that all E. faecium strains were able to induce 
α haemolysis (partial haemolysis) on horse blood. This result is inconsistent with a 
previous study by Kivanc et al. (2011), which reported that all E. faecium isolates derived 
from breast milk samples were found to be non-haemolytic strains, although such 
factors are recognised to be important in contributing to bacterial pathogenesis and 
disease. Previous studies indicated that cytolysin produced by Enterococcus spp. are 
capable of lysing human, horse, and rabbit erythrocytes. Expression of cytolysin is 
controlled by an operon having genes encoded cyl1, cyl2, cylA, cylM, and cylB. These 
genes have been attributed to haemolytic activity previously (Cox et al., 2005; Solheim 
et al., 2009; Van Tyne et al., 2013). However, none of my isolates harboured these genes, 
suggesting that they have acquired other genes that possibly have a role in haemolysin 
activity. 
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This study was extended to investigate other virulence factors that are assumed to play 
an important role in microbial pathogenicity including biological activity of lipase and 
protease. 
Such virulence factors have been reported to play a crucial role in bacterial infections 
(Furumura et al., 2006; Sava et al., 2010). For example, a previous study by Asha et al. 
(2005) reported that lipase activity was detected in clinical isolates of E. faecium at a 
high frequency when compared to strains of non-clinical origin. All E. faecium strains in 
the present study had detectable lipolytic and proteolytic activity. These activities may 
contribute to these isolates becoming more harmful to neonates, particularly, preterm 
infants in NICUs. A remarkable degree of homology was revealed between feeding tube 
and faecal sample strains isolated from the twin infants. Moreover, these strains 
harboured the same genes and displayed a low number of SNPs difference from each 
other. This observation may support the suggestion that these isolates are likely to be 
the same clone and have a common source of origin. 
Acid tolerance is also one of the important characteristics of bacterial cells. The ability 
of bacteria to survive and grow in the highly acidic conditions of the stomach is a 
significant feature which may present the opportunity of bacterial colonisation and 
potentially cause infections in the patient. Thus, in present study, the ability of 24 E. 
faecium to survive and grow under acidic conditions was investigated. All E. 
faecium strains were clearly resistant to exposure to low acidity for 2 hours. These 
results are consistent with the study reported by Ispirli et al. (2015), where E. faecium 
isolated from the human gut are characteristically resistant to low pH and bile salts. 
Similarly, Mubarak and Soraya (2018) also found that E. faecalis (ATCC-29212) has an 
excellent growth capability to adapt to a very acidic environment. Zhang et al. (2013b) 
reported that the gltK gene is responsible for bile resistance in E. faecium E1162. Data 
from the present study indicated that all E. faecium strains that harboured the gltK gene 
and are able to grow and resist conditions of low acidity. This suggests that this gene 
may contribute to resistance to acidic conditions and can be considered as a feature 
which may result in infections of neonates. The interesting observation was that there 
was no significant variation of the acidic resistance of the isolates analysed in the 
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present study. Therefore, it is likely that the same clone of bacteria has colonised the 
feeding tubes and the gut of the neonates and were excreted in the faeces, during the 
three-month period.  
In the present study, the heat tolerance analysis was carried out on the 24 E. 
faecium isolates, in order to determine their ability to tolerate heat at 55 °C for 30 
minutes in liquid infant formula. All E. faecium isolates showed a high level of heat 
resistance. E. faecium has been recognised to be heat-resistant, for example, a study by 
McAuley et al. (2012) reported that E. faecium is one of the most heat resistant species 
to be isolated from pasteurised milk collected from dairy factories. This was validated in 
separate study by Ma et al. (2007) showing that E. faecium is more heat-tolerant when 
compared to Salmonella in ground beef, by about 17 times. However, the acquisition of 
heat resistance by these strains should be take into consideration, particularly among 
neonates in the NICU. Premature babies could be exposed to such organisms from 
contaminated milk, which includes ingestion of these organisms via feeding tubes. The 
risks of microorganisms carrying virulence genes, being highly resistant to a variety of 
antibiotics and involved in nosocomial infections, would seriously increase the concern 
to the neonate’s health. A previous study by Khalkhali and Mojgani (2017) reported that 
virulence genes and biogenic amine genes were determined among E. faecium TA0033 
and E. faecalis TA102 isolated from human milk. Although, some enterococci are used 
as probiotics, which is still controversial among this group, however, a number of human 
infections have been associated with species of the genus Enterococcus. Nevertheless, 
the frequent isolation of E. faecium from foods and human sources shows that ability of 
this organism to tolerate stresses during the processing of milk and food products or 
inside the human body. 
Bacterial capsular polysaccharides are another important virulence of many 
microorganisms. They protect these microbes against environmental stress and allow 
bacteria to escape from the host immune system (Wilson et al., 2002; Ogrodzki and 
Forsythe, 2015). Bacterial capsule production was determined in the present study by 
colony appearance on two different growth media: soya and whey-based infant formula. 
The results showed E. faecium strains were unable to produce capsular material on both 
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types of media used in this study. Furthermore, they were able to produce a high 
amount of biofilm on the same media, although the results indicate no obvious link 
between biofilm formation in these strains and capsule production. Capsules 
may provide resistance to desiccation, serum activity, and play a significant role in 
evading phagocytic killing (Ogrodzki and Forsythe, 2015). 
Another important virulence factor might include the ability of the organisms to attach 
to human epithelial cells. In this study, the attachment ability and invasion of human 
epithelial cells by E. faecium strains was assessed to determine the potential risk of 
infection to neonates in NICUs. Human epithelial cell lines are most commonly used as 
host models to examine host-pathogen interactions. The Caco-2 monolayer cell line was 
used to assess their adhesion and invasion potentials as it is one of the most 
commonly used as a model of the intestinal epithelium (Sambuy et al., 2005). It has been 
used in a wide range of experimental bacterial infections. For instance, Aleksas et al. 
(2015) studied meningitic strains of E. coli K1 isolated from neonatal nasogastric feeding 
tubes using different cell lines, including Caco-2. In the present study, all strains from 
different sources showed high adherence to the Caco-2 cell line. This result is in 
agreement with Nami et al. (2015), who reported that E. faecium CM33 had high 
adhesive potential to Caco-2 cells. This indicates that the tested isolates possess a key 
factor to facilitate and contribute to adherence. Different components of surface 
molecules are required for mediating adhesion of microorganisms to the intestinal 
epithelium. 
Adhesive matrix molecules, termed MSCRAMMs (microbial surface components 
recognizing adhesive matrix molecules), are recognised by several studies to play an 
important role of the cellular adhesion of E. faecium. For instance, the Acm collagen-
binding adhesin of E. faecium contributes to the pathogenesis of experimental 
endocarditis. EcbA, E. faecium collagen binding protein A, and fibrinogen are able to 
recognise adhesive matrix molecules. Moreover, the efaA gene was hypothesised to be 
involved in cell wall adherence. (Hendrickx et al. 2009; Sava et al., 2010; Soheili et 
al., 2014, Yang et al., 2016). The present analysis showed that all of these genes were 
present in all E. faecium genomes. This suggests that these genes may play an important 
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role in their ability to adhere to Caco-2 cells, however, this isolate showed low invasion 
potential. Although slight variation in the ability of these isolates to invade Caco-2 cells 
was noted, no significant difference was observed. This suggests that these strains 
would be considered to have low invasive potential and their ability to attach to Caco-2 
cells does not necessarily reflect their ability to invade cells. 
These isolates demonstrated an ability to adhere to Caco-2 cells, produce high levels of 
biofilm, resist human serum and persist in low pH. Such properties may provide the 
reason explaining their persistence among the two neonates investigated during the 
period. Moreover, these strains harbour several virulence genes such as acm, ebpA, 
ebpB, ebpC, ecbA, esp and sqrA. These isolates compare to previously characterised 
pathogenic strains, including vancomycin-resistant E. faecium isolated from the 
bloodstream (Aus 0004), and a strain isolated from the blood of a patient with 
endocarditis (DO) and VREF bloodstream VREF isolate (Aus0085). The E. faecium strains 
isolated in this study were found to share similar virulence genes as mentioned 
previously, whilst these genes are not present in E. faecium T110, which is a probiotic 
strain. 
This observation suggests that the existence of additional virulence could enhance the 
virulence, fitness and persistence of these isolates, as well as increase the incidence of 
infection. The acquisition of different virulence factors among multidrug-resistant 
strains possibly contributes to their emergence as prominent nosocomial pathogens, 
and furthermore, could be the reason behind their high prevalence among two neonates 
during the three-month period. Indeed, premature babies (twins) in neonatal intensive 
care units are more at risk of being colonised by multidrug-resistant strains. These 
neonates lack a developed immune system, have an undeveloped gut microflora, and 
are highly susceptible to infections. Moreover, prolonged hospitalisation of neonates in 
NICUs may present the opportunity of bacterial colonisation of feeding tubes. However, 
it was clear that E. faecium isolated in this study had the ability to colonise and persist 
in feeding tubes and faecal samples among both neonates over three months. This could 
contribute to hospital-acquired infections. Additionally, the SNP typing suggested that 
these strains had very low numbers of SNPs difference from each other, showed a 
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significant degree of homology between the strains. Profiling these isolates in this study 
also indicated that all isolates were typed as ST80 belonging to clonal complex (CC17) 
among both babies in the NICU. This finding strongly suggests that E. faecium isolated 
from feeding tubes and faecal samples from the two neonates had likely originated from 
the same source.
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Chapter 6. Conclusions and Future Work 
6.1. Conclusions 
Preterm infants in Intensive Care Units (ICUs) are considered to be high-risk patients due 
to their increased susceptibility to infections during hospitalisation (Ramasethu, 2017) 
and exposure to harmful pathogens through various routes. There are several risk 
factors to neonatal infection, the most important of which would include the use of 
medical devices such as nasogastric enteral feeding tubes (NEFTs). These tubes may also 
contribute to colonisation of neonates by pathogenic microorganisms, as they are often 
required to feed new-borns (Hurrell et al., 2009a; Gómez et al., 2016). The colonisation 
of nasogastric enteral feeding tubes by opportunistic pathogens has not received much 
attention prior to this study. The accumulation of bacterial clumps inside feeding tubes 
from biofilm formation can act as a locus and it has been recognised as a possible source 
of infectious organisms. Ingestion of these organisms would likely increase the risk of 
neonatal infection. 
➢ The first part of this study (chapter 3) involved profiling a unique clinical 
collection of A. baumannii isolated from neonatal feeding tubes from NICUs in 
two separate hospitals. Consequently, characterisation of a range of phenotypic 
and genotypic traits were applied to answer several key questions. This involved 
identifying the species, source and relatedness of these strains. Furthermore, it 
was determined whether some of the strains originated from common sources, 
such as being transferred to multiple patients within specific neonatal units. 
Moreover, we sought to evaluate the possible risk to neonates acquiring these 
organisms through feeding tubes. 
All strains isolated from feeding tubes were identified as A. baumannii using 
rpoB sequencing. The representative strains were confirmed as A. baumannii through 
whole genome sequencing (WGS). The analyses revealed an agreement between the 
rpoB and WGS data, suggesting that the partial rpoB sequence is likely to be a reliable 
and rapid identification method for Acinetobacter species. The PFGE technique showed 
that all strains clustered into five different pulsotypes, with the majority of strains 
clustering with pulsotype Ac1. During a period of five months, strains of the same 
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pulsotype (Ac1) were isolated from both hospitals (KAH and PRH). This indicates the 
ability of these strains to survive and persist for long period of time, possibly in both 
biotic and abiotic environments. MLST analysis revealed 2 different STs (ST193 and 
ST113). However, PFGE differentiated the isolates into 5 distinct patterns, whereas 
MLST identified two different STs, suggesting that PFGE is a more discriminatory typing 
method than MLST for these isolates. 
All strains showed a high level of biofilm formation and produced more biofilm at 37 °C 
than at 25 °C in infant formula. Biofilm formation in A. baumannii is therefore influenced 
by incubation temperature. This study also revealed that there was no correlation 
between biofilm formation and capsular material produced, as well as amount of 
cellulose produced. Multiple drug-resistant strains of A. baumannii were detected in 
this study. This illustrates the fact that the neonates were exposed to strains which were 
highly resistant to antibiotics. These strains also showed an ability to survive at low 
acidity (pH 3.5) for up to 2h, which may increase the risk of exposure to bacterial 
pathogens in neonates. Tolerance of desiccation, resistance to human serum, and high 
level of biofilm formation were also observed. These features enable the strains to cause 
infection as a result of ingestion. These results would indicate survival and persistence 
of these strains in hospitals where neonates are at high risk of nosocomial infection in 
NICUs. 
The genome comparison study revealed that all sequenced ST113 isolates harboured 
genes of the csu cluster and were able to form biofilm and to adhere to the Caco2 cell 
line. Non ST113 strains lacked the csu locus and were poor biofilm formers with low 
Caco-2 attachment. There was a significant correlation between epithelial cell 
adherence and biofilm formation. Such traits may confer persistence and survival of 
these strains in neonatal intensive care units and colonisation in enteral feeding tubes. 
This could explain the ability of these isolates to successfully colonise neonatal feeding 
tubes and offers the opportunity for these isolates to survive and potentially cause 
subsequent infections in the neonate. The majority of these strains were able to persist 
and replicate inside macrophages for up to 72 hours of incubation and were observed 
to be moderately cytotoxic to Caco-2 cells. Such characteristics might enhance the ability 
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of these strains to evade the host immune response and cause bacteraemia. In addition, 
it can be expected that the pathogenic potential of A. baumannii could lead to infection 
of neonates in NICUs. 
In general, these isolates were defined as multidrug-resistant and showed an ability to 
form significant amounts of biofilm. These isolates have also shown the ability to 
tolerate acidic conditions, desiccation, and survive in human serum. Furthermore, other 
important observations included their ability to attach and invade intestinal epithelial 
cells and persist inside macrophages. These features could allow them to survive and 
facilitate their persistence and transmission in the NICU. Additionally, contaminated 
neonatal feeding tubes could serve as reservoirs for pathogenic A. baumannii. This 
strongly indicates a possibility of neonatal infections resulting from the persistent 
exposure by ingestion in hospitals where the neonates are at high risk of nosocomial 
infection in NICUs. 
➢ The second part of the study (chapter 4) aimed to profile a diverse clinical 
collection of Enterobacter species, in particular E. hormaechei, by applying a 
range of phenotyping and genotyping methods to elucidate the potential risk of 
these species to neonates in NICUs. Additionally, this part of the study aimed to 
evaluate possible correlations between E. hormaechei isolated from sepsis and 
neonatal feeding tubes and the frequency of virulence genes.  
 PFGE profiles indicates that all of the Enterobacter strains formed unique, 
distinguishable pulsotypes. These strains were isolated from an NICU during a 7-year 
period and were unlikely to be related to one another. fusA typing was able to identify 
E. hormaechei and E. aerogenes, but was not able to discriminate between the 
subspecies of E. hormaechei, while the rest of strains were not clearly identified and 
clustered within the Enterobacter genus. Misidentification is a problematic issue during 
clinical infection, particularly in NICUs, because it may result in inappropriate treatment 
of the disease and mislead the investigation and attribution of the source of infection. 
WGS was performed for accurate identification and typing of pathogens. 
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The quantity of biofilm formation was higher in infant formula when compared to TSB 
medium and higher at 37 °C compared to 25 °C. It was noted that the quantity of biofilm 
production was influenced by formula type and incubation temperature for the majority 
of tested isolates. Capsules and production of cellulose were confirmed to have no 
active role in biofilm production. In this study, the results also indicated no association 
between the morphology of Enterobacter isolates on Congo Red agar, which revealed 
Curli fimbriae expression. 
The majority of Enterobacter species were able to produce capsular material on whey 
rather than soya-based infant formula. This finding may indicate the difference in 
composition of infant formula used possibly affects the production of capsular material. 
Protease and haemolysins were detected among the tested Enterobacter strains, which 
also, possess genes for enterobactin and aerobactin siderophore biosynthesis 
(entABCDE and IucC). This may enhance the ability of pathogenic bacteria to grow in a 
human host in conditions of low-level iron concentrations and facilitate replication 
during infections. All tested strains showed an ability to survive in human serum, 
suggesting this would be of increased clinical concern to neonates in the NICU, especially 
those with compromised immune systems, making them highly susceptible to infections.  
Enterobacter were defined as multidrug-resistant and harboured resistance genes, such 
as fosA, blaACT β-lactamase and efflux pump AcrAB-TolC. Among these isolates, only E. 
hormaechei subsp. steigerwaltii 1977 isolated from CSF showed resistance to all 
antibiotics used in this study and possessed more antimicrobial resistance genes. Such 
isolates raise concern, suggesting that more attention should be given to neonates in 
NICUs to control the spread of these MDR isolates, particularly among preterm and low 
birth-weight infants. These isolates demonstrated the ability to maintain their viability 
during a 14-day period of desiccation in infant formula. Furthermore, these isolates 
showed a clear resistance to exposure to pH 3.5 for 2 hours. All E. hormaechei isolates 
were found to harbour the rpoS gene which is associated with various stress responses. 
Moreover, isolates were shown to have different nucleotide sequences corresponding 
to this gene, possibly suggesting a positive correlation between bacterial acid tolerance 
and rpoS activity.  
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This part of the study provided the first known investigation into the possible correlation 
between E. hormaechei isolated from sepsis and neonatal feeding tubes and how closely 
related they are. Also, it was essential to evaluate the potential risk to neonates 
acquiring organisms from enteral feeding tubes through ingestion of contaminated feed. 
This work has shown that feeding tube strains exhibited a similar behaviour to that 
observed in isolates from CSF and sepsis cases, as they have the ability to adhere to and 
invade Caco-2 and HBMEC cell lines. It was interesting to note that feeding tube isolates 
showed no significant difference when compared to sepsis isolates for their ability to 
attach to Caco-2. Also, these strains were able to persist and replicate inside 
macrophages for up to 72 hours of incubation and showed a similar level of MTT 
reduction to some sepsis strains. Other important observations included their ability to 
attach to and invade intestinal epithelial cells and persist inside macrophages. Feeding 
tube strains also shared the same virulence genes despite differing from each other by 
a very high number of SNPs (up to 66,582 SNPs).  For example, curli fimbriae genes 
csgABCD have been detected in all assessed E. hormaechei strains. However, the 
CsgA protein is the major subunit of curlin, which has been linked to the ability of E. 
hormaechei to attach to Caco2 cell-lines. It is clear that these strains would have the 
ability to cause infections in neonates in NICUs. There are several reasons which may 
explain the potential risk of these species to neonates in NICUs. The isolates recovered 
from neonatal feeding tubes were defined as multidrug-resistant and showed an ability 
to form significant amounts of biofilm. These strains also showed an ability to tolerate 
acidic conditions, desiccation, and survive in human serum. It can be concluded these 
features could allow them to survive and facilitate their persistence and dispersal within 
the NICU. The results of this study indicate that these bacteria are potentially virulent 
and could present a significant risk to the health of premature neonates in the NICU. 
➢ The third part of this study (chapter 5) focussed on analysis of samples collected 
from preterm infant twins during their hospitalisation in NICU. This longitudinal 
study of twin babies aimed to compare potentially pathogenic isolates within 
and between the feeding tubes and faeces of two twin babies over time. Their 
exposure to pathogens through different routes of transmission may result in a 
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potential infection. The level of exposure during the infant’s hospitalisation is 
expected to influence the microbial colonisation in their gut.   
The isolates collected from two premature babies were identified using 16S rRNA 
sequencing. Due to the limited resolution of this method, E. faecium isolates were 
selected as representative strains among the most common species isolated, and 
confirmed by Whole-genome sequencing to help provide a complete picture of diversity 
among the population.  
SNP typing suggested that these strains had very low numbers of SNPs difference from 
each other and showed a significant degree of homology between the strains. Profiling 
the isolates in this part of the study revealed that all isolates were typed as ST80, 
belonging to clonal complex (CC17), among both babies in the NICU. This analysis 
showed that E. faecium isolated from feeding tubes and faecal samples from the two 
neonates had a remarkable degree of homology between them, suggesting that they 
likely originated from the same source. 
All E. faecium strains demonstrated a high amount of biofilm formation. Indeed, the 
ability of bacteria to form biofilms inside feeding tubes are a major concern. It is believed 
that bacterial biofilms are able to persist on medical device surfaces and are an 
important risk factor for invasion and dissemination of microbes within the host, and 
therefore carries an increased risk of disease. All E. faecium strains in the present study 
had detectable lipolytic and proteolytic activity and were able to induce α-haemolysis. 
Additionally, these strains showed an ability to tolerate human serum. When taken 
together, these findings would suggest an increased clinical concern to neonates in 
NICUs with compromised immune systems, who are highly susceptible to infections. 
Data from the present study indicated that all E. faecium strains harboured the gltK gene 
and were able to replicate in and resist conditions of low acidity. This suggests that this 
gene may contribute to resistance to acidic conditions and can be considered as a 
feature which may result in infections of neonates. Moreover, these strains showed an 
ability to tolerate heat at 55 °C for 30 minutes in liquid infant formula. These risks would 
seriously increase the concern to the neonate’s health. Premature babies could be 
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exposed to such organisms from contaminated milk or the surrounding environment, 
which includes ingestion of these organisms via feeding tubes. 
These isolates demonstrated an ability to adhere to Caco-2 cells, produce high levels of 
biofilm, resist human serum and persist in low pH conditions. Such properties may 
provide a reason to explain their persistence among the two neonates investigated 
during the study period. Moreover, these strains harboured several virulence-
associated genes such as acm, ebpA, ebpB, ebpC, ecbA, esp and sqrA. This observation 
suggests that the existence of additional virulence factors could enhance the virulence, 
fitness and persistence of these isolates, as well as increase the incidence of infection. 
The acquisition of different virulence factors among multidrug-resistant strains could 
possibly contribute to their emergence as prominent nosocomial pathogens, and 
furthermore, could be the reason behind their high prevalence among the two neonates 
during the three-month period.  
These results led to the conclusion that these strains isolated from different neonatal 
locations were indeed the same clone and were able to persist and be transferred 
between the two premature infants in the NICU. This suggests that the isolates 
recovered from feeding tubes and faecal samples among the two neonates were likely 
derived from the same local source. It was also concluded that the persistence of 
antibiotic-resistant E. faecium, acquired by premature infants during hospitalisation in 
the NICU, may lead to an increased risk among these neonates. The gut microbiota 
composition during the first 3 months may have important health consequences and 
may be linked to numerous problems later in life 
In summary, the present study has provided additional further insight to support the 
existing knowledge of the important risk factors of these isolates with respect to 
neonatal infections in NICUs. This study has provided evidence of colonisation and 
persistence of opportunistic pathogens (belong to the ESKAPE group) in neonatal 
feeding tubes, which are important causes of nosocomial infection and dissemination of 
multidrug-resistant (MDR) strains. Feeding tubes act as a loci where bacterial cells can 
adhere, colonise, and produce multi-species biofilm. These bacteria are likely to be 
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resistant to different stress conditions and therefore pose a serious potential risk to 
neonates in NICUs.  
 
6.2. Future directions  
The present study focused on profiling a clinical collection of strains isolated from 
neonatal feeding tubes, faecal samples and sepsis samples from neonates in NICUs, to 
evaluate the important risk factors of these isolates with respect to neonatal infections 
in NICUs. However, further research is needed to extend our knowledge about 
physiological and virulence traits, and to find an effective method or policy that can 
prevent the spread of such strains among neonates in NICUs. Future work should focus 
on the following areas: 
➢ Real-time qPCR analysis would be required to determine gene expression among 
examined isolates. 
➢ Performing proteomic approaches to investigate the synthesis of virulence 
proteins and their mechanisms of action. Proteomic profiling may contribute to 
a better understanding of pathogen physiology. 
➢ Knockout methods using gene deletion for studying genes to confirm the role of 
each gene in virulence-related traits. 
➢ Characterisation of isolates obtained from samples taken from different sites in 
the hospital environment, as well as from carers and different milk samples, to 
identify potential reservoirs of infection. 
 
The present PhD study has also provided important recommendations in controlling and 
preventing such strains from being transmitted between neonates, which may occur due 
to prolonged hospitalisation. For example, improving practices in the preparation of 
feed would be a significant step in controlling and preventing infection through milk 
sharing and contamination of equipment used in feed preparation. Additionally, heavy 
colonisation by pathogenic bacteria can be prevented by avoiding placement of enteral 
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feeding tubes for prolonged periods. Improved personal hygiene is also recommended, 
which is essential to preventing the growth and transmission of pathogens, and as a 
result, protect the babies in the NICU. Moreover, routine microbiological 
screening should be performed to detecting probable sources of pathogens, particularly 
in NICUs with preterm infants and low birthweight neonates in order to minimise and 
prevent the possible risk of pathogen transmission.
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